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TARGETED DELETION OF FUNCTIONALLY VALIDATED ENHANCERS DEFINES 
THEIR ROLE IN MOUSE LIMB DEVELOPMENT 
Publication No.________     
Mark Joseph Nolte, Ph.D. 
 Supervisory Professor: Richard R. Behringer, Ph.D. 
Transcriptional enhancers are genomic DNA sequences that contain clustered 
transcription factor (TF) binding sites. When combinations of TFs bind to enhancer sequences 
they act together with basal transcriptional machinery to regulate the timing, location and 
quantity of gene transcription. The diversity in morphological and behavioral traits between and 
within species is at least partially a result of the differential expression of individual genes and 
gene networks during embryological and postnatal development. Thus elucidating the genetic 
mechanisms responsible for differential gene expression is essential to an understanding of 
development, evolution and disease. Numerous methods are in use to identify and characterize 
enhancers. Several high-throughput methods generate large datasets of enhancer sequences with 
putative roles in embryonic development. However, few enhancers have been deleted from the 
genome to determine their roles in the development of specific structures, such as the limb. 
Manipulation of enhancers at their endogenous loci, such as the deletion of such elements, is 
essential to understanding the regulatory interactions, rules and complexities that contribute to 
faithful and variant gene transcription – the molecular genetic substrate of evolution and 
disease. To understand the endogenous roles of two distinct enhancers known to be active in the 
mouse embryo limb bud we deleted them from the mouse genome. I hypothesized that deletion 
of these enhancers would lead to aberrant limb development.  
The enhancers were selected because of their association with p300, a protein associated 
	  	   ix	  
with active transcription, and because the human enhancer sequences drive distinct lacZ 
expression patterns in limb buds of embryonic day (E) 11.5 transgenic mice. To confirm that the 
orthologous mouse enhancers, mouse 280 and 1442 (M280 and M1442, respectively), regulate 
expression in the developing limb we generated stable transgenic lines, and examined lacZ 
expression. In M280-lacZ mice, expression was detected in E11.5 fore- and hindlimbs in a 
region that corresponds to digits II-IV. M1442-lacZ mice exhibited lacZ expression in posterior 
and anterior margins of the fore- and hindlimbs that overlapped with digits I and V and several 
wrist bones. We generated mice lacking the M280 and M1442 enhancers by gene targeting, 
replacing the enhancers with a neomycin resistance gene that was subsequently removed by Cre 
recombinase. Intercrosses between M280 -/+ and M1442 -/+, respectively, generated M280 and 
M1442 null mice, which are born at expected Mendelian ratios and manifest no gross limb 
malformations. Quantitative real-time PCR of mutant E11.5 limb buds indicated that significant 
changes in transcriptional output of enhancer-proximal genes accompanied the deletion of both 
M280 and M1442. However, when alizarin red and alcian blue stains were used to visualize 
bone and cartilage in neonatal null mice we observed that all limb bones were present in their 
expected positions, an observation also confirmed by histology of E18.5 distal limbs. Fine-scale 
measurement of E18.5 digit bone lengths found no differences between mutant and control 
embryos. Furthermore, when the developmental progression of cartilaginous elements was 
analyzed in M280 and M1442 embryos from E13.5-E15.5, transient development defects were 
not detected. These results demonstrate that M280 and M1442 are not required for mouse limb 
development. Additionally, these studies highlight the importance of experiments that 
manipulate enhancers in situ to understand their contribution to development. More broadly, our 
findings suggest that transcriptional regulation is complex and that no single enhancer validation 
method is yet capable of predicting whether an enhancer is required for development. 
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INTRODUCTION  
An ever-expanding understanding of vertebrate limb development is desirable from at 
least two levels of biological inquiry: from what one may call a proximate, or developmental 
level, and from an ultimate or evolutionary level. At the proximal or developmental level 
researchers attempt to describe the molecular genetic mechanisms responsible for the 
specification, differentiation and growth of the limb during embryogenesis (reviewed in 
(Rabinowitz and Vokes, 2012) (Zeller et al., 2009) (Tickle, 2006)). The attractiveness of the 
limb system for molecular developmental studies derives from the complex, coordinated 
generation of bones, muscles, nerves and tendons along three interdependent axes: proximal-
distal (shoulder/femur to digit tips); dorsal-ventral (back of hand/foot to palm); anterior-
posterior [thumb (digit 1) to pinky (digit 5)]. The limb has become an ideal system within which 
key concepts in developmental biology are tested, confirmed, rejected and generated. For 
example, the concepts of diffusible signals (Rosello-Diez et al., 2011) (Cooper et al., 2011), 
signaling pathway crosstalk (Laufer et al., 1994) (Pajni-Underwood et al., 2007), and organizing 
centers embodied in the apical ectodermal ridge (AER) (Sun et al., 2002) and zone of polarizing 
activity (ZPA)(Hill., 2007), (Furniss et al., 2008) are interwoven into a genetic explanation for 
the pattering and outgrowth of the limb into three general regions: the stylopod comprising the 
humerus, the zeugopod comprising the radius and ulna, and the autopod comprising the bones of 
the wrist and the digits. Developmental mechanisms discovered in the context of limb 
development, and conceptual themes formulated to account for the complexity of our increasing 
understanding of limb development should continue to be transferrable to an understanding of 
the development of other structures and disease. Perhaps this is both the hope and the reason 
behind the consistent production of research centered on limb development, particularly in the 
mouse and chick. 
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Continued research on vertebrate limb development also appeals to questions and 
observations stemming from an ultimate or evolutionary level of biological inquiry (Zakany and 
Duboule, 2007; Shubin et al., 2009). Widely divergent vertebrate fore- and hindlimb 
morphologies appear in the fossil record and in extant organisms, including species with 
reduced or supernumerary bone numbers (Shubin et al., 2006), webbed autopods (Hockman et 
al., 2008) and limb bone elongations (Sanchez-Villagra and Menke, 2005; Mitgutsch et al., 
2012). Exploration into how these varying morphologies appeared and disappeared in the fossil 
record, and how they are maintained and contribute to fitness in extant vertebrates enhances our 
understanding of evolutionary mechanisms. The continued study of the proximate causes of 
appendage development in numerous organisms has undoubtedly demonstrated that limb 
development in all organisms depends on the interplay of key conserved genes and signaling 
pathways, such as the homeobox (Hox) transcription factors, Sonic hedgehog (Shh), Bone 
morphogenetic proteins (Bmp) and Fibroblast growth factors (Fgf) (Shubin et al., 1997), 
(Rabinowitz and Vokes, 2012).  Although a consensus picture of the genetic circuits underlying 
limb development has emerged from genetic studies in mice and chick, less is known about the 
genetic components responsible for the execution and regulation of these circuits.  
One important form of transcriptional regulation that may simultaneously contribute to 
the diversity of the deployment of limb-related genetic circuits and final species-specific limb 
morphologies is encoded in transcriptional enhancers. Enhancers can be defined as primary 
sequences of genomic DNA that contain clustered transcription factor (TF) binding sites 
(Levine, 2010). When particular TFs or combinations of TFs bind to enhancer sequences they 
can act in concert with basal transcriptional machinery at a promoter to regulate the timing, 
location and quantity of gene expression (Banerji et al., 1981), (Visel et al., 2009b), (Ohler and 
Wassarman, 2010). Enhancers may be located 5’, 3’, or within the introns of the genes they 
regulate (Chandler et al., 2007; Feng et al., 2008), and the proximity of multiple TF binding 
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sites within enhancers confers them with modular behavior. An enhancer can be removed from 
its endogenous loci, linked in any orientation to a reporter gene (lacZ, for example), and still 
regulate the reporter gene transcription in a repeatable temporal and spatial pattern (Mortlock et 
al., 2003). Research aimed at uncovering the molecular genetic sources of divergent limb 
morphology, such as the role that enhancer variation may play in species-specific activation of 
gene circuits, serves as a bridge between the motivations underpinning questions centered on 
proximate and ultimate explanations of limb development. 
Recent reviews have synthesized the current understanding of the importance of limb 
enhancers in disease etiology (and the relevance of enhancers in other forms of disease genesis 
and progression) (VanderMeer and Ahituv), (Sakabe et al., 2012). Other papers have hinted at 
the relevance of enhancer biology in explaining diverse limb morphologies characterized in 
paleontological and comparative embryological studies (Chen et al., 2005; Cretekos et al., 2005; 
Nolte et al., 2009). These papers do much to lay the conceptual and observational foundation 
necessary to generate excitement about the role that enhancers play in generating a diversity of 
limb patterns, both adaptive and maladaptive. On the other hand, functional analyses of limb 
enhancers (or enhancers in general) have somewhat lagged behind the enthusiasm for the topic. 
An appropriate way to characterize the role of a particular genetic element in development and 
disease is to use functional genetic methods to manipulate the element at its endogenous locus. 
As with genes, functional manipulation of enhancers can be achieved using conventional gene 
targeting techniques as well as by using somewhat more recently employed Cre-lox 
recombination techniques that rearrange genetic loci independent of extensive mouse embryonic 
stem cell handling (Herault et al., 1998), (Nagy et al., 2003), (Spitz et al., 2005) . The few limb 
enhancers that have been functionally manipulated have contributed greatly to our 
understanding of enhancer regulation generally and limb development and evolution specifically 
(discussed below). However, given the complexities of limb development (Taher et al., 2011a) 
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and limb diversity there are a great many more limb-specific enhancers to be characterized and 
identified. Numerous methods exist to identify potential tissue-specific enhancers; so much so 
that the availability of datasets composed of potential enhancers – limb and otherwise – has far 
outpaced careful functional genetic experimentation to characterize enhancers. In response to 
this situation several relevant questions come to mind: Are all methods used to identify 
enhancers equally valid, or are some better than others? In other words, which methods provide 
the least amount of false positives? Do all active enhancers in a particular tissue share a 
common modified-chromatin signature? If not, why not? If so, how do we filter away false 
positives; that is, other genetic elements that may carry the chromatin signature as well but that 
do not contribute to tissue-specific gene expression? Do highly conserved enhancers contribute 
to gene activation involved in the genesis of shared tissue elements across multiple species, 
while non-conserved enhancers contribute to more derived aspects of tissues?  I suggest that no 
matter what methodology is used to identify putative enhancers, an endogenously based, 
functional genetic approach to enhancer characterization is necessary to address these questions.  
Indeed, functional genetic experiments are essential to appropriately interpret and model 
enhancer behaviors responsible for congenital limb malformations and the evolution of diverse 
limb morphologies. Therefore, below I will briefly review what is known from studies that 
functionally manipulated limb enhancers and discuss the methods used to identify enhancers. 
One method in particular – the use of Chromatin immunoprecipitation with sequencing (ChIP-
seq) targeted at an enhancer-associated protein – produced a plethora of data suggesting that 
hundreds of enhancers contribute to region-specific development of the mouse limb. I then 
introduce the functional genetic approach I took to put these particular findings to the test. 
 
 
Enhancer-gene proximity led to first discoveries of limb-specific enhancers 
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The assumption that enhancer elements were likely situated somewhere near gene 
transcription start sites led to the characterization of some of the earliest discovered limb-
specific enhancers. The Hoxb6 enhancer is among the earliest characterized enhancers to drive 
reporter gene expression in the embryonic mouse limb, although it also directs expression 
elsewhere including the trunk between the limbs (Schughart et al., 1991). It was determined that 
strong limb-specific enhancer elements lie between 1,200-3,600 base pairs (bps) upstream of 
Hoxb6 because this region was consistently capable of expanding and intensifying anterior and 
posterior lacZ expression in the undifferentiated mesenchyme of early mouse limb buds when 
added to a lacZ-transgene directed by a smaller 1.2 kb upstream sequence (Schughart et al., 
1991). 
The limb-specific Prx1 enhancer was identified in a manner similar to the Hoxb6 
enhancer. In transgenic mice, this Prx1 enhancer, a 2.4 kb stretch of DNA just 5’ of Prx1, was 
capable of driving lacZ expression that recapitulated most of the known Prx1 limb mesoderm 
expression pattern from E10.5 to birth, though small differences were noted (Martin and Olson, 
2000).  
 Neither the Prx1 nor Hoxb6 enhancer can direct transcription in the limb ectoderm. The 
AER, a portion of the distal limb ectoderm, is essential for proper limb development. The AER 
is required for limb outgrowth, and signals from the AER, including FGF family members, are 
required, via a genetic circuit, to maintain Shh expression in the ZPA. Two AER-active 
enhancers were discovered that served and serve as tools to dissect the AER’s role in limb 
development (see below): one is associated with retinoic acid receptor β2 (RARβ2) and the 
other comes from the Msx2 locus (Mendelsohn et al., 1991; Reynolds et al., 1991; Liu et al., 
1994). As was the case with the Prx1 and Hoxb6 enhancers, the RARβ2 and Msx2 AER-
enhancers were relatively close to their cognate gene’s transcriptional start site (located within 
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the 3100 bps upstream of RARβ2; and located within the 500 bps upstream of Msx2). 
Interestingly, RARβ2 is not usually expressed in the AER, suggesting that when this enhancer is 
removed from its endogenous context it is not restrained by nearby repressor elements 
(Mendelsohn et al., 1991). 
 
Endogenously manipulated limb enhancers  
 
By uniting the tissue-specificity of limb enhancers with Cre recombinase and other 
endogenously manipulated genes (such as floxed Bmps, for example) the functional role of 
particular genes during limb development can be assessed. But a fuller understanding of limb 
development is only possible when the enhancers themselves are also manipulated in their 
endogenous loci; such experiments have the potential to elucidate the role of individual 
enhancers in the elaboration of the limb.  To appropriately complement transgenic assays – 
which may or may not faithfully mimic the regulatory abilities of a tested enhancer at its 
endogenous loci –it is necessary to manipulate them within their native genomic context. The 
use of homologous recombination to introduce a manipulated genomic fragment into the 
genome of mouse ES cells, or gene targeting, has been used extensively to knockout, disrupt 
and modify hundreds of genes (Nagy et al., 2003). This same approach has been used, 
comparatively, to a limited extent to knockout or modify enhancer loci, but those loci that have 
been targeted tell us much about the nature of gene regulation during limb development. 
Moreover, two methods that employ the Cre recombinase technology in concert with meiotic 
recombination to delete, duplicate or invert portions of the mouse genome have also been used 
to characterize in a detailed manner the enhancer activity of one locus, the Hoxd cluster, in the 
mouse (Herault et al., 1998; Spitz et al., 2005). Insights gleaned from the functional dissection 
of Hoxd cluster regulation beg for continued research of similar intensity at other loci relevant to 
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limb generation.  For purposes of this discussion we consider any disruption of an enhancer’s 
endogenous locus as a functional alteration, including those caused by transgene insertions and 
chromosomal alterations.  
 
Sonic Hedgehog Enhancer 
 
While producing transgenic mice for the purpose of expressing a reporter gene in a 
rhombomere 4-specific manner, Sharpe et al. (1999) disrupted a long-range enhancer positioned 
approximately 850 kb from Shh (Lettice et al., 2002). Interestingly, later cloning efforts revealed 
that the insertion of the transgene concatemer resulted in the duplication of intron 5 of Lmbr1, 
the gene within which the Shh-regulatory sequence is located (Lettice et al., 2002). This 
suggested that in addition to sequence mutations/alterations, topographical changes to an 
enhancer could alter transcriptional output of regulated genes as well. Altered limb morphology 
induced by the duplicated enhancer included polydactyly, extra inverted claws and dorso-ventral 
patterning defects. In mutants, ectopic anterior expression of numerous genes that regulate distal 
limb patterning were also observed including Shh, Ffg4/8 and Hoxd12/13 (Sharpe et al., 1999). 
Such anterior misexpression of these genes had been noted before in mouse and chick models 
displaying limb patterning defects, including preaxial polydactyly (Riddle et al., 1993; Masuya 
et al., 1995; Sagai et al., 2004; Masuya et al., 2007).  
The transgene-disrupted enhancer was later called the Zone of Polarizing Activity 
Regulatory Sequence (ZRS) because of its ability to drive lacZ-reporter gene expression in a 
manner similar to Shh expression in the ZPA (Lettice et al., 2003). Further confirmation that the 
ZRS regulated limb-specific Shh expression came when gene targeting was used to delete the 
1.2 kb enhancer (Sagai et al., 2005). The mutant mice displayed distally truncated fore- and 
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hindlimbs at E12.5 and in situ hybridization showed loss of Shh expression in developing limbs 
(Table 1). 
 The differences in phenotypes associated with the different alterations to the ZRS above 
hint at the complexity of enhancer-gene transcription relationships: complete deletion of the 
ZRS resulted in severe skeletal truncations in both fore- and hindlimbs (Sagai et al., 2005). 
However, a topographical change to the ZRS induced by transgene insertion resulted in an 
imbalanced phenotype, with hindlimbs more severely affected than forelimbs (Sharpe et al., 
1999). Duplication-based mutations of the ZRS are also responsible for some reported human 
familial syndactylies (Wieczorek et al.; Sun et al., 2008). Moreover, numerous single nucleotide 
polymorphisms in this enhancer have been linked to distinct, yet related, distal limb 
malformations in humans (Wieczorek et al.; Furniss et al., 2008) (also, human SHH mutations 
summarized in (VanderMeer and Ahituv)). These results suggest that enhancer sequences as 
well as the topographical relationship between an enhancer and its regulated gene are important 
for proper gene transcription. The range of phenotypes associated with ZRS alterations also 
hints at the diversity of enhancer mutations that could potentially contribute to varied limb 
morphologies in extant and extinct vertebrates. 
 
Prx1 Enhancer 
 
The discovery and characterization of the Prx1 enhancer was discussed previously. The 
ability of this enhancer to regulate limb-specific expression patterns that mimic endogenous 
Prx1 suggested that its targeted deletion should phenocopy the limb malformations of Prx1 null 
mice, which manifest shortened long bones in fore- and hindlimbs (Martin et al., 1995; Lu et al., 
1999). However, when the limb-specific Prx1 enhancer was deleted the limbs were 
indistinguishable from control littermates, suggesting that redundant Prx1 limb enhancers 
	  	   9	  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 1. Phenotypes associated with endogenously manipulated limb enhancers. Targeted 
limb enhancer deletions cause a range of phenotypes, from no alteration (Prx1), to moderate 
(Hoxd GCR + Prox) to severe (Shh). Neomorphic changes in limb patterning have been reported 
for a deleted (Tcfap2α) and replaced (Prx1) limb enhancer. Red indicates site of detected 
phenotype. See text for details and references.  	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compensate for its loss (Cretekos et al., 2008). Interestingly, when gene targeting was used to 
replace the mouse Prx1-limb enhancer with the orthologous bat enhancer (from Carollia 
perspicillata) the homozygous bat-enhancer-mice develop slightly longer forearms and express 
1.7 fold higher amounts of Prx1 than control littermates (Cretekos et al., 2008). These results 
demonstrate that although redundant enhancers regulate Prx1 limb expression, minor sequence 
variation in a single enhancer can account for some of the length differences observed in mouse 
and bat forelimb morphology [~93.5% sequence similarity between mouse and bat in the two 
core conserved regions of this enhancer (Martin and Olson, 2000; Cretekos et al., 2008)]. 
 
Tcfap2α Enhancer 
 
Like Prx1, Tcfap2a is required for mouse craniofacial and limb development. Mice 
lacking both copies of Tcfap2a lose their cranial neural crest cell derivatives, display midline 
clefting and possess malformed radii (Schorle et al., 1996; Zhang et al., 1996; Nottoli et al., 
1998; Brewer et al., 2004). Zhang et al. (2003) identified an enhancer element in the fifth intron 
of Tcfap2a that could direct lacZ expression to the frontal nasal process and limb bud 
mesenchyme when linked to the Tcfap2a minimal promoter region (Zhang and Williams, 2003). 
Further refinement of this enhancer identified the downstream conserved element (DCE), which 
is highly conserved in all vertebrates, indicating that the DCE performs an essential role in 
regulating Tcfap2 expression during vertebrate appendage development (Donner and Williams, 
2006; Feng et al., 2008). 
To functionally test this hypothesis, Feng et al. (2008) used gene targeting to remove 
530 bps from the Tcfap2a-fifth intron, which included the entire DCE. Concordant with the 
known role of the DCE in regulating limb-specific Tcfap2a transcription, mice bearing a 
homozygous deletion of the DCE invariably manifested a patterning defect in the forelimbs, but 
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not in the hindlimbs. Forelimbs of DCE null mice possessed an extra posterior digit, concordant 
with reduced Tcfap2a expression in mutant limb buds (Feng et al., 2008). Thus, contrary to the 
results obtained from the Prx1-enhancer knockout mice, the deletion of Tcfap2a’s fifth intron-
enhancer demonstrates that single enhancers can play important roles during limb development. 
On the other hand, the Tcfap2a-enhancer null mice did not recapitulate the limb phenotypes 
observed in mice harboring Tcfap2a -/- alleles (Schorle et al., 1996; Zhang et al., 1996; Nottoli 
et al., 1998; Brewer et al., 2004) thus the action of partially redundant Tcfap2a-limb enhancers 
at this locus seems likely. 
 
Tbx4 Enhancer 
 
Several genes are differentially expressed in the fore- and hindlimb, including Tbx4 and 
Tbx5. Tbx4 is preferentially expressed in the hindlimb (Chapman et al., 1996); although mice 
lacking this gene die in mid-gestation, hindlimb development was still observed to have been 
adversely affected (Naiche and Papaioannou, 2003).  
To identify hindlimb-specific enhancer elements Menke et al. (2008) inserted an IRES-
βgeo reporter construct into the 3’-UTR of Tbx4 in three separate BAC transgenes that spanned 
varying lengths of the Tbx4 locus (Menke et al., 2008). Eventually, two core enhancer elements 
residing in the BACs were characterized via their ability to drive lacZ expression: hindlimb 
enhancer A (HLEA) is 1073 bps, and hindlimb enhancer B (HLEB) is 654 bps. Interestingly, 
both HLEA and HLEB were capable of driving lacZ expression in a medial forelimb domain in 
transgenic mice at E10.5-11.5. Thus their ability to direct forelimb gene expression is likely 
suppressed at their endogenous locus by additional insulating regulatory elements. 
Because removal of HLEA from the IRES-βgeo-containing BAC had the greatest impact 
on depleted βgeo staining, gene targeting was used to remove this enhancer from the mouse 
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genome to test its function during development. Whole mount in situ hybridization in E10.5 
embryos showed that Tbx4 expression was reduced in mutant hindlimbs. These expression 
differences presaged the morphological changes observed in adult mice, which included 
shortening of pelvic, femur, patella and tibia bones along at least one of their axes. Additionally, 
hindlimb digits 1, 3 and 5 were significantly smaller when compared to those of control 
littermates (Menke et al., 2008). Again, these results demonstrate that a single enhancer can 
harbor regulatory information necessary for proper limb development and that disruption of a 
single enhancer could potentially provide varied morphological substrates for evolution. 
However, the hindlimb phenotype in HLEA null mice is less severe than that observed in mice 
with a temporally guided, limb-specific deletion of the Tbx4 gene indicating again that other 
enhancers partially compensate for the loss of HLEA (likely HLEB in this case) (Naiche and 
Papaioannou, 2007). 
 
Hoxd Cluster 
 
The Hoxd cluster genes, which along with Hoxa genes are required for autopod 
development (Davis et al., 1995; Fromental-Ramain et al., 1996; Zakany and Duboule, 1996; 
Zakany et al., 1997), are regulated by a wide array of enhancers, located both on the 5’- or 
centromeric and 3’- or telomeric sides of the cluster. Functional tests employing numerous 
chromosomal inversions and deletions using two Cre/loxP-based methods, TAMERE and 
STRING (Herault et al., 1998; Spitz et al., 2005), aided researchers in illuminating the 
multifaceted regulation of the Hoxd cluster. 
Several mouse lines carrying human or mouse Hoxd-cluster-containing transgenes, along 
with the mapping of an X-ray induced inversion that generated mice lacking nearly the entire 
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ulna, indicated that the centromeric side of the cluster housed its limb-specific enhancers 
(Davisson and Cattanach, 1990; Herault et al., 1997; Peichel et al., 1997; Spitz et al., 2001). The 
initial centromeric enhancer region, some 240 kbps upstream from the cluster, was later shown 
to contribute to distal limb reporter gene expression in BAC transgenic mice (Spitz et al., 2003; 
Gonzalez et al., 2007). The region spanned roughly 40 kb of strongly conserved sequence and 
was termed the Global Control Region (GCR) because of its ability to regulate limb expression 
of numerous genes in the vicinity (e.g. Lnp). It was later shown that another centromeric 
enhancer region, called Prox, also contributed to the proper spatial expression of 5’ Hoxd genes, 
such as Hoxd13 (Gonzalez et al., 2007). Specific elements within the GCR and Prox, called the 
CsB and CsC, respectively, directed lacZ expression in the autopods of transgenic mice. 
Interestingly, in a large transgene construct containing both the entire GCR and Prox regions, 
but not the intervening sequence, the distal- and anterior-most expression pattern of Hoxd genes 
was not recapitulated, suggesting that the relative positioning of these two elements – their 
genomic architecture – is also important for faithful endogenous gene expression (Gonzalez et 
al., 2007). 
Further characterization of the GCR’s regulatory role crystalized when Spitz et al. 
(2005) used the STRING method to invert a chromosomal region spanning the Hoxd cluster that 
resulted in a 3 Mb separation between Hoxd1-10 and Hoxd11-13. In situ hybridization against 
Hoxd10 showed that its expression was lost in the distal limb buds but retained in the proximal 
limb buds; the opposite was observed for Hoxd11. Therefore, the GCR, which maintained its 
association with Hoxd11 throughout the inversion, continued to regulate its distal expression. 
And Hoxd10, though out of range of the GCR, maintained its proximal expression domain, 
presumably due to another enhancer region on the telomeric end of the cluster called the Early 
Limb Control region (ELCR) (Zakany et al., 2004; Spitz et al., 2005).  
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The TAMERE method was used to produce a series of deletions and expansions of the 
internal Hoxd cluster and permitted a better characterization of the ELCR’s role in Hoxd-cluster 
limb expression (Herault et al., 1998). For example, internal Hoxd cluster deletions placed 5’ 
Hoxd genes closer to the ELCR. These genes – such as Hoxd13, which is usually expressed in 
autopodal posterior margins after E10 – were now expressed in the anterior and posterior 
margins of E9-9.5 limb buds. Hoxd13’s topographical shift towards the telomeric side of the 
cluster put it under the control of the ELCR, which is capable of directing earlier, more anterior 
expression of Hoxd genes (Tarchini and Duboule, 2006). 
The GCR and ELCR are not the only stretches of enhancers required for proper temporal 
and spatial expression of the Hoxd genes in the limb. When a gene desert centromeric to the 
GCR was inverted using STRING (Spitz et al., 2005), the transcriptional output of Hoxd10-13 
was reduced relative to control limbs, suggesting that important topographical interactions 
between additional enhancers and Hoxd genes had been disrupted. Four discrete enhancers 
within the centromeric gene desert – whose regulatory potential was predicted based on 
chromosome conformation capture assays (both 3C and 4C), sequence conservation, and 
enhancer-related chromatin marks (discussed below) – directed lacZ expression in the limbs of 
transgenic mice (Montavon et al., 2011). 
The various chromosomal rearrangements discussed above illuminated the location of 
limb-specific regulatory regions relative to the Hoxd cluster and provided further evidence that 
the distance between enhancers and genes can influence gene expression and ultimate limb 
patterning. 
To assess the importance of specific enhancers or enhancer-containing regions within the 
Hoxd cluster topography, Cre-mediated recombination was used to delete various enhancer 
elements. Interestingly, the numerous enhancer elements spread throughout the approximately 
830 kb large gene desert centromeric to the Hoxd cluster seem to be partially complimentary, 
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with no single enhancer-region deletion resulting in drastic multi-digit malformations. Still, 
minor phenotypes are associated with single enhancer-region deletions; for example deletion of 
a 240 kb region spanning GCR and Prox results in the absence of a single phalange in digit 5. 
On the other hand, deletions that span several enhancer regions lead to increasingly severe digit 
phenotypes. For example, a deletion spanning the entire 600 kb gene desert results in phalange 
loss in all digits, while a 830 kb deletion that removes the entire characterized centromeric 
enhancer expanse (gene desert + GCR + Prox) results in a severely stunted digit array with 
reduced bone growth in newborn mice; this phenotype resembles that of homozygous Hoxd8-13 
null mice (Montavon et al., 2011).  
The surprisingly subtle nature of the phenotypes associated with deletions of vast 
enhancer regions indicates that the autopodal transcription of Hoxd genes is well buffered 
against perturbations that may affect the activity of any single enhancer element. These 
observations also suggest that isolated non-topographical sequence variations within any given 
enhancer element in this region are unlikely to be responsible for large differences in autopod 
morphology between species. Rather an accumulation of numerous sequence changes across the 
centromeric enhancer interval would likely be required to contribute to striking differences in 
vertebrate autopod morphology. It has been demonstrated in transgenic mice, however, that a 
Greater Horseshoe Bat GCR-ortholog is capable of driving lacZ expression in expanded 
zeugopod and stylopod domains in addition to the expected autopod domain (Ray and Capecchi, 
2008) (see also (Chen et al., 2005)). This indicates that species-specific regulatory sequences 
reside in the bat GCR, though they were not mapped to the GCR-CsB enhancer or any other 
GCR region. In contrast to, or in concert with enhancer sequence variation, the above discussion 
indicates that chromosomal rearrangements, even relatively minor insertions and deletions 
within and around the Hoxd locus (Gonzalez et al., 2007), could greatly impact the temporal and 
spatial expression of Hoxd genes and thus the ultimate morphology of the limb. 
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Gremlin Global Control Region 
 
Work on the limb-specific Gremlin-GCR suggests that global control regions may not 
just be a unique regulatory feature of the collinearly expressed Hox gene loci. The GCR that 
regulates autopodal expression of Gremlin and the nearby gene, Formin, was discovered in a 
circuitous fashion. The phenotypic effects of disrupting this GCR were initially attributed to the 
disruption of Formin, approximately 40 kb downstream of Gremlin, because of its relationship 
to mapped lesions that made up the limb deformity (ld) mutation (Maas et al., 1994; Wang et al., 
1997; Zeller et al., 1999). However, two other ld alleles identified from phenotypic screens were 
then discovered to disrupt Gremlin, placing Gremlin in the same ld complementation group as 
Formin. Moreover, Formin null mice do not manifest limb defects but do present partial renal 
agenesis, whereas Gremlin null mice possess malformed limbs due to AER disruption. This led 
Zuniga et al. (2004) to hypothesize that the ld lesions in Formin were actually disrupting 
enhancer elements responsible for limb-specific expression of Gremlin (Zuniga et al., 2004).  
Confirmation of this hypothesis came when gene targeting was used to delete exon 10 of 
Formin, completely disrupting its C-terminal domain. While mice homozygous for the Formin-
exon 10 deletion have normal limbs, another line of mice possessing a deletion from Formin 
exons 10-24 phenocopied the ld limb defects. Gremlin expression was absent in the autopod of 
these mice. Therefore, it was concluded that regulatory elements internal to the Formin exon 10-
24 interval regulated limb expression of Gremlin (Zuniga et al., 2004). Further confirmation of 
this conclusion came when a BAC transgene that harbored lacZ in the Gremlin locus 
recapitulated endogenous autopod Gremlin expression only when the Formin exon 19-24 
interval was present; when the exon 19-24 interval was removed from the BAC lacZ expression 
was abolished in the developing limb (Zuniga et al., 2004). 
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Methods used to identify limb enhancers 
 
In the post-genomic era, cross-species sequence conservation is an integral part of 
enhancer identification, either as a starting place, as when an enhancer is predicted based solely 
on sequence comparisons (Pennacchio and Rubin, 2001; Haeussler and Joly, 2011), or as a 
validation of other methods, as when a region bound by a TF in a ChIP-seq experiment is also 
highly conserved between species (Visel et al., 2009a). An increasingly diverse array of 
sequence comparison assumptions and algorithms are augmenting the detection of sequences 
encoding functional enhancer activity. For example, the assumption that genes and their 
associated regulatory milieu need to be inherited and selected together prompted Ahituv et al.  
(2005) to utilize cross-species syntenic regions to identify conserved non-coding sequences that 
could potentially regulate developmental genes (Ahituv et al., 2005). Another study 
demonstrated that orthologous yet non-conserved (defined as below 70% identity over 100 bp), 
non-coding sequences, called covert elements, could be detected when the ordering and distance 
between TF binding sites within these elements was taken into account (Taher et al., 2011b). 
Taher et al. (2011) showed that 7/8 covert elements from human and zebrafish discovered using 
their method drove similar reporter gene expression in a zebrafish transgenic assay. An AER-
specific enhancer near the Dach1 locus, which is itself expressed in the AER (Caubit et al., 
1999), was identified using yet another sequence comparison algorithm called Gumby. The 
Dach1-AER enhancer was one among numerous putative conserved enhancers identified from 
sequence comparisons of recently diverged species (e.g. human and mouse vs. human and frog) 
characterized by extremely low Gumby p-values (Prabhakar et al., 2006). Interestingly, another 
method, focusing on sequences conserved across vast phylogenetic distances, from human to 
fish (fugu in this case), had also resulted in identification of a limb-specific enhancer near the 
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Dach1 gene (Nobrega et al., 2003). Despite the somewhat complex complimentary and 
divergent natures of these sequence-based enhancer discovery methods one outcome of their 
application is clear: there are now large quantities of potential enhancers identified near genes 
expressed throughout limb development. Their role in development and evolution awaits 
analysis via transgenic and functional genetic methods.  
 Further bioinformatic and evolutionary approaches can be applied to the criterion of 
sequence conservation to identify enhancers that may drive transgenic lacZ expression in 
unique, species-specific ways. For example, Prabhakar et al. (2008) first identified non-coding 
regions of the genome that were highly conserved between all sequenced terrestrial vertebrates. 
This data set was further filtered using a statistical test that identified human sequences that had 
rapidly diverged from other vertebrates. The authors then focused on a 546 bp sequence, 
human-accelerated-conserved-noncoding-sequence 1 (HACNS1), which was the fastest 
evolving human-specific sequence in the last 6 million years, the time since the last human-
chimpanzee common ancestor. When HACNS1 was ligated to a minimal promoter and lacZ it 
drove expression in the E11.5 mouse limb bud, including the distal tip, suggesting it may have 
played a role in shaping unique human limb morphologies (Prabhakar et al., 2008). It would be 
interesting to functionally test the role of HACNS1 during limb development by either deleting 
it or replacing the homologous sequence in mice with those from the human and chimpanzee. 
 In addition to conventional sequence-based approaches used to identify enhancers are 
those methodologies that take advantage of more recent chromatin immunoprecipitation (ChIP) 
and sequencing technologies. As an example, Vokes et al. (2008) targeted the ubiquitously 
expressed Rosa 26 locus with a floxed-stop cassette and a flag-tagged Gli3-repressor (Gli3R) 
cDNA. Therefore, upon limb-specific, Cre-mediated recombination the stop cassette was 
removed and the tagged Gli3R was expressed. Genomic regions interacting with Gli3R, termed 
Gli binding regions (GBRs), were then identified via ChIP-on-chip. The regulatory potential of 
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several GBR enhancers was then tested by scoring their ability to drive lacZ expression in 
transgenic mice and comparing the lacZ expression pattern with that from genes associated with 
the GBRs. In this manner Gli-associated enhancers were shown to drive limb-specific lacZ 
expression patterns mimicking portions of the limb-specific Gli1, Blimp1 and Gremlin 
expression domains (Vokes et al., 2008).  
In a similar vein, Kouwenhoven et al. (2010) coupled their knowledge that heterozygous 
mutations in p63 correlate with split hand/foot malformation (SHFM) with ChIP-seq 
methodologies to identify binding sites of p63 throughout the mouse genome. Then using a set 
of bioinformatic criteria, such as proximity of binding sites to the Dlx 5/6-containing SHFM 
7q21 interval, the researchers identified putative p63-regulated enhancers. One enhancer, p63-
binding site (BS) 1 was shown to drive reporter gene expression in both zebrafish and mouse 
AERs. Importantly, when the p63 binding site was mutated in the BS1-transgene construct, no 
reporter gene expression was noted in mouse AERs (Kouwenhoven et al., 2010). This work 
demonstrates that methodologies based on single transcription factors can be used to identify 
enhancers with limb-specific activity. 
 Recently, ChIP-seq was used to provide a catalog of tissue-specific enhancers available 
to researchers for further characterization or manipulation. This resource is found on the Vista 
Enhancer Browser (http://enhancer.lbl.gov) (Visel et al., 2007b). Tissue-specific enhancers 
made available on this site are first tested for their ability to direct lacZ expression in transgenic 
mice; images of the mice along with the sequence and chromosomal location of the enhancer are 
provided. Numerous enhancers have been tested that were identified based on sequence 
conservation alone (Nobrega et al., 2003; Pennacchio et al., 2006; Visel et al., 2007a; Visel et 
al., 2008) [also reviewed in (Pennacchio and Rubin, 2001)]. In 2009, enhancers from a ChIP-
seq-based data set were added to the Vista Browser (Visel et al., 2009a). Limb-specific 
enhancers in this data set were discovered by homogenizing E11.5 mouse limbs and sequencing 
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the DNA crosslinked to antibody bound-p300. p300 is a general transcriptional co-activator with 
histone acetyltransferase activity associated with enhancers and active transcription (Heintzman 
et al., 2007; Xi et al., 2007) (also reviewed in (Chan and La Thangue, 2001)). A subset of the 
p300-associated enhancers derived from limb tissue were tested for their ability to reproducibly 
regulate transgenic lacZ expression in E11.5 mice. However, to date none of the transgenically 
examined p300 limb-specific enhancers have been tested in an in vivo functional genetic 
context. 
 Related to enhancer-p300 associations are a number of other chromatin marks used to 
identify putative enhancers via ChIP-seq methods, including H3K4me1 and H3K27ac 
(Heintzman et al., 2007; Hon et al., 2009; Ong and Corces, 2011; Cotney et al., 2012). The 
rapidly accumulating data on whole genome chromatin signatures for enhancers can be 
creatively combined with uniquely tailored bioinformatic screens to identify novel types of 
regulatory elements. For example, Birnbaum et al. (2012) took advantage of 25 available ChIP-
seq datasets that recorded the chromatin-related marks of active enhancers. The authors then 
took these datasets through a series of screens to identify sequences that overlapped with the 
previously discussed p300 dataset and with exons (rather than introns or intergenic sequences) 
of genes that were not themselves expressed in limbs but were near genes that were, such as 
Dlx5 and 6. In this manner Birnbaum et al. (2012) demonstrated that four of these sequence 
types, termed enhancer-exons (eExons), regulated a lacZ expression in the E11.5 mouse limb 
(Birnbaum RY, 2012).  
The usefulness of this approach was further confirmed by employing chromosome 
conformation capture (3C), another technique that is increasingly used to decipher enhancer-
enhancer and enhancer-gene interactions. In this case, a 3C assay confirmed that one of the 
eExons, Dyn-eExon15, associated with the promoters of two genes some 900 kb away, Dlx 5 
and 6, both of which are related to SHFM (Birnbaum RY, 2012). Both 3C and 4C (another 
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flavor of 3C, used when only one potentially interactive sequence is known) were also used to 
better understand the complex interactions between the Hoxd cluster with both the extensive 
centromeric (5’) and telomeric (3’) enhancer regions; these experiments showed that multiple 
enhancer elements, including the GCR, Prox and enhancers within the centromeric gene desert 
come together to regulate 5’-Hoxd gene members, such as Hoxd13 (Montavon et al., 2011). 
 Another attempt to catalog and map enhancers throughout the entire mouse genome 
resulted in the creation of a regulatory or enhancer sensor. The regulatory sensor (called SBlac) 
is composed of, 5’-to-3’, a single loxP site, the human β-globin promoter and the lacZ reporter, 
all flanked by the Sleeping Beauty transposon inverted repeats (Ruf et al.). The β-globin 
promoter has no activity on its own, and therefore can only aid in lacZ transcription when next 
to enhancer elements. Offspring generated from mice harboring both a spermatid-specific 
Sleeping Beauty transposase transgene and the SBlac transgene sensor therefore have SBlac 
insertions in unique locations throughout the genome. The SBlac is capable of “reading” the 
regulatory potential at its unique insertion site. Ninety-eight out of 165 (60%) transgenic mice 
scored for lacZ expression showed tissue-specific expression patterns, including some in the 
E11.5 limb. Interestingly, SBlac transgenes and Vista-enhancers (deposited on the Vista 
Enhancer Browser (Visel et al., 2007b)) located near each other regulated similar expression 
patterns, with SBlac-regulated expression patterns always being more restricted. These findings 
accord well with those from the functional studies already discussed at the Prx1, Hoxd and 
Tcfap2a loci that enhancer activity at endogenous loci is often different from that characterized 
in ectopic transgenic experiments.  
 The single loxP site in each SBlac sensor can also be use to modify the genome around 
enhancers using TAMERE or STRING (Herault et al., 1998; Spitz et al., 2005); in this manner 
the location of specific enhancers can be ascertained. For example, Ruf et al. (2011) used local 
transposition to place two separate SBlac sensors adjacent to Myc in two different mouse lines. 
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Each sensor recapitulated portions of Myc’s endogenous expression pattern. However, when the 
lines were crossed and TAMERE was used to delete the 830 kb interval between the SBlac 
sensors the remaining sensor no longer directed a Myc-like lacZ expression, indicating that the 
enhancers regulating that portion of Myc’s expression had been deleted (Ruf et al.). Similar 
experiments could be used to both identify and, importantly, functionally manipulate limb-
specific enhancers at their endogenous loci, including enhancers that were identified in two 
separate assays, such as the Vista-enhancers mentioned previously. 
 Many of the techniques described above generate vast lists of potential tissue-specific 
enhancers. And although a selection of enhancers pulled out of each type of screen were 
subjected to additional transgenic assays in either mice or zebrafish to better characterize their 
regulatory roles, none of them, except for a few enhancer loci in the SBlac system, were 
manipulated in a functional genetic manner. It is worth noting that many of the putative 
enhancers collected in these assays are cross-referenced to the Vista-enhancer database; 
presumably an enhancer found it two or more datasets is less likely to be a false positive. Recall 
that this database includes enhancers that were identified because of their extreme conservation 
as well as enhancers that proved to associate with p300 in a ChIP-seq experiment. However, to 
date, none of the Vista-p300-associated enhancers have themselves been deleted from the mouse 
genome. Triangulation of independent results as a measure of confidence in methodologies is 
logically sound, but at some point I believe it is important to test the validity of enhancer-
discovery methods on their own merits by using gene targeting to delete a subset of the putative 
enhancers they produce. 
 
Conceptual themes in enhancer biology derived from functional genetic experiments of 
limb-specific enhancers 
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After surveying the available research on functionally manipulated, limb-specific 
enhancers it is useful to draw attention to four conceptual themes that emerge from the disparate 
motivations, methods and findings connected to each enhancer study. No priority is intended in 
the ordering of their presentation. These conceptual themes can serve as general assumptions 
and observations to be refined, refuted or expanded by further research on limb enhancers.  
Firstly, it is commonly appreciated that transgenic assays – wherein individual enhancers 
are used to drive reporter gene expression in non-endogenous integration sites – do not indicate 
the necessity or even the in vivo function of the tested enhancer. When this conceptual 
appreciation is acted on via the use of functional genetic approaches to modify (often delete) the 
enhancer at its endogenous locus the results can be stunningly telling. For example, enhancer 
deletions informed us of the apparent complete redundancy of the Prx1 enhancer (Cretekos et 
al., 2008) versus the morphological dependency of the limbs on the Tbx4 and Tcfap2a enhancers 
(Feng et al., 2008; Menke et al., 2008). No matter the final outcome of enhancer deletion 
experiments one commonality among all of the studies is the observation that phenotypes do not 
perfectly correlate with the entire spatial expression domain of enhancers as assayed via 
transgenic reporter mice. This indicates that in all cases enhancers behave differently – likely 
due to local interactions with other enhancers, repressors and insulators – when in endogenous 
or ectopic contexts (for examples see (Cretekos et al., 2008; Feng et al., 2008; Menke et al., 
2008; Montavon et al., 2011). Thus, despite the operational definition of enhancers as 
autonomous, modular regulatory units (Visel et al., 2009b; Levine, 2010; Ohler and Wassarman, 
2010), in reality they exert their influences in a context-dependent manner. This point may seem 
trivial, but it is only after carrying out functional, endogenous experiments on enhancer loci in 
order to parse their ectopic/endogenous behaviors that additional hypothesis about 
transcriptional regulation can be tested: What elements partially (or, more rarely, fully) 
compensate for this enhancer? What regulatory sequences work in concert with or against this 
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enhancer? How common are transcriptional enhancer networks? (Again see discussions in 
(Cretekos et al., 2008; Feng et al., 2008; Menke et al., 2008; Montavon et al., 2011)). Moreover, 
it has been elegantly argued that meaningful discussions about the homology or novelty of limb 
structures must take into account the regulatory mechanisms responsible for limb development 
(Woltering and Duboule, 2010); such mechanisms can only be determined by carrying out 
functional genetic experiments. 
The second general observation gleaned from the functional genetic experiments above 
is that although the regulation of transcription by enhancers seems to be structured in a network 
or web-like fashion, complete redundancy, where the absence of one enhancer is completely 
compensated for by another (nearly always un-characterized) enhancer, is rare. Indeed, 
complete compensation by an as yet uncharacterized enhancer was seen only in the absence of 
the Prx1 enhancer (Cretekos et al., 2008). This observation held true even for deleted 
chromosomal regions near the Hoxd cluster that presumably contain numerous enhancer 
elements – deletions of hundreds of base pairs did not completely compromise autopod 
morphology, implying the action of a regulatory network with compensatory effects. Yet the 
absence of numerous enhancer elements did result in observable, even if subtle, anatomical 
alterations, illuminating the unique role of individual Hoxd regulatory regions (Montavon et al., 
2011). In should be mentioned too that in cases where no phenotype is scored in the absence of 
an enhancer, such as the Prx1-enhancer, this does not strictly mean that there is no phenotype – 
it only suggests that no phenotype was detected. Again, if indeed gradualism is the norm in 
evolutionary processes, and if that gradualism is at least partially encoded in enhancer elements 
then we may expect the phenotypes in enhancer-deleted mouse lines to be subtle, or, perhaps, 
only detectable under certain conditions that mimic natural environments. 
The third generalization stems from the observation of compensatory enhancer networks 
discussed above and from the phenotypic subtlety of enhancer knockout mice relative to mice 
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harboring homozygous deletions for the genes they regulate. For example, when Tbx4 is deleted 
at early time points in the hindlimb, development of the limb bud fails to proceed (Naiche and 
Papaioannou, 2007). In contrast, HLEA (Tbx4 enhancer) null mice possess a milder phenotype, 
exhibiting slightly shortened (though statistically significant) digits, for example (Menke et al., 
2008). Similarly, the multiple individual enhancer-region deletions (such as the GCR) 
surrounding the Hoxd locus are manifested in mice as modestly malformed autopods with 
missing or altered phalanges. Only after the deleting of multiple Hoxd enhancer-regions 
simultaneously do the autopods of mice reach the level of malformation seen in Hoxd8-13 null 
mice (Montavon et al., 2011). There are exceptions of course; the Shh-ZRS null mice lack distal 
limb elements altogether (Sagai et al., 2005), but this is just an extreme example of the general 
observation that individual enhancers, despite redundancy, do contribute to the elaboration of a 
functioning limb, often in a piecemeal and subtle fashion (Guenther et al., 2008). Such 
observations suggest that mutations to individual enhancers, most strictly those leading to 
deletions and expansions, would at least lead to modest morphological variation, if not large. 
And these subtle variations could obviously serve as substrates for evolutionary phenomena, 
such as natural selection or genetic drift, for example. Developmental biologists pursuing 
functional genetic experiments to evaluate the role of enhancers need to be prepared to analyze 
subtle phenotypes (relative to single and bi-genic knockout experiments) and to advocate the 
relevance of these phenotypes for understanding the molecular genetic basis of evolution 
(Baguna and Garcia-Fernandez, 2003), where genetic causality may more often than not be 
allied with subtle variation rather than the striking deformities accompanying gene-based 
disease research.  
Lastly, large chromosomal inversions and deletions at the Hoxd locus highlighted the 
importance of topography between enhancer-enhancer and enhancer-gene relationships in 
promoting proper transcription. If the distance between an enhancer and its associated gene is 
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too great or to small, proper regulation is lost, as when Hoxd10 was no longer expressed in 
distal limb buds after an inversion had placed it out of range of the distal-acting enhancers 
(Spitz et al., 2005). In another experimental approach, 4C-chromosome capture was used to 
directly detect long-range interactions between multiple enhancers involved in Hoxd gene 
transcription (Montavon et al., 2011). Enhancer duplications, such as those recorded for the Shh-
ZRS and Bmp2 enhancer (Sharpe et al., 1999; Lettice et al., 2002; Dathe et al., 2009), also 
suggest that rearrangements in topography may be as important as the enhancer sequences 
themselves in dictating appropriate transcription. Directly testing the importance of topography 
at loci other than the Hoxd cluster will be necessary to fine tune our understanding of the 
contribution of topographical variation to gene transcription in normal, disease and species-
specific contexts. 
 
Functional analysis of p300-associated, limb-specific enhancers in the mouse 
 
 Of the numerous limb-specific enhancers discussed above it is interesting to note that a 
large proportion of them were in one sense or another identified based on two criteria: proximity 
to a gene of interest and sequence conservation (there are exceptions of course, the ZRS that 
regulates Shh, for example). An exciting possibility that results from screens that are gene-blind, 
such as those that focus on chromatin marks, is that enhancers relevant to limb development and 
evolution may be discovered regardless of their association to a particular gene. The Vista-
ChIP-seq dataset produced by Visel et al. (2009), for example, identifies enhancers based on 
their association with p300, not on their proximity to any gene. Because p300 possesses histone 
acetyltransferase activity its presence at a particular locus is considered a proxy for the 
H3K27ac chromatin modification, which itself is considered a signature of active enhancer 
regulated transcription. In this sense, the p300 ChIP-seq dataset has a biological justification 
	  	   28	  
beyond sequence conservation or gene proximity to be trusted as a method of active enhancer 
discovery. Therefore, to understand the roles of endogenous enhancers during vertebrate 
development I deleted two Vista-p300-associated enhancers from different genomic loci known 
to be active in the mouse embryo limb bud (enhancer.lbl.gov). Importantly, the enhancers were 
selected because of unique lacZ expression patterns driven by human enhancer sequences in 
E11.5 mice – images of which are available on the VEB. Thus, the outcome of my enhancer 
targeting experiments would permit me to simultaneously assess the utility of the p300 ChIP-seq 
dataset in identifying required limb-specific enhancers and to assess my findings in light of the 
results and concepts derived from the above discussed functional experiments. This is the first 
study to explore the consequences of deleting enhancers selected solely because of their 
association with p300 in a particular tissue (the limb). Thus, broadly it will address the value of 
the p300 ChIP-seq dataset in identifying enhancers required for development. I hypothesized 
that limb development and ultimate limb morphology would be disrupted in mice harboring 
deletions of p300-associated, limb-specific enhancers. 
 
Transgenic mice: Selection of putative transcriptional enhancers for functional genetic 
manipulation 
 
The transcriptional enhancers evaluated in this project were derived from bioinformatic 
analyses of vertebrate genomes and functional genetic studies conducted in the mouse 
(discussed below). These earlier studies relied on the human genome as the base or reference 
sequence for the bioinformatic and/or functional genetic approaches. I will describe how the 
enhancers that I manipulated were cloned and constructed into transgenic vectors and gene 
targeting constructs based on the findings of this previous research, starting with M280, and 
then discussing M1442. 
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M280 enhancer: Identification and validation 
 
 In 2004, Bejerano et al. identified 481 non-coding segments of the human genome, 
termed ultraconserved elements, which are perfectly conserved (100% sequence identity) 
between the human, mouse and rat genomes across at least 200 bps. The extreme conservation 
of these non-coding sequences suggested they might play an essential role in regulating gene 
transcription during vertebrate development. To test this, Pennacchio  et al. (2006) made a 
collection of transgenic mice harboring different transgenes composed of an ultraconserved 
element with ± ≈ 500 bp of flanking sequence linked to the lacZ reporter gene (Kothary et al., 
1989; Pennacchio et al., 2006). The ultraconserved segments and their flanking sequences were 
obtained from human DNA. Transgenic mouse embryos were collected and scored for positive 
lacZ expression at E11.5. Among the numerous lacZ positive embryos obtained from this 
experiment were four that carried the same transgene and expressed lacZ in a consistent, 
distinctive pattern in the middle of E11.5 limb buds (Table 2). Because each embryo harbored 
an independent transgene insertion event it was concluded that the ultraconserved element, 
called hs280, was responsible for the reproducible lacZ expression pattern in the limb buds and 
not some other genomic regulatory elements nearby to the independent insertion events of the 
hs280-lacZ transgenes (H280-tg).  
 In all four H280-tg E11.5 mouse embryos analyzed (Pennacchio et al., 2006), the lacZ 
expression pattern forms a somewhat equilateral triangular or wedge-shaped pattern in the 
middle of the fore- and hindlimb buds. The base of this triangular expression pattern runs along 
the distal tip of the bud, extending about half way up the distal-anterior edge and half way down 
the distal-posterior edge of the limb bud. The equilateral sides of the expression pattern extend 
from the anterior-most and posterior-most points of the distal margin of expression, 
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Table 2. Highly conserved and p300-associated enhancer sequences obtained from the 
VISTA Enhancer Browser (VEB; enhancer.lbl.gov). Blue text refers to human genomic 
sequence data/information taken directly from the VEB and Bejerano, G. et al. (2004) and Visel, 
A. et al. (2009). Black text refers to mouse genomic sequence; mouse enhancer sequences deleted 
in this study are in bold. Images of hs280 and hs1442 transgenic mice taken directly from the 
VEB (enhancer.lbl.gov; Visel et al. 2007b). 	  
	  	   31	  
 
 
 
 
 
 
 
 
 
 VISTA-hs280 VISTA-hs1442 
Human enhancer drives 
lacZ expression in E11.5 
transgenic mouse 
limb buds 
  
Number of lacZ-positive 
embryos/ transgene-
positive embryos 
4/4 10/11 
Method of discovery Ultraconservation + p300-association p300-association 
Overlapping position in 
mouse genome (mm9) 
Chr. 4: 117,063,735-
117,065,404 
Chr. 1: 165,827,290-
165,830,012 
Name of mouse ortholog M280 M1442 
Total length 1,676 bp 2,723 bp 
Both enhancers are 
intronic: Host gene Rnf220 (2
nd intron) Kifap3 (19th intron) 
Percent identity of mouse-
on-human BLAT search 
(UCSC Genome Browser; 
mm9-on-hg19) 
94.9% (across entire length 
of enhancer) 
91.9% (across 1,440 bp of 
total length) 
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respectively, and meet at a point – analogously the tip of the triangle, pointing dorsally – in the 
center of the limb bud. This well-defined expression pattern corresponds to the future location 
of digits II-III and potentially to elements of the central wrist and ankle. Three of four embryos 
also displayed lacZ expression in the first pharyngeal arch and the same proportion scored 
positive for lacZ in the neural tube. Two of four embryos scored positive for lacZ expression in 
the tail bud. Images of H280-tg mice and others from Pennacchio et al. (2006) are freely 
accessible on the Vista Enhancer Browser (VEB; enhancer.lbl.gov) (Pennacchio et al., 2006; 
Visel et al., 2007b). The observation that the H280-tg expression pattern overlapped with limb 
mesenchyme that would eventually give rise to digits II-III – a region of the developing limb 
that is rarely studied independent of its relationship to the molecular processes set in motion by 
the well-known expression of Sonic Hedgehog (Shh) in the posterior limb bud – and the fact that 
four-of-four transgenic embryos displayed a consistent limb expression pattern led to my 
decision to further investigate the role of hs280, or its orthologs, in limb development. 
 This decision was bolstered by another data set that was generated to identify potential 
limb-specific enhancers. Visel et al. (2009) used Chromatin Immunoprecipitation with 
sequencing (ChIP-seq) to identify non-coding regions of the mouse genome that were associated 
with p300, a general transcriptional activator, in dissected E11.5 limb buds(Visel et al., 2009a). 
Information regarding these p300-associated enhancers can also be accessed on the VEB 
(enhancer.lbl.gov)(Visel et al., 2007b). Enhancers involved in active transcription are associated 
with p300 because of the various pro-transcription functions carried out by p300: it is thought to 
serve as a bridge between two or more transcription factors, it can serve as a scaffold upon 
which numerous other transcription-related proteins are assembled, and it possesses histone 
acetyltransferase activity, which can modify histones and potentially other proteins as 
well(Chan and La Thangue, 2001; Kalkhoven, 2004). One of the 2,105 identified putative 
enhancers associated with p300 was a 952 bp segment that overlapped with 48 bps of the 
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previously described ultraconserved element, hs280 (or, to be more specific: overlapped with 
the mouse ortholog of hs280). Therefore, two independent data sets, one based on extreme 
sequence conservation and one based on p300 association and active transcription in E11.5 limb 
buds, indicated that this genomic region was important for vertebrate limb development. To 
further characterize the regulatory capacity of these sequences in the mouse I treated the 
orthologous mouse sequences as one putative enhancer, Mouse-280 (M280), which spanned the 
length of the ultraconserved and p300-asociated elements for a total length of 1,577 bps. 
Minimal additional sequence was added to this core enhancer region (Gompel et al., 2005; 
Pennacchio et al., 2006; Visel et al., 2007b; Cretekos et al., 2008) during the cloning process 
that generated the recombinant DNA used in our transgenic and gene targeting analyses (see 
below) so that that the total length of the interrogated element is 1,676 bps (Table 2, Fig. 1). 
 
M1442 enhancer: Identification and validation 
 
 In addition to M280, I selected another enhancer from the p300 data set for further 
investigation. As was the case for production of transgenic mouse embryos based on 
ultraconserved elements, transgenic mice harboring a p300-associated element linked to lacZ 
were generated with the human orthologous p300-associated sequence. And similarly, images of 
these transgenic mouse embryos are available on the VEB(Visel et al., 2007b). One such group 
of transgenic mouse embryos, analyzed at E11.5, was made using the p300-associated element 
hs1442 (H1442-tg). Ten of eleven embryos displayed positive lacZ expression in the fore- and 
hindlimbs (Table 2). Specifically, the consistently observed lacZ expression pattern was graded, 
with strongest intensity concentrated in the posterior half of the limb bud and then tapering off 
in intensity towards the middle of the bud and becoming faint to absent in the anterior half. This 
aspect of the expression pattern is reminiscent of Shh expression in the early developing limb 
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Figure 1. M280 is composed of an Ultraconserved and p300-associated sequence. M280, the 
sequence used to make lacZ reporter mice and the sequence targeted for deletion in M280tm1 -/- 
mice, is made of an Ultraconserved element (dark blue), a p300-associated element (green) and 
flanking sequence (black). Thus M280 (purple) is larger than its human counterpart, hs280. Light 
blue box overlaps the Ultraconserved sequence and the region shared between the Ultraconserved 
and p300-associated sequences. VEB refers to the VISTA Enhancer Browser and researchers who 
curate it. MJN refers to author of this research. 	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 bud (Lettice et al., 2003), although Shh expression is even more tightly restricted to the 
posterior edge of the limb bud. Nonetheless, the lacZ expression pattern driven by hs1442 
clearly overlaps with endogenous Shh expression. In addition to the graded posterior expression 
domain, H1442-tg embryos displayed a relatively thin expression domain that ran along the 
distal arc of the fore- and hindlimb buds. This portion of the pattern forms a crescent shape that 
encompasses the distal posterior as well as the distal anterior edges of the limb bud. The 
crescent is reminiscent of apical ectodermal ridge-specific expression of certain Fgf genes, but it 
is not clear from the images on the VEB that the lacZ expression pattern is indeed ectodermal 
rather than or in addition to mesenchymal. 
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MATERIALS AND METHODS 
 
Generation of M280 gene targeting vector 
 
The M280 gene targeting vector was engineered in four steps, using the pBluescript II KS (-) 
plasmid (pBS) as the vector backbone. First, a HindIII/Xho1 fragment containing a loxP-flanked 
(flox) neo expression cassette (from PGK-neobpA-loxP) was inserted into the HindIII and Sal1 
pBS sites. Upon ligation of these two fragments the adjoining Sal1-Xho1 sites were abolished. 
Second, the 5’-arm of homology was inserted into the vector. Previous to insertion, the 5’-arm 
of homology was generated using PCR amplification with Phusion high-fidelity DNA 
polymerase (Finnzymes, product code: F-530). Template DNA for the amplification of the 5’-
arm of homology (and the 3’-arm) was sourced from 129S6/SvEv inbred mice (Taconic).  The 
5’-arm of homology amplicon was designed such that the HindIII restriction endonuclease 
would cut an endogenous HindIII site near the 5’-end (left end) of the amplicon and also a 
HindIII site engineered into the amplicon via the 3’-primer (right primer). 5’-arm of homology 
primers are: 5’arm-L-8extra (TTTATTTGTGTGTGGTATTTGCATGTGTGC); 5’arm-R-
addHindIII (TATAAGCTTCTGGTGCAAGCCTCTGGAAG). The 5’-arm of homology was 
inserted into the HindIII site of the vector. Third, the 3’-arm of homology was generated using 
the Phusion DNA polymerase. The forward primer (left end of amplicon) was designed so that a 
Sal1 sight was introduced into the amplicon. After amplification, a Xho1 site internal to the 
amplicon could be used to remove 725 bp from the 3’-end (right side) of the amplicon, priming 
the amplicon for ligation into the targeting vector. The 3’-arm of homology amplicon was cut 
with Sal1 and Xho1 and cloned into the targeting vector that had been cut with Xho1. Upon 
ligation of these two fragments the internal Sal1-Xho1 site was abolished. 3’-arm of homology 
primers are: 3armSal-Lb (ACCTGTCGACCTTGAATCTCATTCTTTTGCAGAG); 3arm-Rb 
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(TCTTCATGAGCTGATTAAACTCCTTGC). Fourth, a herpes simplex virus-thymidine kinase 
expression negative selection cassette (MCTK1; (Mansour et al., 1988)) was amplified with 
flanking Not1 sites using Phusion DNA polymerase and ligated into the Not1 site of the 
targeting vector (MCTK1 amplicon derived from pMCTK1). All components of the targeting 
vector were sequenced prior to combination, and the completed targeting vector was sequenced 
to verify that the neo expression cassette replaced the M280 enhancer and that no other changes 
were introduced. The completed M280 gene targeting vector was linearized using the single 
Kpn1 site. The 5’- and 3’-arms of homology provide 3656 and 2579 base pairs (bps) of 
homology, respectively (total homology = 6235 bps). 
 
 
Generation of M1442 gene targeting vector 
 
The M1442 gene targeting vector was engineered in four steps, using the pBluescript II KS  
(-) plasmid (pBS) as the vector backbone. First, the 5’-arm of homology was engineered using 
the Phusion DNA polymerase, with a 5’-primer containing an introduced Spe1 site and a 3’-
primer containing an introduced EcoR1 site. Template DNA for the amplification of the 5’-arm 
of homology (and the 3’-arm) was sourced from 129S6/SvEv inbred mice. The Spe1/EcoRI 5’-
arm of homology amplicon was inserted into the Xba1 and EcoR1 sites of pBS. Upon ligation of 
these two fragments the adjoining Spe1-Xba1 sites were abolished. 5’-arm of homology primers 
are: 5armL-addSpe1 (AAAACTAGTGAGCAAGGCAAGGTTTTTGG); 5armR-addEcoR1 
(AAGAATTCCTCAATAATGTGGTTTCCCTTG). Second, an EcoR1/Xho1 fragment 
containing a loxP-flanked (flox) neo expression cassette (from PGKneobpA-lox) was inserted 
into the EcoR1 and Xho1 pBS sites. Third, the 3’-arm of homology was engineered using the 
Phusion DNA polymerase, with a 5’-primer containing an introduced Xho1 site and a 3’-primer 
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containing an introduced Kpn1 site. The Xho1/Kpn1 3’-arm of homology amplicon was inserted 
into the Xho1 and Kpn1 sites of pBS. 3’-arm of homology primers are: 3armL-addXho1 
(CCACTCGAGGTTCAGCATTACTGCAAAGCAC); 3armR-addKpn1 
(ATAGGTACCTATCCTGGAGCTGGAGAGATGG). Fourth, a Not1/SacII fragment 
containing a herpes simplex virus-thymidine kinase expression negative selection cassette 
(MCTK1; (Mansour et al., 1988)) was inserted into the Not1 and SacII sites of the targeting 
construct (The MCTK1 fragment was derived from the same amplicon described for use in the 
M280  gene targeting construct). All components of the targeting vector were sequenced prior to 
combination, and the completed targeting vector was sequenced to verify that the neo 
expression cassette replaced the M1442 enhancer and that no other changes were introduced. 
The completed M1442 gene targeting vector was linearized using the single Kpn1 site flanking 
the 3’-arm of homology opposite the MCTK1 cassette. The 5’- and 3’-arms of homology 
provide 3047 and 3002 base pairs (bps) of homology, respectively (total homology = 6049 bps). 
 
Generation of targeted ES cell clones and germline alleles for M280 
 
The M280 targeting vector was linearized with Kpn1 outside the 3’-arm of homology. Twenty-
five µg of vector was electroporated in duplicate into PC3 cells (O'Gorman et al., 1997). 
Electroporated cells underwent 10 days of selection in medium that contained G418 and FIAU 
(Behringer et al., 1994). Three-hundred-seven G418, FIAU-resistant ES cell colonies were 
picked for the M280 targeting vector and screened via mini-Southern Blot (Ramirez-Solis et al., 
1992). When digested with Drd1 and hybridized with a 5’-external probe, correctly targeted ES 
cell clones were identified by a 15.4 kb band originating from the non-targeted locus on one 
sister chromosome and a second 9.6 kb band from the targeted locus on the other sister 
chromosome. Alternatively, the same correctly targeted ES cells could be identified by the 15.4 
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kb band from the non-targeted locus and an additional 5.7 kb band from the targeted locus when 
digested with Drd1 and hybridized with a 3’-external probe. A targeting frequency of 3.5% (11 
of 307) G418, FIAU-resistant ES cell colonies screened for the 5’- and 3’-external probes was 
achieved. Two correctly targeted ES cell lines were injected into C57BL/6J blastocysts and 
transferred into 2.5-day-post-coitum pseudopregnant Swiss foster mothers. A range of 
chimerism from 20-90% (agouti pigmentation) was observed in the foster offspring. The 
targeted, PC3 ES cells are homozygous for a protamine-Cre transgene; the Cre recombinase is 
expressed in the male germline and results in excision of the PGK-neobpA-lox cassette and the 
accompanying internal Drd1 site. Excision of the PGK-neobpA-lox cassette was verified by 
digesting genomic DNA acquired from kidney or tail tissue from heterozygous individuals with 
Drd1 and hybridization to either the 5’- or 3’-external Southern Blot probes; this resulted in the 
visualization of 15.4 and 13.7 kb bands. Deletion of the M280 enhancer was verified by 
digesting genomic DNA with Drd1 and hybridization with a Southern Blot probe 
complimentary to the sequence of the enhancer itself. Thus in homozygous individuals no 13.7 
kb band was observed. Male chimeras were bred to B6 females, and a subset of agouti offspring 
were genotyped using the Southern Blot procedure outlined above to confirm germline 
transmission of the targeted M280 allele.  Confirmed transmitting male chimeras were then bred 
to 129S6/SvEv females to maintain the lines on a 129S6/SvEv inbred background. The F1 
progeny from the crosses, and all other crosses, were genotyped by PCR using DNA collected 
from tail biopsies. The PCR reaction consisted of three primers that could distinguish the three 
genotypes, non-targeted, heterozygous targeted, and homozygous targeted: 280-PreEnh-Lb 
(GGTTCAATCAGCCTTTCATTCCAG); 280-wtEnh-R6 
(AGGCTTCCAGGGCTGATAACAAG); 280-PostEnh-Rd 
(AGGCAGCTCTGTCTCTGCAAAAG). Primer set 280-PreEnh-Lb + 280-wtEnh-R6 provides 
a 405 bp amplicon that signifies the non-targeted allele. Primer set 280-PreEnh-Lb + 280-
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PostEnh-Rd provides a 248 bp amplicon when amplified across the deleted M280 allele; on the 
non-targeted allele the 280-PreEnh-Lb + 280-PostEnh-Rd primer set does not produce an 
amplicon when using Choice taq DNA polymerase (Denville Scientific Inc.). Note that because 
the PC3 cells used for electroporation of the targeting vector are homozygous for the protamine 
Cre, all F1 progeny from the male chimeras X 129S6/SvEv females will be heterozygous for the 
Cre; thus F1 progeny must be crossed to additional 129S6/SvEv individuals and genotyped for 
the presence/absence of the Cre transgene. 
 
Generation of targeted ES cell clones and germline alleles for M1442 
 
The M1442 targeting vector was linearized with Kpn1 outside the 3’-arm of homology. Twenty-
five µg of vector was electroporated in duplicate into PC3 cells (O'Gorman et al., 1997). 
Electroporated cells underwent 10 days of selection in medium that contained G418 and FIAU 
(Behringer et al., 1994). Two-hundred-twenty-two G418, FIAU-resistant ES cell colonies were 
picked for the M1442 targeting vector and screened via mini-Southern Blot (Ramirez-Solis et 
al., 1992). When digested with Xba1 and hybridized with a 5’-external probe, correctly targeted 
ES cell clones were identified by a 14.4 kb band originating from the non-targeted locus on one 
sister chromatid and a second 6.6 kb band from the targeted locus on the other sister chromatid. 
Alternatively, the same correctly targeted ES cells could be identified by the 14.4 kb band from 
the non-targeted locus and an additional 6.8 kb band from the targeted locus when digested with 
Xba1 and hybridized with a 3’-external probe. A targeting frequency of 2.7% (6 of 222) G418, 
FIAU-resistant ES cell colonies screened for the 5’- and 3’-external probes was achieved. Two 
correctly targeted ES cell lines were injected into C57BL/6J blastocysts and transferred into 2.5-
day-post-coitum pseudopregnant Swiss foster mothers. A range of chimerism from 50-80% 
(agouti pigmentation) was observed in the foster offspring. The targeted, PC3 ES cells are 
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homozygous for a protamine-Cre transgene; the Cre recombinase is expressed in the male 
germline and results in excision of the PGK-neobpA-lox cassette and the accompanying internal 
Xba1 site. Excision of the PGK-neobpA-lox cassette was verified by digesting genomic DNA 
acquired from kidney or tail tissue from heterozygous individuals with Xba1 and hybridization 
to either the 5’- or 3’-external Southern Blot probes; this resulted in the visualization of 14.4 and 
11.7 kb bands. Deletion of the M1442 enhancer was verified by digesting genomic DNA with 
Xba1 and hybridization with a Southern Blot probe complimentary to the sequence of the 
enhancer itself. Thus in homozygous individuals no 11.7 kb band was observed. Male chimeras 
were bred to C57BL/6J females, and a subset of agouti offspring were genotyped using the 
Southern Blot procedure outlined above to confirm germline transmission of the targeted V442 
allele.  Confirmed transmitting male chimeras were then bred to 129S6/SvEv females to 
maintain the lines on a 129S6/SvEv inbred background. The F1 progeny from the crosses, and 
all other crosses, were genotyped by PCR using DNA collected from tail biopsies. The PCR 
reaction consisted of three primers that could distinguish the three genotypes, non-targeted, 
heterozygous targeted, and homozygous targeted: 1442-PreEnh-L2 
(AAAGCCCAAAGGTTTTTCTCAAGG); 1442-wtEnh-R1 
(CAAACATCTCCTACAAGCACTCACG); 1442-PostEnh-R2 
(GTGAACTCGGCAGGTAACAGACAG). Primer set 1442-PreEnh-L2 + 1442-wtEnh-R1 
provides a 496 bp amplicon that signifies the non-targeted allele. Primer set 1442-PreEnh-L2 + 
1442-PostEnh-R2 provides a 264 bp amplicon when amplified across the deleted M280 allele; 
on the non-targeted allele the 1442-PreEnh-L2 + 1442-PostEnh-R2 primer set does not produce 
an amplicon when using Choice taq DNA polymerase (Denville Scientific Inc.). Note that 
because the PC3 cells used for electroporation of the targeting vector are homozygous for the 
protamine Cre, all F1 progeny from the male chimeras X 129S6/SvEv females will be 
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heterozygous for the Cre; thus F1 progeny must be crossed to additional 129S6/SvEv 
individuals and genotyped for the presence/absence of the Cre transgene. 
 
Generation of M280 and M1442 transgene constructs and associated transgenic mice 
 
Transgenic mice were produced with two general types of constructs: 1) constructs harboring 
either M280 or M1442, the minimal heat shock protein 68 promoter (HSP68), and the E. coli β-
galactosidase (lacZ) reporter gene [phspPTlacZpA; (Kothary et al., 1989)]; or 2) constructs with 
the same configuration as in “1” but having been built using the Invitrogen Gateway 
Technology. Constructs in category 1 were used as templates to amplify the enhancer-fragments 
used in category 2. Enhancer fragments were amplified from genomic DNA from 129S6/SvEv 
mice using Phusion High-fidelity DNA polymerase (Finnzymes, F-530) with primers designed 
to have flanking HindIII sites. The 2723 bp M1442 amplicon was inserted into the 
phspPTlacZpA HindIII site. M1442 transgene primers are: 1442-tg-L 
(TTTAAGCTTAGGGAAACCACATTATTGAG), 1442-tg-R 
(GTTAAGCTTGCTTTGCAGTAATGCTGAAC). Excision of the transgene away from the 
plasmid backbone was achieved by cutting with Sal1. The 1676 bp M280 amplicon was blunt-
end cloned into the phspPTlacZpA Sma1 sites because after amplification it was noticed that 
there was an internal HindIII site in the M280 vector. M280 transgene primers are: 280-tg-L 
(TGGAAGCTTCTTCCAGAGGCTTGCACCAG), 280-tg-R 
(TCTAAGCTTTTGCTCTCTGTCCCCTGTCC). Excision of the transgene away from the 
plasmid backbone was achieved by cutting with Sal1. 
 To generate the Invitrogen Gateway-based transgenes, M280 and M1442 PCR-generated 
amplicons were obtained from the transgene vectors described above. Left and right primers (5’ 
and 3’) for both M280 and M1442 amplicons were designed with flanking Xho1 sites for easy 
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insertion into the pENTR 3C (Invitrogen, A10560) Xho1 site. M280 Gateway transgene-
production primers are: 280-Xho-L (TGCCTCGAGCCTGCAGTCTCTCCCC), 280-Xho-R 
(GGTCTCGAGGTCAGTATCATGACC). M1442 Gateway transgene-production primers are: 
1442-Xho-L (GTTCTCGAGACTTTCATTTAGGAGG), 1442-Xho-R 
(CTGCTCGAGCTACACAAACATGA). The pENTR 3C multi-cloning site is flanked by the 
attL1 and attL2 recombination sites. Upon insertion of either enhancer fragment the 5’ pENTR 
3C Sal1 site (nearest to attL1) was destroyed. Using the Invitrogen Clonase II Plus Enzyme Mix 
(12538-120) the enhancers were then transferred from the pENTR 3C vector to a plasmid 
containing Gateway cloning sites (attL1/attL2) upstream of HSP68 and lacZ (kindly provided 
by Nadav Ahituv, University of California San Francisco; based on initial vector in (Kothary et 
al., 1989)). The Sal1 site just 5’ of the attL2 recombination site in the pGW-HSP-LZ vector was 
removed via the LR Clonase recombination event, therefore both the M280 and M1442 
Gateway-based transgenes were excised away from the pGW-HSP-LZ backbone via two Sal1 
sites that flank the entire transgene. Each transgene was sequenced before excision and 
preparation for pronuclear injection into mouse zygotes. Transgenic mice were generated with 
both the M280 and M1442 enhancers in either the phspPTlacZpA or pGW-HSP-LZ vector via 
pronuclear microinjection (Brinster et al., 1985) into zygotes obtained from either FVB/N 
intercrosses (used for the stable transgenic lines characterized herein) or [C57BL/6 X SJL]F1 
hybrid intercrosses. Generation zero (G0), E11.5 embryos harboring the phspPTlacZpA-based 
transgenes were collected from foster mothers and analyzed for lacZ expression by X-gal 
staining. Stable transgenic lines were generated using the pGW-HSP-LZ-based vectors. Six of 
twenty G0 mice screened were positive by PCR for the M280-pGW-HSP-LZ transgene; of these, 
3 founders (50%) expressed lacZ (as assayed by X-gal staining) in developing limbs. M280-
pGW-HSP-LZ transgene PCR genotyping primers are: 280GWtg-L 
(CTCTTGGGCCTTGGGGATAGTAG), 280/1442GWtg-R2 
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(AGTGCTGCCTCTGACCTCATGG). Eight of twenty-nine G0 mice screened were positive by 
PCR for the M1442-pGW-HSP-LZ transgene; of these, 2 founders (25%) expressed lacZ (as 
assayed by X-gal staining) in developing limbs. M1442-pGW-HSP-LZ transgene PCR 
genotyping primers are: 1442GWtg-L2 (AATGTCCTCTGACCTCCACATGC), 
280/1442GWtg-R2 (AGTGCTGCCTCTGACCTCATGG). 
 
Quantitative real-time PCR analysis 
 
M280tm1/tm1, M1442tm1/tm1, or 129S6/SvEv (wild type) mice were intercrossed and E11.5 
embryos were collected from sacrificed females. Forelimb and hindlimb autopods (hands and 
feet) were dissected away from three embryos of the same genotype and pooled together (1 
sample = 12 autopods; 6 forelimbs and 6 hindlimbs). Pooled autopods were moved into 500 µl 
Ambion TRIzol Reagent (15596) and homogenized using sterile 1mL syringes and 27G x ½ 
(0.4mm x 13mm) needles. Total RNA was obtained following the manufacture’s guidelines 
(Ambion TRIzol Reagent, 15596) and RNA quality and concentration was assessed on a 
NanoDrop Spectrophotometer (ND-1000; 260/280 nm ≥ 1.8; 260/230 nm ≥ 1.9). Five hundred 
ng of total RNA from each sample was used to make cDNA with the Invitrogen SuperScript III 
First-Strand Synthesis System for RT-PCR (18080). Quantitative RT-PCR (qPCR) was carried 
out in duplicate or triplicate on oligo-dT-primed cDNA (n=8 biological replicates per genotype) 
on an ABI 7500 Real-Time System (Applied Biosystems). Initially, numerous endogenous 
controls were tested: Gapdh, Mouse-actin, Mouse-18S ribosomal RNA, Mll and Rbbp4. Results 
calculated with reference to different endogenous control genes did not always agree. For 
example, one endogenous control may provide non-significant transcriptional change for one 
gene of interest (GOI), while another endogenous control would provide a significant up- or 
down-regulation. I decided to dispense with Gapdh because it provided very inconsistent results 
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over several trials. I also dispensed with Mouse-actin because I reasoned that in a developing 
tissue, such as a E11.5 limb bud, that cell movement and growth may lead to fluctuating levels 
of cell cortex proteins such as actin. Ultimately I settled on using Rbbp4 because it provided 
consistent results in two or three trials per GOI. And most importantly, Rbbp4 was originally 
selected because of its consistent transcriptional levels across numerous amniocyte stem cell 
lines (Maguire et al., 2013) (special thanks to Colin T. Maguire, University of Utah, for 
directing me to his publication and for suggestions concerning qPCR internal controls). The 
comparative CT method was employed to determine the relative expression of numerous GOI 
after normalization to the Rbbp4 endogenous reference and calibration to wild-type GOI 
expression levels (Applied Biosystems, Guide to Performing Relative Quantitation of Gene 
Expression Using Real-Time Quantitative PCR). Primer sequences for genes assessed are in 
Table 3 below. The primer set for Prx1 was obtained from Cretekos, C. et al. (2008). All other 
primer sets were designed using Oligo Architect (http://www.sigmaaldrich.com/life-
science/custom-oligos/dna-probes/product-lines/probe-design-services.html) or the Roche 
Universal ProbeLibrary Assay Design Center (https://www.roche-applied-
science.com/webapp/wcs/stores/servlet CategoryDisplay?catalogId 
=10001&tab=Assay+Design+Center&identifier=Universal+Probe+Library&langId=-1). All 
primer pairs were designed to flank at least one intron (if possible); additionally, most primer 
sets were designed such that at least one primer annealed to an exon-exon junction. 
 
Whole Mount In Situ Hybridization (WMISH) 
 
WMISH was carried out using standard protocols (Nagy et al., 2003). Embryonic day 10.5 and 
11.5 embryos were collected several weeks or months before the WMISH experiment from 
mutant or unaltered 129S6/SvEv intercrosses. Embryos were fixed in 4% paraformaldehyde 
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Table 3. Primer sets for Quantitative Real-time Polymerase Chain Reaction. All sequences 
read from 5’ to 3’. 	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Gene Name Forward Primer Reverse Primer 
Atpb1 TCAGGTTCCTGGAAAAGTACAAG TTGGGTTCACTGGGAACATT 
BC055324 GTAAGAACAGCGAATGTG TGAATGAATAACTCCTACCA 
Dmap1 TTAAGTCGGCAGGTGTCA GCTCCACACCAAGTTCCA 
Eri3 GATGAGTGGATGGCGAAGG GCACTGTCCTGGAAGCAT 
Gorab CAAGAACAGCGACTAATGGA CCTGAGGATGCCAATGTC 
Kifap3 CAGTGATGAAGAGGAGGAGTT GGCACCTGGCTTTAGTTTG 
Nme7 GCTGGTGTTGATTGACTATGG TCCGCTGCTTCTTTCCTT 
Prdx1 CCGCTCTGTGGATGAGATTAT GTATCACTGCCAGGTTTCCAG 
Prx1* GATCTCGCACGTCGGGTGAACC GCCAGCATGGCTCGCTCATTC 
Rbbp4 CTTAGTGCTTCAGATGACCATACC GCATCCACCACCTTTCCTT 
Rnf220 CAGCGACATTGAGAAAATC CAGCCAACACTCTTCACA 
Scyl3 GAATATCCAGTCAGTAAGAGA AACCTGCTCATTGAAGAT 
Tmem53 CCAAGTATAGTGCTATCTACC CCGCTCAATCTCATAGTC 
 
*Primer set obtained from Cretekos, et al. (2008). 
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overnight, rinsed three times in PBS-Tween-20 (PBT), and walked through a series of 
methanol:PBT washes until dehydration in 100% methanol. Embryos were then stored at -20 ° 
C. Both sense and antisense Rnf220 riboprobes were amplified from cDNA collected from 
E12.5 129S6/SvEv whole embryos and then cloned in pBluescript II KS (-). Rnf220 riboprobe 
primers were obtained from Mouse Genome Informatics website (www.informatics.jax.org; 
primer set ID: MTF1124). The Shh riboprobe was obtained from Andrew McMahon’s 
laboratory (Echelard et al., 1993). I designed the primer sets for all other riboprobes used in this 
study (Kifap3, Dmap1, Nme7) using Oligo Architect (http://www.sigmaaldrich.com/life-
science/custom-oligos/dna-probes/product-lines/probe-design-services.html). Primer sets are 
provided below in Table 4. As with production of the Rnf220 riboprobe, the probes for Kifap3, 
Dmap1, Nme7 were amplified from cDNA collected from E12.5 129S6/SvEv whole embryos 
and cloned into pBluescript II KS (-), except for the Rnf220 riboprobe, which was cloned into 
pGem-T Easy (Promega). 
 
 
Forelimb autopod bone measurements 
 
Embryonic day 18.5 forelimbs stained with alcian blue and alizarin red from M280tm1/tm1, 
M1442tm1/tm1, or 129S6/SvEv (wild type) mice were cut so as to separate the forearm, which 
includes the autopod/stylopod (radius + ulna + hand), from the hind arm. Genotyped limbs were 
obtained from heterozygous intercrosses between either M280tm1/+ or M1442tm1/+ mice, or from 
homozygous intercrosses between either M280tm1/tm1, M1442tm1/tm1, or 129S6/SvEv (wild type) 
mice. The forearms were then placed, palm-side down, into the 13 mm diameter, 1 mm depth 
well of a 25 x 25 mm silicon isolator (Electron Microscopy Sciences, cat. # 70336-02) that was 
fitted onto a 25 x 75 x 1 mm microscope slide The small well in the middle of the silicon 
isolator was filled with 1:1 95 % ethanol:glycerol; the well with forearm was capped with a 22 
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Table 4. Primer sets for Whole Mount In Situ Hybridization. All sequences read from 5’-3’. 	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Targeted 
transcript/ 
Sequence 
cloned into 
vector 
Adaptor 
Restriction 
Enzyme Sites 
Engineered 
into Primers: 
Forward/ 
Reverse 
Forward Primer Reverse Primer 
Dmap1 SacII (Rev.) CGTAGTTATTCAC GATCGGTATGACCAC 
AGTCCGCGGATTC 
AGACACTGTTGGCTCAG 
Kifap3 XbaI/XbaI TGTCTAGAAAAGA CACGAGCTTTGGCAAG 
AATCTAGACTTA 
AAGCGGTCATCCATGC  
Nme7 XhoI/PstI GCACTCGAGAATC AGAGCGAGAGATTCG 
CTCTGCAGCAGATG 
CAAAAGTATCAGG 
Rnf220* N/A ACGGAGGAAGC AAGATGAAGGG 
CCGAGATAGCTG 
CCGTTCAAGC 
Shh** N/A N/A N/A 
 
*Obtained from www.informatics.jax.org; primer set ID: MTF1124 
 
**Obtained from A. McMahon Lab (Echelard et al., 1993) 
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by 22 mm slide cover. Light pressure was applied to the slide cover to ensure that the forelimbs 
from each individual were oriented uniformly. Images of limbs were taken on a Leica M205 
Fluorescence Microscope with fluorescent filters removed (brightfield) at the same 
magnification and settings. Because the lacZ expression patterns driven by both M280 and 
M1442 did not intersect with the developing stylopod (radius and ulna) we expected the 
morphology of the radii to be unaffected by the enhancer deletions in our two lines of targeted 
mice. Upon measuring the mineralized portion (stained red by alizarin red) of E18.5 radii we 
found there to be no statistical difference in the length of radii between genotypes when 
corrected for body weight. Therefore, all of our subsequent measurements of autopod bone 
elements were normalized to an individual’s radius length. Bone lengths were measured in both 
right and left autopods in Photoshop using arbitrary units with the ruler tool. Measurements for 
right and left bone elements were averaged and used in the final calculations. 
 In accordance with the expression pattern in our M280-pGW-HSP-LZ transgenic mice, 
bone elements of forearm digit III were measured in E18.5 M280tm1/tm1 embryos and compared 
to wild-type controls: third metacarpal, phalanges 1-3. Digit III bone elements (mineralized as 
well an un-mineralized portions) were measured individually and then length measurements 
were combined for a total length that was normalized to radius length. 
 In accordance with the expression pattern in our M1442-pGW-HSP-LZ transgenic mice, 
the mineralized as well an un-mineralized portions of forearm digits I and IV were measured in 
E18.5 V442tm1/tm1 embryos and compared wild-type controls: phalanges 1-2 for digit I; fifth 
metacarpal and phalanges 1-3 for digit IV. Bone elements for each digit were measured 
individually and then length measurements were combined for a total length that was 
normalized to radius length. 
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Measurements of E15.5 Crown-rump (CR), mandible, ulna and humerus lengths 
 
Images of whole E15.5 embryos were taken on a Leica M205 Fluorescence Microscope 
with fluorescent filters removed (brightfield) at the same magnification and settings. In Adobe 
Photoshop the length of the desired cartilage element (e.g. CR-length or mandible length) was 
measured using the ruler tool and lengths are reported as “arbitrary length units.” 
 
Limb-only bone and cartilage stain 
 
Collected E18.5 embryos were placed in a 100 mm petri dish, sealed with paraffin, and left at -
20°C overnight. (The E18.5 time point was chosen to avoid weight and size differences that may 
have resulted from chance differences in nursing opportunities). The next day embryos were put 
into water that had cooled for one minute after boiling. Embryos were left in the water for 15-30 
seconds, until skin turned a milky white (blanched). After briefly patting the embryos dry, the 
skin was completely removed from the fore- and hindlimbs and then the limbs were dissected 
off the rest of the embryo: Scapula to digits for forelimb, and tibia to digits for hindlimb. Limbs 
were placed in 95% ethanol overnight without rocking to avoid damage to the digits. Limbs 
were then moved to 25 mm petri dishes filled with filtered alcian blue stain (20% acetic acid, 
0.05% alcian blue in 95% ethanol; filtered with Whatman paper) and left overnight, or for 
approximately 12 hours. (To keep the limbs from being jostled too much during solution 
changes they were placed inside open tissue cassettes that sat inside the petri dishes). After 
alcian blue staining the limbs were washed several times in 95% ethanol over five hours. Cover 
the limbs in 1.5% potassium hydroxide (KOH) for one hour, then change to 0.5% KOH and 
leave overnight. Early the next morning change the solution to alizarin red stain (0.5 % KOH, 
0.015% alizarin red in water), completely covering the limbs, and before leaving for the day 
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change the solution to 0.5% potassium hydroxide/20% glycerol. Leave limbs in 0.5% potassium 
hydroxide/20% glycerol for one full day. When samples are appropriately cleared (~24 hours), 
place them in glycerol:95% ethanol (1:1) for documentation and storage. 
 
Embryonic cartilage staining; limb alignment; assay for transient developmental defects 
 
Embryonic day 13.5-15.5 embryos were stained with alcian blue to visualize cartilage as 
described elsewhere (Nagy et al., 2003), with the following changes: E13.5 embryos stained in 
alcian blue for 2-3 hours, E14.5 embryos stained for 4-5 hours, and E15.5 embryos for 6.5-7 
hours. Left limbs are dissected away from stage-matched embryos from and imaged with a 
Leica M205 Fluorescence Microscope with fluorescent filters removed (brightfield) at the same 
magnification and settings. In Adobe Photoshop limbs are aligned together in one file, with the 
proximal tip of the ulna as the reference point. Embryonic limbs are then traced in Adobe 
Illustrator and overlaid onto one another. Because of minor but common differences in 
developmental maturation between litters, mutant and control embryos were compared only if 
from the same litter. In this manner I could assess whether mutant limb elements were larger or 
smaller or aberrantly shaped relative to controls. Similar to the analysis performed with E18.5 
digit lengths, I assessed developmental progression of autopod elements that would likely be 
affected by the absence of the deleted enhancers based on the expression patterns in my driven 
by each enhancer in our stable transgenic lines. Mutant and control autopods were scored as 
equal or non-aberrant if half the cartilage elements under consideration, plus one, were of equal 
size and shape when their outlines were overlaid on one another. Equality was also scored if 
there was a combination of equal, large and small mutant elements within a single pairwise 
comparison, with the count of any category never exceeding the majority of elements under 
consideration. In contrast, mutants were scored as aberrant and smaller than controls if one half 
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of the elements under consideration, plus one, were smaller in size and shape that control 
elements. Aberrantly large mutant autopods were scored in the same manner as aberrantly small 
autopods. 
 
X-gal and Salmon-gal detection of transgene activity 
 
Either X-gal (Goldbio.com; Cat # X4281C) or Salmon-gal (LabScientific, Inc; Cat# X668) was 
used as a substrate to detect lacZ expression in my transgenic mouse lines following established 
procedures (Nagy et al., 2003; Sundararajan et al., 2012). Both reactions were carried out either 
the same day or the day after collection of embryos. Salmon-gal was used only for the weakly 
expressing M280GWtg lines (see Results chapter). When using the Salmon-gal protocol 
(Sundararajan et al., 2012) I left embryos in Salmon-gal Staining Solution for 30 minutes. 
Embryos were fixed before the staining reaction in 4% paraformaldehyde, but were not post-
fixed. After X-gal or Salmon-gal staining embryos were washed in PBS, imaged (in PBS) if 
necessary, and stored in 70% ethanol. 
 
Nuclear Fast Red, and Hematoxylin and Eosin staining of embryonic limb sections 
 
To assess the extent of lacZ expression in my transgenic lines, embryos from E11.5-E15.5 were 
embedded in Paraffin wax and sectioned at between 6 and 12 microns. Sectioned material was 
counterstained with Nuclear Fast Red (Sigma-N3020) for approximately 3-5 minutes. 
Embryonic day 18.5 limbs were collected for histological sections using hematoxylin and eosin 
(H&E) stains. Prior to embedding into Paraffin wax, E18.5 limbs were fixed in 10% Formalin 
overnight, washed three times in PBS for at least 10 minutes, and rinsed in 0.5M EDTA for 48 
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hours to remove calcium deposition of the bone. Sections of E18.5 limbs ranged from 6-10 
microns.  
 
Method for identifying potential shadow enhancers near M280 
 
The sequence for M280 was entered into the ECR Browser (http://ecrbrowser.dcode.org) 
using the appropriate genomic coordinates (mm9). It was noticed that extending from mouse to 
Xenopus laevis (frog) there are two conserved peaks within this regulatory region [520 (large) 
and 148 (small) bps, respectively]. Both the large and small sequence blocks derived from the 
frog genome were selected by clicking; within the new dialogue box the TFBS option in the 
upper right was selected. Once taken to the webpage “http://rvista.dcode.org/cgi-
bin/rFromXB.cgi”  the default parameters were left as they were (i.e. vertebrate, etc.). All TF 
binding sites (TFBS) were selected and submitted (i.e. SELECT ALL option). A list of  184 
conserved putative TFBS was returned. This list was narrowed down to 14 TFBS by looking for 
an association between the name of the TF and the key words “limb, development, mouse” on 
both Pubmed and GoogleScholar (Appendix 1). These 14 TFBS then allowed me to interrogate 
other forms of putative regulatory sequences around M280 (p300-bound sites and highly 
conserved human-mouse-rat sequences); the prediction was that shadow enhancers for M280 
would harbor similar clusters of these 14 TFBS.  
The list of putative M280 shadow enhancers ± 1 Mb from M280 was generated from two 
previously published datasets: A) limb-specific p300 binding sites (N=6), see Supplemental 
Material in Visel, et al., 2009); and B) regions of highly constrained conservation between 
humans, rats, and mice (N=12; although not ultraconserved), see Supplemental Material in 
Visel, et al., 2008. FASTA files for each putative shadow enhancer were genetated; sequences 
used were from  mouse genomome build mm9 (UCSC Genome Browser). Mouse genome 
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coordinates for each putative shadow enhancer were then submitted to the ECR browser; which 
generated a visual readout of multi-species alighnements. Aligned sequences corresponding to 
hg19 (human genome; (which had been aligned to the mm9 base sequence on the ECR Browser) 
were then clicked. In the top right of the new dialogue box the tab labeled “conserved 
transcription factor binding sites” was selected. This opens up a new window 
(http://rvista.dcode.org/cgi-bin/rFromXB.cgi). In the new rVista widow I clicked Submit. In the 
next window I selected the following TFBS based on their association with limb development as 
previously described: AP2ALPHA, CHX10, CLOX, E2F1_Q3, E2F1DP1RB, E2F4DP1, 
E2F_Q3, ETS_Q4, ETS_Q6, FOXM1, GATA2, HOXA4, NRF2, PEA3. I then clicked Submit 
and then, in turn, Check It. To collect the list of conserved TFBS I clicked on the tab labeled 
“Conserved” under the “Summary” option. The output file generated permitted me to visualize 
the conserved TFBS between mm9 and hg19. In the readout the first sequence is the mouse 
sequence, the second is the human sequence. The best candidate shadow enhancers for M280 
were selected based on their possession of clusters of TFBS originally identified in the large and 
small block of conservation descrived in above.  
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RESULTS 
 
As was briefly explained above, the enhancers I selected to characterize were based 
largely on images of previously generated transgenic mice (Table 2). These images indicated at 
least partially, through the presence of a well-defined lacZ expression pattern, the regulatory 
capabilities of the enhancers. Importantly, the imaged transgenic mice were made using human 
genomic sequences (Pennacchio et al., 2006; Visel et al., 2007b; Visel et al., 2009a) and were 
scored for limb-specific (and other tissues) lacZ expression at a single time point, E11.5. 
Therefore, it was necessary to assess whether the orthologous mouse enhancer behaved in a 
similar manner. To do this I generated a series of transgenic mice that harbored transgenes 
wherein the reporter gene, lacZ, was driven by either M280 or M1442, and a minimal promoter, 
HSP68 (Kothary et al., 1989) (Table 5). 
 
Gross analysis of M280 transgenic mice 
 
Initially, M280 was cloned upstream of the minimal promoter, HSP68, and the reporter 
gene, lacZ, using traditional cloning methods. The linearized and purified transgene was then 
injected into F2 zygotes from (C57BL/6 X SJL)F1 intercrosses and transferred to 
pseudopregnant Swiss females via oviduct transfer. As a first pass to determine whether M280 
behaved similarly to hs280, I collected E11.5 embryos (G0 embryos) from foster mothers and 
scored them for the presence of the M280 transgene via lacZ staining (Fig. 2B).  
 Embryos with a positive lacZ signal possessed an expression pattern comparable to that 
seen in hs280-transgenic mice from the VEB (Fig. 2A, B). The expression pattern was triangular 
or wedge-shaped in appearance and was centered in the middle of the autopod portion of the 
limb bud. The autopod-centered expression pattern in the M280-transgenic mice differed from 
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Table 5. Summary of M280 and M1442 transgenic mice. 	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Summary	  of	  transgenes	  constructed	  with	  M280	  
Vector	  
backbone	  used	  
Zygote	  strain	  
for	  pronuclear	  
injection	  
#	  lacZ	  positive	  
/	  genotyped	  
positive	  for	  
transgene	  
Embryos	  
collected	  at	  
E11.5	  (G0)	  or	  
stable	  line	  
produced	  
Expression	  
pattern	  in	  limb	  
buds	  at	  E11.5	  
similar	  to	  that	  
reported	  on	  
the	  VEB	  (see	  
Table	  4	  and	  
Figs.	  2)^	  
phspPTlacZpA*	   [C57BL/6 X SJL]F1 Intercross	   2/2	   G0	  
1	  embryo	  similar;	  1	  embryo	  dissimilar	  (expression	  throughout	  limb	  bud)	  pGW-­‐HSP-­‐LZ**	   FVB/N	   7/8	   G0	   Similar	  pGW-­‐HSP-­‐LZ**	   FVB/N	   3/5	   Stable	   Similar	  	  
Summary	  of	  transgenes	  constructed	  with	  M1442	  
phspPTlacZpA*	   [C57BL/6 X SJL]F1 Intercross	   1/1	   G0	   Dissimilar	  (no	  expression	  in	  posterior	  limb	  bud)	  pGW-­‐HSP-­‐LZ**	   FVB/N	   4/4	   G0	   SimilarŦ	  pGW-­‐HSP-­‐LZ**	   FVB/N	   2/8	   Stable	   SimilarŦ	  	  *See	  Kothary	  et	  al.,	  1989	  **	  See	  Visel	  et	  al.,	  2007b;	  Visel	  et	  al.,	  2008	  ^See	  also	  Figs.	  4,	  5,	  7	  and	  9	  Ŧ	  In	  addition	  to	  the	  predicted	  posterior	  expression	  pattern,	  forelimbs	  also	  showed	  lacZ	  expression	  in	  the	  anterior	  margins	  of	  the	  autopod	  (see	  text).	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Figure 2. G0 M280 and M1442 Transgenic mice collected at E11.5. (A-F) Related to M280 
enhancer. (G-L) Related to M1442 enhancer. (A) Image of hs280 transgenic embryo taken from 
the VEB (enhancer.lbl.gov; Visel et al. 2007b). (B) Transgenic embryo that harbors transgene 
composed of M280, HSP68 and lacZ. (C-F) Representative transgenic embryos that harbor 
transgene composed of M280 flanked by Gateway recombination sites (see text), HSP68 and 
lacZ. (E, F) Close-up of right limb buds. (G) Image of hs1442 transgenic embryo taken from the 
VEB (enhancer.lbl.gov; Visel et al. 2007b). (H) Transgenic embryo that harbors transgene 
composed of M1442, HSP68 and lacZ. (I-L) Representative transgenic embryos that harbor 
transgene composed of M1442 flanked by Gateway recombination sites (see text), HSP68 and 
lacZ. (K, L)) Close-up of right limb buds. Scale bars in (B) and (H) are 0.5 mm. Scale bars in (F) 
and (K) are 0.25 mm. 	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that in their hs280 counterparts in that the intensity of the lacZ signal diminished towards the 
distal edge of the autopod, whereas the four hs280-transgenic embryos on the VEB showed 
strong lacZ expression extending from the center of the autopod to its distal borders. 
Nonetheless, our G0 M280-transgenic mice confirmed that M280 possesses similar regulatory 
capabilities as its orthologous human sequence. The differences in limb bud lacZ expression 
could be due to sequence diversity throughout the entire length of the orthologous sequences or 
to the site of transgene insertion, which could influence the activity of the enhancer. 
 My M280 G0 E11.5 transgenic embryos also manifested lacZ expression in locations 
other than the limb, including the neural tube, the isthmus between mid- and forebrain, the oral 
groove region of the first pharyngeal arch and the tail bud. Some of the extra-limb patterns of 
expression are also seen in the hs280-transgenic mice on the VEB website, including the neural 
tube, tail bud and regions of the first-through-third pharyngeal arches (Fig. 2). 
 After generating the M280 transgene using traditional cloning methods I decided to 
make another construct that was a more faithful mimic of that used to generate the transgenic 
mice on the VEB. The human-sequence-based transgenic mice I was comparing our transgenic 
embryos to contained transgenes composed of the minimal promoter, HSP68, and lacZ as well, 
but the enhancers were inserted into the transgene vector using the Invitrogen Gateway 
Technology cloning system rather than with traditional cut-and-paste cloning techniques (Ko, 
2001). In the Gateway system, fragments of interest are transferred from one plasmid to another 
via site-specific recombination events mediated by agents based on the activity of the 
bacteriophage lambda. Although the recombination event that transfers, say, an enhancer 
sequence, into an expression vector containing HSP68 and lacZ, does not require the use of 
restriction enzymes it does leave behind short sequences from the recombination sites (various 
types of att sites) that flank the transferred sequence – the enhancer in this case. Therefore, to 
recapitulate the transgenic environment used in the embryos on the VEB as faithfully as 
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possible I decided to re-construct the M280-transgene using the Gateway system. This enabled 
me to have more confidence that any similarities or differences observed in the expression 
patterns of the hs280- and M280-transgenic mice were due to the species-specific enhancers and 
not to the flanking transgene environments. 
 To make a new transgene utilizing Invitrogen Gateway Technology (M280-GWtg) I 
subcloned M280 into the Gateway vector that would then permit me to move the enhancer to 
any other Gateway vector of my choice (pENTR 3C, Invitrogen, A10560). The M280 enhancer 
was then moved to the same vector used to generate the human-based transgenic mice observed 
on the VEB (Pennacchio et al., 2006; Visel et al., 2007b), which contained a Gateway cloning 
site, the HSP68 minimal promoter and the lacZ reporter gene. 
 As was done for the original M280-transgenic embryos, M280-GWtg embryos were 
initially collected at E11.5 (G0) and scored for their lacZ expression patterns in limb buds to 
verify that the M280 regulated a well-defined, limb-specific expression pattern in the context of 
the Gateway transgene similar to that observed in hs280-transgenic embryos. Positive lacZ 
expression was scored in eight embryos from this experiment, seven of which exhibited a 
reproducible expression pattern in both the fore- and hindlimb autopods (Fig. 2C-F). As was the 
case for previously described expression patterns driven either by M280 or hs280, these seven 
transgenic embryos’ lacZ expression was triangular or wedge-shaped, with the base of the 
triangular expression pattern running along the distal margins of the autopod (Fig. 2E, F). In 
strongly expressing individuals, the lacZ expression pattern was most intense in the middle of 
the autopod; additionally, the intensity of the signal was maintained up to the distal border of the 
autopod in a region that would correspond to the location of digit III. Moderately intense lacZ 
expression was also detected in the regions that would likely give rise to digits II and IV. In 
weakly expressing individuals the lacZ expression pattern was mostly confined to the middle of 
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the autopod, and in some cases extended towards the distal autopod margin, though faintly, into 
the region of future digit I.  
 Seven of the eight positively expressing embryos had lacZ expression in the tail bud and 
in the pharyngeal arches. Particularly consistent, is the expression in the proximal margins of 
the oral groove of the first pharyngeal arch. Half of the embryos displayed neural tube 
expression that extended from at least the hindbrain through to the tail, and five of the eight 
embryos appeared to have lacZ expression that outlined the somites in the posterior half of the 
embryo. In some of these cases it appeared that the nerves emanating from the developing 
neural tube (spinal cord) were also lacZ positive. Therefore, though M280 directs gene 
expression in a specific, delimited manner in E11.5 limb buds it also possesses the capacity to 
consistently direct expression in at least the E11.5 neural tube, tail bud and first pharyngeal arch 
(Fig. 2C, D). 
From these observations I concluded that M280 can consistently drive gene expression 
in the middle of the autopod at E11.5 in regions that approximately correspond to the future 
locations of digits I-III and perhaps to regions that will give rise to the distal portions of wrist 
and ankle elements. Consistent with the intent of this project, I determined to focus my 
assessment of M280 as it relates to limb development, leaving close attention to the extra-limb 
expression patterns for a later time. With this information in hand I decided to generate stable 
M280-GWtg lines to assess the regulatory capacity of M280, specifically in the limb, throughout 
development. 
I designed a primer set to specifically detect the presence of the M280-GWtg. Of five 
M280-GWtg positive mice, three produced embryos that had detectable lacZ expression in 
E11.5 limbs. Two of these three stable lines expressed lacZ relatively weakly. Therefore, only 
two lines were used to characterize M280’s regulatory capacity throughout development, one of 
the weak lines (M280-GWtg-Line 1, or just M280L1) and the remaining, relatively strongly 
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expressing line (M280-GWtg-Line 2, or just M280L2). Because neither of our stably expressing 
lines showed a lacZ expression pattern as intense as those observed in our G0 embryos, I decided 
to change the protocol used to detect lacZ expression. Traditionally, X-gal (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside), an organic compound made from galactose linked to indole, is 
cleaved by β-galactosidase (enzyme product of the lacZ gene) and the products of this reaction, 
in the presence of ferric and ferrous ions, form the blue precipitate that is scored in lacZ-reporter 
gene experiments. A more sensitive approach to detecting lacZ expression/activity is achieved 
by using Salmon-gal (S-gal; 6-chloro-3-indolyl-β-D-galactopyranoside) in conjunction with the 
tetrazolium salt NBT (nitroblue tetrazolium) (Sundararajan et al., 2012). The sensitivity of the 
S-gal approach to detecting lacZ activity can also easily lead to high background; therefore the 
amount of time that embryos were left in the S-gal + NBT solution was determined empirically 
(Fig. 3; see Materials and Methods). 
Embryos assayed for lacZ expression from both lines indicated that the limb-specific 
expression pattern regulated by M280 spans a narrow window of mouse embryonic 
development, from E10.5 to E11.5 (Figs. 4 and 5). In both lines, limb bud expression was first 
detected at E10.5 and only persisted through to E11.5. In all E12.5 M280-GWtg embryos 
collected I never detected lacZ expression in the developing limb. The shape of the expression 
pattern in E10.5 limb buds presaged the somewhat triangular shape of the E11.5 expression 
pattern. Moreover, lacZ expression was just as intense at E10.5 as it was at E11.5. The intensity 
of the signal in S-gal stained embryos also permits one to appreciate that the expression pattern 
appears to be mesenchymal and that it does not extend into ectodermal cells (such as the AER; 
this was later confirmed by sectioning through M280-GWtg limb buds; Figs. 3 and 6). The 
narrow window of M280-regulated, limb-specific expression implies that any aberrations in 
limb development, specifically in digits II-VI, in mice lacking M280 would likely be the result 
of gene misregulation early in the mesenchymal cells that give rise to these autopod elements. 
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Figure 3. Salmon-gal staining technique preferred to detect lacZ expression in M280L1 and 
M280L2. (A-C) E11.5 M280L1 embryos. (D-F) E11.5 M280L2 embryos. (A, D) Reporter gene 
expression assayed with X-gal. (B, E) Reporter gene expression assayed with Salmon-gal; 
incubated overnight at room temperature. (C, F) Reporter gene expression assayed with Salmon-
gal; incubated for 30 minutes at 37° C. Red rectangles indicate conditions selected for all 
subsequent analyses of M280L1 and M280L2. Scale bars = 0.5 mm. 	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Figure 4. M280L1 drives lacZ expression in E10.5 and E11.5 limb buds. (A-D) Control 
embryos. (E-H) M280L1 embryos. (A, E) E9.5. (B, F) E10.5. (C, G) E11.5. (D, H) E12.5. Scale 
bars = 0.5 mm. 	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Figure 5. M280L2 drives lacZ expression in E10.5 and E11.5 limb buds. (A-E) Control 
embryos. (F-J) M280L2 embryos. (A, F) E9.5. (B, G) E10.5. (C, H) E11.5. (D, I) E12.5. (E, J) 
E13.5. Scale bars = 0.5 mm. 	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Figure 6. Cross-section through E11.5 M280-GWtg limb bud. (A) E11.5 forelimb bud. (B, C) 
Sections through E11.5 limb bud. Dotted lines (a) and (b) Show approximate section planes 
shown in (a’) and (b’). M280 is capable of driving lacZ expression in mesenchymal cells, but not 
ectodermal cells. M280-driven expression is strongest in the center of the forelimb bud, 
corresponding to the future location of digit III. Scale bar in (A) is 0.5 mm. Scale bar in B applies 
to C as well, and is 100	  μm. 	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Expression of lacZ was also detected in the posterior neural tube, somites and tail bud as 
early as E9.5 (Figs. 4 and 5). Expression in the tail bud is maintained until E12.5, and 
occasionally at the very tip of the tail in E13.5 embryos. The most intense lacZ expression in the 
pharyngeal arches occurs at E10.5, and is clearly intense in arches 1-3, particularly in the oral 
groove of arch 1. The expression in the arches is weaker at E11.5, and concomitant with the 
development of more advanced facial structures at E12.5 the expression in the craniofacial 
region is absent or weak embryos of this age. 
 
Histological sections of M280 transgenic mice 
 
To gain a better understanding of the spatial extent of the expression pattern regulated by 
M280, we sectioned numerous forelimb buds from E11.5 M280GWtg embryos. Sections were 
then stained with Nuclear Fast Red to distinguish lacZ-expressing cells from non-expressing 
cells. (Expression of lacZ in the sectioned embryos was originally assayed using X-gal rather 
than S-gal because at the time of sectioning we had not decided to use S-gal). Cells positive for 
lacZ were observed in the central interior of the E11.5  limb buds (Fig. 6). Expression was 
especially intense in the core group of expressing cells and weakened gradually, in gradient 
fashion, at increasingly greater distances from the core expressing cells. Cells positive for lacZ 
were not observed in the ectoderm, lending credence to the observation in over-exposed, S-gal 
stained M280GWtg embryos that M280 does not regulate gene transcription the AER. I did not 
section transgenic embryos from other time points because M280 is active in the limb during 
such a narrow developmental window that it did not seem necessary. The lacZ expression 
pattern noted in the sections corresponds to that detected in whole transgenic embryos and 
further supports the hypothesis that mice lacking M280 could potentially manifest defects in the 
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development of the central autopod. Specifically, tissues corresponding to digits II-IV, but 
especially digit III, may be adversely affected in a developing limb bud that lacks M280. 
 
Gross analysis of M1442 transgenic mice 
 
As was the case with M280, M1442 was cloned upstream of the minimal promoter, 
HSP68, and the reporter gene, lacZ, using traditional cloning methods. The linearized and 
purified transgene was then injected into F2 zygotes from (C57BL/6 X SJL)F1 intercrosses and 
transferred to pseudopregnant Swiss females via oviduct transfer. As a first pass to determine 
whether M1442 behaved similarly to hs1442, I collected E11.5 embryos (G0 embryos) from 
foster mothers and scored them for the presence of the M1442 transgene via lacZ staining (Fig. 
2H). 
 Only a single embryo positive for this M1442 transgene displayed lacZ expression in the 
E11.5 limb, and the pattern was somewhat different from that seen in hs1442-transgenic mice 
from the VEB (Fig. 2G, H). The M1442 transgenic embryo manifested a lacZ expression pattern 
that ran along the anterior flank of the forelimb, with the highest intensity near the proximal 
margins of the limb bud and the weakest expression about midway along the anterior margins of 
the autopod. No expression was seen in the distal margins of the autopod, nor was expression 
detected in the posterior margins of the autopod as had been the case for ten of the eleven 
embryos expressing lacZ under control of hs1442 as reported on the VEB. A similar, though 
fainter, expression pattern was seen in the hindlimbs of the M1442 transgenic embryo. Portions 
of the frontonasal complex, forebrain, midbrain and numerous anterior somites also showed 
lacZ expression; a single embryo on the VEB also shows forebrain lacZ expression. Therefore, 
though my single M1442 transgenic embryo did not compare extensively with hs1442 
transgenic embryos, it did demonstrate that M1442 could at least direct gene expression in 
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E11.5 limb buds. Moreover, I was not willing to draw meaningful conclusions from a single 
embryo – the somewhat novel expression pattern in the anterior region of the limb bud could 
have been the result of the site of transgene insertion or it could have been the result of enhancer 
sequence differences between mouse and human. By the time this single transgenic result was 
available I had already made additional M1442 transgene constructs using the Invitrogen 
Gateway Technology to more faithfully mimic the transgene vectors used on the VEB. 
Consequently, we generated G0 transgenic embryos using constructs composed of M1442 and 
the Gateway reporter construct described above (M1442-GWtg). 
As was done for the original M1442-transgenic embryo, M1442-GWtg embryos were 
initially collected at E11.5 (G0) and scored for their lacZ expression patterns in limb buds to 
determine whether the M1442 regulated a well-defined, limb-specific expression pattern in the 
context of the Gateway transgene similar to that observed in hs1442-transgenic embryos. 
Positive lacZ expression was scored in four embryos from this experiment; all embryos 
manifested an identical limb bud expression pattern, though in one of the four the signal was 
very weak. Similar to hs1442-transgenic embryos, M1442-GWtg embryos had intense lacZ 
expression in the posterior margins of the autopod in both fore- and hindlimbs (Fig. 2I-L). 
However, this posterior expression was less graded towards the middle and anterior regions of 
the bud than that seen in numerous hs1442-transgenic embryos on the VEB. Curiously, as was 
seen in the single M1442-transgenic embryo described previously (non-Gateway) the forelimbs 
of G0 M1442-GWtg embryos indicated active lacZ expression in the proximal-anterior borders 
of the limb bud (Fig. 2K, L). Again, this pattern was observed only in forelimbs, and was not 
observed in any hs1442-transgenic embryos on the VEB. It is very likely that the M1442-GWtg 
inserted into different locations in the four embryos. Therefore, the proximal, anterior lacZ 
expression patterns are not likely due to the random regulatory inputs at the sites of transgene 
integration, rather they may be due to sequence differences between the mouse and human 
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enhancers. M1442-GWtg embryos also expressed lacZ in the genital tubercle; this was noted in 
nine of eleven hs1442 embryos on the VEB. One of the four M1442-GWtg embryos also 
showed expression in the developing eye. These observations permitted me to conclude that 
M1442 is capable of driving gene expression in the posterior and anterior margins of E11.5 limb 
buds. With this information in hand I decided to generate stable M1442-GWtg lines to assess the 
regulatory capacity of M1442, specifically in the limb, throughout development. 
 I designed a primer set to specifically detect the presence of the M1442-GWtg. Of eight 
M1442-GWtg positive mice, two produced embryos that had detectable lacZ expression in 
E11.5 limbs. Thus, these two lines were used to characterize M1442’s regulatory capacity 
throughout development (M1442-GWtg-Line 1 and Line 2, or just M1442L1 and M1442L2). I 
will describe the expression pattern born by M1442-GWtg in each line in turn, beginning with 
M1442L1. 
At E9 in 1442L1 there is lacZ expression almost throughout the whole embryo, but it is 
particularly intense in the flanks of the embryo about a third of the distance from the developing 
tail bud, just ventral to the somites, in what is likely the lateral plate mesoderm that gives rise to 
the mesenchymal portion of the limb bud (Fig. 7A). By E10.5, reporter gene expression is 
weakly expressed in the limb bud in a diffuse manner, with a slightly more intense signal 
coming from the bud’s posterior half (Fig. 7B). Similar to the patterns seen in previously 
described M1442-based transgenic embryos, by E11.5 the intense posterior signal of lacZ 
expression is detectable in fore- and hindlimb buds (Fig. 7C). Also visible at this time point is 
expression in the now expected proximal-anterior borders of the forelimb bud – though this 
signal is less intense than that of the posterior limb bud. By E12.5 it is clear that the posterior 
autopod expression is confined to the regions just proximal to and including the mesenchymal 
condensation that will give rise to digit V (Fig.7D). Additionally, the proximal, anterior 
expression has intensified. Also noteworthy is the fact that there is no intense proximal, anterior 
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Figure 7. M1442L1 drives lacZ expression in the limb throughout development. (A-F) E9.5-
E14.5 embryos, respectively. (G, H) Dorsal view of E15.5 forelimb and hindlimb, respectively. 
(I-J) Dorsal and ventral view E16.5 forelimb, respectively. (K, L) Dorsal and ventral view of 
E16.5 hindlimb, respectively. Strong lacZ expression begins in the anterior forelimb at E13.5 and 
continues in the region of digit I until E16.5 (white arrowheads). Scale bars = 0.5 mm. 	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lacZ expression in the hindlimb at this point. In E13.5 forelimbs the posterior expression pattern 
is clearly confined to the base of future digit V and tissue just proximal to it – tissue that likely 
corresponds to posterior wrist elements (Fig. 7E). Importantly, at E13.5, the anterior lacZ 
expression is now detectable more distally than it was before, being present in developing digit 
I. In E13.5 hindlimbs one can detect expression in developing digit V, as well as a faint 
indication that anterior lacZ expression is present as a thin line running along the anterior border 
where the ventral and dorsal domains of the developing limb meet. Embryonic day 14.5 lacZ 
positive limbs are similar to E13.5 (Fig. 7F). By E15.5, expression is intense throughout 
forelimb digit I and in the wrist region just below the base of digit V (Fig. 7G, H). Hindlimbs at 
this time point are characterized by relatively intense lacZ expression in the tip of digit I. 
Expression is diminished greatly in digit I of forelimbs by E16.5, and is all but absent in the 
hindlimb footplate (Fig. 7I-L). Interestingly, expression is present in the skin throughout the 
entire limb and embryo in general at E16.5. Indeed, if the skin is removed one can see that there 
is very little expression in the underlying tissue (sections of M1442-GWtg animals also show 
that M1442 can direct expression in the dermis of E15.5 embryos; Fig. 8). At E17.5 lacZ 
expression is absent in the limb (not shown). Thus, M1442L1 embryos demonstrate that 
M1442’s regulatory capacity is dynamic, active in specific, but changing locations of the 
developing limb, with a strong activity in the anterior and posterior margins of the limb bud. 
In E11.5 embryos from the M1442L2 line, lacZ expression is intense in both the anterior 
and posterior margins of the forelimb. In the hindlimb, though the expression is strongest in the 
posterior bud, there is a patch of relatively strong expression near its anterior base (Fig. 9A). 
Reporter gene expression persists in this manner in the limb bud through to E14.5 (Fig. 9B-D). 
The intensity of the lacZ signal decreases in the anterior border of the forelimb as development 
progresses on until it is concentrated largely into digit I; a similar process occurs in the 
hindlimb, with intense anterior expression confined to the distal tip of digit I by E15.5 (Fig. 9E, 
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Figure 8. E16.5 M1442-GWtg expression confined largely to skin. (A) E16.5 control embryo. 
(B) E16.5 M1442-GWtg embryo. (C, E) Dorsal view of skinned M1442L1 and M1442L2 
forelimbs, respectively. (D, F) Ventral view of skinned M1442L1 and M1442L2 forelimbs, 
respectively. Note the strong expression that still remains in the region of the falciform carpal, 
proximal to digit I. (G) Section through digits of an E15.5 M1442-GWtg forelimb showing lacZ 
expression confined to region corresponding to developing dermis. All scale bars = 0.5 mm, 
except in (G) wherein scale bar = 25µm. 	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Figure 9. M1442L2 drives lacZ expression in the limb throughout development. (A-D) 
E11.5-E14.5 embryos, respectively. (E, F) Dorsal view of E15.5 forelimb and hindlimb, 
respectively. (G, H) Dorsal and ventral view E16.5 forelimb, respectively. (I, J) Dorsal and 
ventral view of E16.5 hindlimb, respectively. (K, L) Ventral view of E17.5 M1442L2 positive 
forelimb and hindlimb, respectively. Strong lacZ expression begins in the anterior forelimb at 
E14.5 and continues in the region of digit I until E16.5 (white arrowheads). Anterior expression 
in the hindlimb begins at E14.5 but does not persist in digit V beyond E15.5. M1442L2-mediated 
limb expression ceases by E17.5. Scale bars = 0.5 mm. 	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F). Also, in E15.5 forelimbs there appears to be expression in the developing epidermis, and 
perhaps the underlying tissues as well, near the base of digits II-IV. By E16.5, M1442L2 
forelimbs have lost their intense lacZ expression in digit 1 and expression has largely moved to 
the skin of the entire limb (and the whole embryo in general). As was the case for M1442L1, 
when the skin is removed from E16.5 limbs there is very little lacZ expression in the underlying 
tissue (Fig. 9G-H; Fig. 8). Additionally, at E16.5, digit I in the hindlimb displays no intense, 
unique lacZ signal relative to the other digits (Fig. 9I, J). By E17.5, M1442 ceases to regulate 
gene expression in the fore- and hindlimbs and in the skin of the entire embryo (Fig. 9K, L). 
Comparing the expression patterns of both M1442L1 and M1442L2 embryos permits a 
consensus picture of M1442-regulated, limb-specific gene expression to crystalize. From the 
observations above, I concluded that M1442 is capable of directing expression in the limb bud 
as soon as it begins developing – its activity, though diffuse, obviously exerted at E10.5, but 
also perhaps as early as E9 in the lateral plate mesoderm that gives rise to the limb. 
Furthermore, M1442 is capable of directing gene expression to the anterior and posterior regions 
around digits I and V as early as E11.5 (in Line 2; though digit I expression begins at E13.5 in 
Line 1) and persists until E15.5. By E16.5, digit-specific and wrist/ankle-specific expression 
regulated by M1442 has diminished and regulatory capacity has switched to direct expression in 
the skin. Guided limb-specific gene expression by M1442 stops at E17.5. Therefore, phenotypes 
associated with deleted M1442 would likely result in aberrations in digits I and V, and in the 
wrist/ankle elements at the base of these digits, in particular the hamate, triquetral and pisiform 
bones proximal to digit V. Additionally, the 1442GWtg expression patterns indicate that 
aberrations in mice lacking M1442 could be detected in the developing skin. It is important to 
note too that on the posterior side of the limb, the lacZ expression pattern persists proximally all 
the way to the distal tip of the ulna; though lacZ-expressing cells do not appear in the ulnar tip 
itself there is clear expression in the flanking dermal and mesenchymal cells. Thus, it cannot be 
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ruled out that any necessary cellular crosstalk between the differentiating cells of the ulna and 
the surrounding tissue may also be disrupted in mice lacking M1442, in which case the 
morphology of either communicating tissue may be altered. 
 
Histological sections of M1442 transgenic mice 
 
To gain a better understanding of the spatial extent of the expression pattern regulated by 
M1442 I characterized M1442-driven gene expression in sectioned limbs from two time points: 
E11.5 and E15.5.  
At E11.5 the M1442-GWtgs drive strong expression in the posterior margins of the distal 
forelimb bud (Fig. 10 A-C). The posterior lacZ signal is stronger than the anterior signal and 
extends deeper into the central mesenchymal cells. It is noteworthy that expression is not 
detected in the epidermal cells. From these observations it seems likely that M1442 may 
contribute to the development of distal-posterior structure, such as digits IV and V, as well digit 
I in the anterior limb bud. 
 Serial sections through E15.5 M1442GWtg forelimbs revealed a somewhat complex 
lacZ expression pattern, one that interfaced with developing bone elements, likely dermal cells, 
and soft tissue surrounding both digits and wrist bones (Fig. 11A-E). Tracking the position of 
E15.5 digits through a series of sections is easy enough, but the task of identifying carpal (wrist) 
elements is a bit trickier. Numerous carpal bones have irregular shapes in cross-section and can 
roughly span the entire dorsal-ventral axis of the limb, seemingly changing position from one 
section to the next. To aid in proper identification of carpal bones I compared my cross-sections 
to the color-coded, 3D-reconstructions of mouse limbs found at the EMAP eMouse Atlas 
Project (http://www.emouseatlas.org) (Delaurier et al., 2008; Husz et al., 2012).                              
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Figure 10. Cross-section through E11.5 M1442-GWtg limb bud. (A) Left E11.5 forelimb bud. 
(B, C) Sections through E11.5 limb bud. Dotted lines (a) and (b) Show approximate section 
planes shown in (a’) and (b’). M1442 is capable of driving lacZ expression in mesenchymal cells, 
but not ectodermal cells. M1442-driven expression is strongest in the posterior limb, 
corresponding to the future location of digit V. Scale bar in (A) is 0.5 mm. Scale bar in B applies 
to C as well, and is 50	  μm. 	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Figure 11. Cross-sections through E15.5 M1442-GWtg limb buds. (A) Orientation guide for 
cross-sections. (B) Schematic of left autopod; Arabic numerals and associated vertical lines 
correspond to approximate plane of sections shown in (C) and (D). Boxed Arabic numerals in (C) 
and (D) correspond to vertical lines in (B). (C) Cross-sections through E15.5 M1442L1 forelimb. 
(D) Cross-sections through E15.5 M1442L2 forelimb. (E) Summary diagram of autopod elements 
that manifest lacZ signal in both M1442-GWtg lines. Roman numerals indicate digit rays.  
Abbreviations in (A): D = dorsal, Ve = ventral. Other abbreviations: ce = centrate, fa = falciform 
carpal, ha = hamate, lu = lunate, pi = pisiform, ra = radius, sc = scaphoid, tr = trapezium, tp = 
trapezoid, tq = triquetral, ul = ulna. Scale bars = 50	  μm. 	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In sections of E15.5 forelimbs, lacZ signal is occasionally observed in the distal tip of 
digit V, in the third phalanx. This expression does not persist along the length of digit V, but 
does reappear in the fifth metacarpal (Fig. 11C.3, D.3). It appears to be absent beyond the distal-
most phalanx of digit V. Along the lengths of digits II and III, and digits IV and V, lacZ 
expression does appear to be relatively constant in what looks like the developing dermal layer 
of the skin – this perhaps foreshadows the almost exclusive epidermal expression pattern driven 
by M1442 observed in E16.5 limbs (Fig. 11C.1-3, D.1-3). All distal tissues comprising digit I 
are positive for lacZ expression, but curiously the first metacarpal and carpal elements just 
proximal to the first metacarpal – the trapezium in particular – do not express lacZ (Fig. 11C.2, 
3 and D.2, 3). The more ventral carpal bone known as the falciform carpal is, however, lacZ 
positive (Fig. 11C.5, D.5). This indicates that on the anterior side of the limb, strong M1442 
expression is restricted to digit I and the falciform carpal. In some sections containing cross-
sections of the fifth metacarpal one can see positive lacZ signal in the bone’s interior. Also, in 
one of my transgenic lines, M1442GWtgL2, lacZ expression can be detected in the base of the 
third and fourth metacarpals (Fig. 11D.2).  
 Proximal to the digits, several carpal elements manifest lacZ expression on the posterior 
side of the limb. The lateral, or posterior-most half of the triquetral bone, which is positioned 
below digit V, shows strong X-gal staining, as does the more ventrally located pisiform bone 
(Fig. 11C.5-7 and D.5, 7). Interestingly, while the lacZ expression in the triquetral appears most 
commonly in the interior trabecular bone cells, the expression in the pisiform is found both in 
the interior trabecular cells and in the thin layer of compact cells surrounding the spongy interior 
(Fig. 11C.6, D.7). Also, I cannot rule out that the posterior-most (or lateral-most) portion of the 
hamate bone does not also manifest lacZ expression because in particular sections distinction 
between the hamate and fifth metacarpal is not easily made (Fig. 11C.4, D.4). Therefore, it 
seems plausible to make a general assertion: 1442-driven gene expression in the posterior 
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margins of the distal forelimb are restricted to the fifth metacarpal and to the lateral margins of 
all posterior carpal bones including the hamate, triquetral and the pisiform. The lacZ expression 
pattern noted in the sections corresponds to that detected in whole transgenic embryos and 
further supports the hypothesis that mice lacking M1442 could potentially manifest defects in 
the development of digit I in the anterior autopod, and digit V in the posterior autopod. 
Additionally, carpal bones proximal to digit V, including the hamate, triquetral and pisiform 
bones would also be expected to manifest developmental abnormalities in mice lacking M1442. 
 
Generating M280 Gene targeted mice 
 
To functionally test the role of M280 during mouse limb development we generated 
mice that lacked M280 using traditional gene targeting methods (referred to as M280-knockouts 
or M280tm1 mice; Material and Methods).  Deletion of M280 was carried out in mouse 
embryonic stem (ES) cells derived from a 129S6/SvEv genetic background. I designed Southern 
Blot probes that permitted me to verify the targeting event on both the 5’- and 3’-side of the 
M280 locus (Fig. 12B). All chimeric M280-knockout mice generated from these cells were bred 
to 129S6/SvEv mice; therefore, all analyses described herein were conducted on 129S6/SvEv 
mouse tissue to avoid variation that may arise due to differences in genetic background. The 
M280 construct was designed such that a loxP-flanked neomycin resistance gene (neor), used to 
aid in the selection of ES cells that underwent a targeting event, replaced the M280 enhancer. 
However, all progeny derived from male chimeric mice generated from the targeted ES cells 
would not possess the neor gene because the targeted ES cells also possessed the Protamine-Cre 
recombinase transgene (PC3 ES cells). This transgene is specifically activated during 
spermatogenesis, permitting the Cre recombinase protein to recombine any loxP sites present in 
the genome of sperm derived from male chimeras (O'Gorman et al., 1997). Therefore, all 
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Figure 12. M280 gene targeting strategy. (A) M280 targeting strategy. Primers represented by 
black arrows; Southern Blot probes represented by shaded boxes. (B) Southern Blot showing 
targeting event in PC3 embryonic stem cells used to generated M280 knockout mice. (C) 
Southern Blot showing removal of neor via Cre recombination of loxP sites. (D) Southern Blot 
for sequence internal to M280 demonstrates its absence in M280tm1 mice. (E) M280 heterozygous 
and homozygous mice are distinguishable by PCR. 	  
	  	   95	    
	  	   96	  
heterozygous, M280tm1 positive offspring obtained from male chimeras possessed a single loxP 
site (34 bps) in place of the M280 enhancer (Fig. 12C). 
Heterozygous M280tm1 offspring from 129S6/SvEv female X M280tm1 male chimera 
crosses were intercrossed to generate M280tm1 knockout (-/-) mice. The same Southern Blot 
probes used to verify the targeting event in the PC3 ES cells were used to validate the removal 
of the neor gene in DNA obtained from M280tm1 heterozygous animals. Additionally, I designed 
a Southern Blot probe complimentary to M280 and showed that indeed this enhancer is absent in 
M280tm1 null mice (Fig. 12D). For continued ease in genotyping M280tm1 mice I also designed a 
set of PCR primers that can distinguish between wild-type, heterozygous and homozygous 
M280tm1 mice (Fig. 12E). In the wild-type situation one primer anneals to the sequence just 5’ of 
M280 while its cognate primer binds within M280 itself; together they generate a 405 bp 
amplicon. An additional primer was designed to anneal to sequence 3’ of M280; however, the 
distance between the 5’ and 3’ primers is too great for faithful amplicon production so that even 
in the wild-type condition only the 405 bp amplicon is generated. Alternatively, in the 
heterozygous or homozygous M280tm1 condition, M280 is absent. Therefore the primer designed 
to bind within M280 cannot do so and because the genome is shortened by the distance equal to 
the size of M280 the 5’- and 3’-primers can generate a 248 bp amplicon. 
 Heterozygous and homozygous M280tm1 mice are born in expected Mendelian ratios, are 
viable, fertile, and exhibit no obvious external limb phenotypes (Table 6; Fig. 13). To assess 
potential limb skeletal phenotypes that were not immediately available upon gross evaluation of 
the external limbs I stained newborn M280tm1 -/- pups with alizarin red and alcian blue. Alizarin 
red is a dye that stains bones red, and alcian blue is a dye that stains cartilage blue. Alizarin red 
and alcian blue stained newborn M280tm1 -/- pups were indistinguishable from wild-type 
littermates. In particular, relative bone position and morphology of fore- and hindlimbs 
dissected away from alizarin redand alcian blue stained M280tm1 -/- newborn pups appeared 
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Table 6. Chi-square test for expected Mendelian ratios in offspring from heterozygous 
M280tm1 intercrosses.  
 
 	  
	  	   98	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(N = 87) WT Het Null 
Expected: 21.75 43.5 21.75 
Observed: 21 46 20 
 
Two degrees of freedom 
Chi-square = 0.31 
Not significant at P = 0.5 
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Figure 13. Newborn and adult M280 null mice are indistinguishable from control 
littermates. (A-F) Control animals. (G-L) M280 null animals. (B, C, H, J) Dorsal and ventral 
forelimbs, respectively. (D, E, J, K) Dorsal and ventral hindlimbs, respectively. (F, L) Alizarin 
red and alcian blue stain for bone and cartilage in control (F) and mutant (L) newborn pups. Scale 
bars in (A-E, G-K) = 9 mm. Scale bars in (F, L) = 1 mm. 
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similar to wild-type limbs. Although observations from my M280GWtg embryos suggested that 
phenotypes would most likely arise in digits I, II or III, I noted no aberrations in the cartilage 
and bone elements of these digits (Fig. 13). These results were corroborated with histological 
sections of control and mutant E18.5 limbs (Figs. 14 and 15). Therefore, initial external and 
internal observations of limb morphology suggested that M280 is not required for proper limb 
development. 
 
Generating M1442 Gene targeted mice 
 
To functionally test the role of M1442 during mouse limb development I generated mice 
that lacked M1442 using traditional gene targeting methods (referred to as M1442-knockouts or 
M442tm1 mice; Material and Methods; Fig. 16).  Like M280, deletion of M1442 was carried out 
in mouse ES cells derived from a 129S6/SvEv genetic background. I designed Southern Blot 
probes that permitted me to verify the targeting event on both the 5’- and 3’-side of the M1442 
locus within the ES cells (Fig. 16B). All chimeric M1442-knockout mice generated from these 
ES cells were bred to 129S6/SvEv mice; therefore, all analyses described herein were conducted 
on 129S6/SvEv mouse tissue to avoid variation that may arise due to differences in genetic 
background. The targeting methodology used at the M1442 locus was the same as that used at 
the M280 locus: the neor gene that replaced M1442 in the targeting event was subsequently 
removed in the germline of M1442-deleted chimeras because I used the PC3 ES cell line for the 
M1442 targeting event (O'Gorman et al., 1997). Therefore, all heterozygous, M1442tm1 positive 
offspring obtained from male chimeras possessed a single loxP site (34 bps) in place of the 
M1442 enhancer. 
 Heterozygous M1442tm1 offspring from 129S6/SvEv female X M1442tm1 male chimera 
crosses were intercrossed to generate M1442tm1 knockout mice. I designed a PCR genotyping 
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Figure 14. Forelimb autopod elements present in E18.5 and newborn M280 null embryos. 
(A-C) Control tissue. (D-F) M280 mutant tissue. (A, D) Alizarin red and alcian blue stain of 
newborn forelimbs. (B, E) H&E stained planar sections through forelimb autopods. (C, F) H&E 
stained frontal sections through forelimb autopods. Abbreviations: ca = capitate; dp = distal 
phalanx; ha = hamate; ip = intermediate phalanx; pp = proximal phalanx; ra = radius; tp = 
trapezoid; ul = ulna. Roman numerals correspond to digit rays. 
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Figure 15. Hindlimb autopod elements present in E18.5 and newborn M280 null embryos. 
(A-C) Control tissue. (D-F) M280 mutant tissue. (A, D) Alizarin red and alcian blue stain of 
newborn forelimbs. (B, E) H&E stained planar sections through hindlimb autopods. (C, F) H&E 
stained frontal sections through hindlimb autopods. Abbreviations: ca = calcaneus; cu = cuboid; 
dp = distal phalanx; ic = intermediate cuneiform; ip = intermediate phalanx; m = metatarsal; na = 
navicular; pp = proximal phalanx; ta = talus. Roman numerals correspond to digit rays.  
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Figure 16. M1442 gene targeting strategy. (A) M1442 targeting strategy. Primers represented 
by black arrows; Southern Blot proves represented by shaded boxes. (B) Southern Blot showing 
targeting event in PC3 embryonic stem cells used to generated M1442 knockout mice. (C) M1442 
heterozygous and homozygous mice are distinguishable by PCR. 	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strategy to distinguish between heterozygous and homozygous M1442tm1 and wild-type mice 
(Fig. 16C). In the wild-type situation one primer anneals to the sequence just 5’ of M1442 while 
its cognate primer binds within M1442 itself; together they generate a 496 bp amplicon. An 
additional primer was designed to anneal to sequence 3’ of M1442; however, the distance 
between the 5’ and 3’ primers is too great for faithful amplicon production so that even in the 
wild-type condition only the 496 bp amplicon is generated. Alternatively, in the heterozygous or 
homozygous M1442tm1 condition, M1442 is absent. Therefore the primer designed to bind within 
M1442 cannot do so and because the genome is shortened by the distance equal to the size of 
M1442 the 5’- and 3’-primers can generate a 264 bp amplicon. 
 Heterozygous and homozygous M1442tm1 mice are born in expected Mendelian ratios, 
are viable, fertile, and exhibit no obvious external limb phenotypes (Table 7). To assess 
potential limb skeletal phenotypes that were not immediately available upon gross evaluation of 
the external limbs I stained newborn M1442tm1 -/- pups with alizarin red and alcian blue. 
Alizarin red and alcian blue stained newborn M1442tm1 -/- pups were indistinguishable from 
wild-type littermates (Fig. 17). In particular, relative bone position and morphology of fore- and 
hindlimbs dissected away from alizarin red and alcian blue stained M1442tm1 -/- newborn pups 
appeared similar to wild-type limbs (Figs 18-19). Gross and histological sections of my 
M1442GWtg mice indicated that the development of digits I and V, and the posterior wrist and 
ankle elements may be adversely affected in M1442tm1 knockout mice; however, I noted no 
aberrations in these elements at this level of analysis (Figs. 18-19). Therefore, initial external 
and internal observations of limb morphology suggested that M1442 is not required for proper 
limb development. 
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Table 7. Chi-square test for expected Mendelian ratios in offspring from heterozygous 
M1442tm1 intercrosses.  	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(N = 58) WT Het Null 
Expected: 14.5 29 14.5 
Observed: 14 31 13 
 
Two degrees of freedom 
Chi-square = 0.32 
Not significant at P = 0.5 
	  	   111	  
  
Figure 17. Newborn and adult M1442 null mice are indistinguishable from control 
littermates. (A-F) Control animals. (G-L) M1442 null animals. (B, C, H, J) Dorsal and ventral 
forelimbs, respectively. (D, E, J, K) Dorsal and ventral hindlimbs, respectively. (F, L) Alizarin 
red and alcian blue stain for bone and cartilage in control (F) and mutant (L) newborn pups. Scale 
bars in (A-E, G-K) = 9 mm. Scale bars in (F, L) = 1 mm. 
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Figure 18. Forelimb autopod elements present in E18.5 and newborn M1442 null embryos. 
(A-C) Control tissue. (D-F) M1442 mutant tissue. (A, D) Alizarin red and alcian blue stain of 
newborn forelimbs. (B, E) H&E stained planar sections through forelimb autopods. (C, F) H&E 
stained frontal sections through forelimb autopods. Abbreviations: ca = capitate; dp = distal 
phalanx; ha = hamate; ip = intermediate phalanx; pp = proximal phalanx; ra = radius; tp = 
trapezoid; ul = ulna. Roman numerals correspond to digit rays. 
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Figure 19. Hindlimb autopod elements present in E18.5 and newborn M1442 null embryos. 
(A-C) Control tissue. (D-F) M1442 mutant tissue. (A, D) Alizarin red and alcian blue stain of 
newborn forelimbs. (B, E) H&E stained planar sections through hindlimb autopods. (C, F) H&E 
stained frontal sections through hindlimb autopods. Abbreviations: ca = calcaneus; cu = cuboid; 
dp = distal phalanx; ic = intermediate cuneiform; ip = intermediate phalanx; m = metatarsal; na = 
navicular; pp = proximal phalanx; ta = talus. Roman numerals correspond to digit rays. 
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Quantitative analysis of transcription in enhancer-deleted mice 
 
Though no gross anatomical aberrations accompanied the deletion of either M1442 or 
M280 I hypothesized that gene transcription was altered at the mutated loci. Both M1442 and 
M280 possess transcriptional enhancer activity, as demonstrated in our transgenic mice, where 
consistent and discreet enhancer-driven lacZ expression was noted in the developing limb buds. 
Moreover, M1442 is located in the 19th intron of Kifap3, while M280 lies within the second 
intron of Rnf220. It is possible that both enhancers regulate the limb-specific transcription of 
their host gene, a regulatory scenario documented before in the developing limb (Zhang and 
Williams, 2003; Donner and Williams, 2006). On the other hand, it is possible the enhancers 
regulate one or several neighboring genes, a regulatory scenario also documented previously 
(Zuniga et al., 2004).  
Because our selection of M1442 and M280 was not based on knowledge of the genes 
they regulate I created a logical framework to determine which genes to assay for transcriptional 
differences between mutant and wild-type animals: Briefly, I decided to assay the host gene, one 
or several genes immediately flanking the 5’- and 3’-margins of the host gene, additional genes 
beyond the immediate neighbors of the host gene if they appeared in a Pubmed and/or Google 
Scholar search in association with the key words “limb” and “development,” and genes that 
were found up to 1 Mb upstream and downstream of the enhancers that were both 1) expressed 
at a statistically significant level in limb buds relative to other cell types (Cotney et al., 2012), 
and 2) associated with the key words “limb” and “development” in a Pubmed and/or Google 
Scholar search. The latter criterion stems from the observation that enhancers contributing to the 
transcriptional regulation of Shh and the HoxD gene cluster are located at distances approaching 
1 Mb (Lettice et al., 2002; Lettice et al., 2003; Sagai et al., 2004; Montavon et al., 2011).  
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To investigate whether deletion of M1442 and M280 affected gene transcription I 
performed quantitative real-time PCR (qPCR) on mutant and wild-type E11.5 limb buds. Upon 
deletion of M280 the transcription of its host gene, Rnf220, was unaffected in E11.5 limb buds, 
but two neighboring genes, Tmem53 and Dmap1, experienced reduced transcription levels (Fig. 
20; Appendix 1). The transcription level of Tmem53 was just 60% of wild-type, while Dmap1 
was just 50% of wild-type. Transcription of another gene, Eri3, located in between M280 and 
Dmap1 was also unaffected, again demonstrating that an enhancer, M280 in this case, can 
regulate multiple genes within a given window in what appears to be a selective manner. 
 Prxd1 is located 700 kb 5’ of M280’s center-point, but previous research had indicated a 
role for this gene in interdigital cell death (Shan et al., 2005), a developmental phenomena that 
most certainly occurs in the spatial domain that overlaps with the lacZ expression pattern 
observed in our M280-lacZ transgenic mice (at E11.5 lacZ is observed in the autopod region 
that will give rise to digits II-IV). And per the criteria described above, Prdx1 is upregulated in 
E10.5/E11.5 limb buds relative to two other cell types(Cotney et al., 2012). Therefore, I 
predicted that M280 might regulate Prdx1 transcription. However, absence of M280 does not 
affect Prdx1 transcription levels (Fig. 20). 
I employed whole mount in situ hybridization (WMISH) to determine if M280’s host 
gene, Rnf220, is expressed in a limb-specific manner that overlaps with M280 regulation (see 
Figs. 4, 5). Previous assays demonstrated that Rnf220 exhibits a broad expression pattern, but 
the results were inconclusive as to whether it has a restricted limb expression pattern 
(www.informatics.jax.org; Rnf220 primer ID: MTF1124). Interestingly, targeted deletion of the 
gene for the chromatin modifying protein, Sin3b, which interacts with the Rnf220-E3 ubiquitin 
ligase for its degradation, results in limb-specific shortening (David et al., 2008; Kong et al., 
2010). Thus even though my qPCR results do not show a lessening of Rnf220 levels, it is 
possible that additional enhancers compensate for M280’s absence and still regulate a central 
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Figure 20. Proximal-M280 transcript levels in E11.5 limb buds. Assayed genes represented by 
gray arrows. The location of M280 represented by vertical, red rectangle. Statistically significant 
transcript level changes at P = 0.05 represented by asterisk. (N=8 biological replicates for each 
genotype; see Materials and Methods).  	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limb-specific Rnf220 expression pattern. Also, expression of Dmap1 was also assessed using 
WMISH because of the genes assayed with qPCR it showed the greatest change upon M280 
deletion. 
 WMISH revealed no observable differences in Rnf220 or Dmap1 expression pattern 
between E11.5 M280 null and control embryos (Fig. 21). Indeed both genes did not appear to be 
expressed in a restricted manner whatsoever in the limb buds. The WMISH results suggest that 
Rnf220 is not regulated in a strongly delimited manner in the limb, at least with the riboprobe 
used, and supports the conclusion from the qPCR results that M280 does not regulated Rnf220. 
These results do not mean, however, that M280 is not needed for Dmap1 expression; rather, the 
resolution provided by WMISH may not be fine enough to detect transcript level changes of 
Dmap1 in the limb. 
 Interestingly, deletion of M1442 altered the transcription of numerous genes located 
approximately 500 kb 5’ or 3’ of M1442 (Fig. 22; Appendix 1). Surprisingly, transcription of 
the host gene, Kifap3, increased by 30%, as did two neighboring genes, Gorab and Scyl3, which 
are located roughly 500 kb 5’ and 30 kb 3’ from the center-point of M1442, respectively. This 
result is unexpected because the transgenic mouse assays described earlier clearly indicate that 
M1442 possess pro-transcriptional properties. The qPCR results suggest that manipulation of 
M1442 may also disrupt transcriptional repression in a region that spans at least from Gorab to 
Scyl3. It is worth noting that the transcriptional output of Kifap3, Gorab and Scyl3 was affected 
in the same way, an increase in expression of about 30%, suggesting that whatever repressive 
mechanism was disrupted by the removal of M1442 uniformly affected this genomic window. 
In contrast to the three previously discussed genes, the expression level of Nme7, which 
is located nearly 410 kb 3’ of the M1442 center-point, is down to 65% of wild-type. I assayed 
this gene for reasons other than the general framework I designed as a guide for selecting the 
others. It is clear that both M1442 (transgenic mouse assays herein) and its human ortholog, 
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Figure 21. Whole mount in situ hybridization in control and M280 null E11.5 limb buds. 
Between eight and ten individuals were assessed per riboprobe.  
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Figure 22. Proximal-M1442 transcript levels in E11.5 limb buds. Assayed genes represented 
by gray arrows. The location of M1442 represented by vertical, red rectangle. Statistically 
significant transcript level changes at P = 0.05 represented by asterisk. (N=8 biological replicates 
for each genotype; see Materials and Methods).  
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M1442, drive expression in the posterior margins of the E11.5 limb bud, which is also the site of 
required Shh expression (Wieczorek et al.; Riddle et al., 1993; Furniss et al., 2008) during limb 
development. Therefore, I surmised that perhaps genes associated with Shh signaling might be 
regulated by M1442 because they too would presumably need to be expressed in the posterior 
E11.5 limb bud. In numerous developmental contexts Shh signaling requires cilia (Haycraft et 
al., 2005; Caspary et al., 2007; Goetz et al., 2009; Wong et al., 2009), as has been well 
documented, for example, in the establishment of cilia-dependent left-right asymmetry during 
vertebrate embryogenesis (Hamada et al., 2002). It is also known that genes in the Nme family 
are important for cilia function, and Nme7 -/- mice display situs inversus, a failure to establish 
proper left-right asymmetry that leads to transposition of internal organs and vasculature 
(Boissan et al., 2009; Vogel et al., 2010). Therefore, the connection between the Shh-like 
expression pattern driven by M1442 and the role of Nme genes in cilia motion made by the 
dependence of Shh signaling on cilia led me to predict that M1442 was regulating Nme7 
transcription. It is worth noting that the transcription of two genes involved in ciliogenesis and 
movement, Kifap3 and Nme7, are impacted by the absence of M1442 in a statistically significant 
manner and that M1442 directs transcription in a region of the developing limb that overlaps 
with Shh expression.  
I also assayed the transcription of Prx1, a well-known transcription factor required for 
limb development (Martin et al., 1995), which is located approximately 600 kb 5’ of M1442, 
and just 70 kb 5’ of Gorab. Removal of M1442 had no effect on Prx1 transcription indicating 
that it does not regulate this gene despite the fact that the Prx1 expression pattern overlaps with 
that observed in our M1442-lacZ transgenic mice. Moreover, this result reinforces the 
observation that for the genomic window assayed, the regulation encoded within M1442 or 
extant because of M1442’s topographical location does not extend beyond Gorab in the 5’ 
direction. 
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The transcription level of two other genes, BC055324 and Atp1b1, were also unaffected 
by M1442 deletion. Though Atp1b1 did not meet all of the criteria above for selecting genes for 
qPCR – for example, Atp1b1 is not associated with search terms “limb” and/or “development” 
in Google Scholar or Pubmed – but is was significantly up-regulated in E10.5 and E11.5 limb 
buds relative to two other cell types (Cotney et al., 2012) and I was curious to see if the positive 
transcriptional regulation conferred on Nme7 by M1442 extended to Nme7’s neighboring gene. 
These results hint at the complexity of the regulatory behavior of M1442 because genes whose 
transcription is partially regulated by M1442 are not necessarily clustered together. While 
Kifap3, Gorab and Scyl3 are neighboring genes whose transcription is negatively regulated by 
M1442, Nme7 is positively regulated by M1442 even though the transcription of two assayed 
genes, BC055324 and Atp1b1, which lie on either side of Nme7 are unaffected. 
I used WMISH to determine if M1442’s host gene, Kifap3, is expressed in a limb-
specific manner that overlaps with M1442 regulation (see Figs. 7, 9). Kifap3 encodes the non-
ATP using component of a kinesin motor. Such cellular machinery is required for ciliary 
mediated Shh expression (Kolpakova-Hart et al., 2007; Wong et al., 2009). Since the qPCR 
results indicated minor Kifap3 expression changes, and since M1442 directs expression in a 
region that overlaps with early limb bud Shh expression I wanted to see if WMISH could 
resolve a limb-specific Kifap3 expression pattern. Expression of Nme7 was also assessed using 
WMISH because of the genes assayed with qPCR it showed the greatest change upon M1442 
deletion. Additionally, a riboprobe for Shh allowed me to monitor its expression – this was 
important both as a control (the probe is very reliable) and because it would be curious to see if 
Shh expression is affected at all by M1442 deletion as their domains of activity clearly overlap.  
WMISH revealed no observable differences in Kifap3 expression between E11.5 M1442 
null and control embryos (Fig. 23). Indeed Kifap3 did not appear to be expressed in a restricted 
manner whatsoever in the limb buds. Nme7 does not appear to be expressed in a spatially 
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Figure 23. Whole mount in situ hybridization in control and M1442 null E11.5 limb buds. 
Between eight and ten individuals were assessed per riboprobe.   
 
 	  
	  	   129	  
 
 
 
 
  
	  	   130	  
restricted manner in the E11.5 limb bud; however, it is possible to discern a slight decrease in 
signal intensity in the mutant bud. The WMISH results suggest that Kifap3 is not regulated in a 
strongly delimited manner in the limb, at least with the riboprobe used. These results do not 
mean, however, that M1442 does not impinge on Kifap3 expression as indicated by qPCR; 
rather, the resolution provided by WMISH may not be fine enough to detect transcript level 
changes of Kifap3 in the limb. On the other hand, these results indicate that the M1442 
regulation of Kifap3 indicated by qPCR is not likely to be a required input for proper limb 
development. Interestingly, although classic Shh-related polydactyly/limb patterning phenotypes 
accompany M1442’s deletion, Shh expression appeared to me to be consistently more intense in 
E10.5-11.5 M1442 null embryos relative to controls (Fig. 24). 
  
Comparative dissection and characterization of mutant mouse limbs 
 
To this point, it has been demonstrated that gross anatomical limb aberrations did not 
accompany deletion of either M280 or M1442; nor did histological sections reveal any absences 
or deficiencies in bone elements and growth. Furthermore, qPCR showed minor transcription 
changes in mutant animals but no obvious connections could be made between the enhancers 
and their regulatory targets. Inasmuch as a lack of a phenotype is more difficult to demonstrate 
than the of presence of one, I found it necessary to employ more traditional approaches to 
phenotypic analysis to show that mutant autopod elements were indeed indistinguishable from 
controls in shape and location: dissection, diagrammatic recording and comparison were in 
order. More specifically, forelimbs extracted from at least three E15.5 and 18.5 embryos were 
analyzed carefully after alcian blue (both E15.5 and 18.5) and alizarin red (E18.5 only) staining 
from each genotype: control littermates, M280tm1 -/-, and M1442tm1 -/-. Under the microscope I 
looked at relevant autopod elements from each embryonic limb and recorded their presence,  
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Figure 24. Limb-specific Shh expression more intense in E10.5-11.5 M1442 null embryos 
than in controls.  	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position and shape by making free-hand sketches. Though this approach is not as sophisticated 
as others I’ve described I think it gave me a very good, almost automatic, impression of the 
integrity or soundness of a particular embryo’s autopod structure. Moreover, the positioning and 
shape of wrist elements are, for lack of a better word, a bit confusing (especially in cross-
section), but by taking the time to analyze individual wrists and sketch their anatomical 
structures I became more confident that indeed my mutant mice, both M280tm1 -/- and M1442tm1 
-/-, did not manifest any obvious morphological defects. In particular, digits II-IV and the wrist 
elements just proximal to them – the trapezoid, capitate and hamate – were indistinguishable 
between M280tm1 -/- and control limbs (Fig. 25). And in M1442tm1 -/- limbs, the elements of 
digits I and V, and the nearby wrist elements – the trapezium, hamate, triquetral and pisiform – 
were indistinguishable from control limbs (Figs. 26-28). Histological sections of E18.5 M1442 
forelimbs also confirmed that development of the carpal elements that experience M1442-
regulated gene expression was unaffected (Fig. 29). 
 
Fine-scale length analysis of autopod bone elements in mutant mice 
 
 I decided to look for subtle defects in the development of digits in my mutant mice. 
Subtle changes in digit bone length had been reported before in another limb-enhancer deletion 
experiment – the Tbx4 limb enhancer. Normal hindlimb development requires early Tbx4 
expression (Hasson et al.; Naiche et al.; Naiche and Papaioannou, 2003). Although mice lacking 
a particular enhancer for Tbx4 appeared to be grossly normal, with all hindlimb bones present 
(though some were modified slightly or fused), it was shown that individual bone lengths were 
altered. For example, digit ray I (metacarpal to distal phalanx) was reduced in size by 8%, while 
digit ray V was reduced by 3% (Menke et al., 2008).      
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Figure 25. E18.5 M280 null autopods are anatomical indistinguishable from controls.  
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Figure 26. Dorsal view of E15.5 M1442 null and control forelimb carpal regions.  
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Figure 27. Palmer/ventral view of E15.5 M1442 null and control forelimb carpal regions.  
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Figure 28. Left lateral view of E15.5 M1442 null and control forelimb carpal regions.  
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Figure 29. Cross-sections through E18.5 M1442 null and control forelimb carpal regions. 
(A) Orientation diagram; D = dorsal, V = ventral. (B) Diagrammatic representation of sectioned 
forelimb carpal elements. Arabic numerals correspond to numerals in upper and lower rows in 
(C). Blue shading indicates elements positive for lacZ signal in M1442-GWtg lines. (C) H&E 
stained sections of E18.5 forelimb carpal regions. Roman numerals refer to digit rays. 
Abbreviations: fa = falciform carpal; pi = pisiform; ra = radius; sc = scaphoid; tp = trapezoid;      
tr = trapezium; ul = ulna. Scale bar is 50 µm.  
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To assess whether M280tm1  -/- mice manifested minor, but significant decreases in the 
length of autopod elements I collected ten mutant and control E18.5 embryos and dissected 
away the forelimbs. The forelimbs were then stained with alizarin red and alcian blue – dyes 
which stain the bones and cartilage, respectively. Weights of each sacrificed embryo were also 
recorded. Results from our M280GWtg experiments indicated that the central digit ray, digit ray 
III, would be more likely than other elements to undergo aberrant development in the absence of 
M280. I measured the length of each of the four individual elements of digit ray III – 3rd 
metacarpal, and the proximal, intermediate and distal phalanges – in each mutant and control 
animal in both right and left limbs. These measurements were then added together to achieve a 
total length for digit ray III and the lengths of digit III from both right and left limbs were 
averaged together. When digit III lengths were normalized to radii length (radius length reflects 
embryo size, recorded as embryonic weight; Pearson product-moment correlation coefficient, r 
= 0.54; Appendix 1) the length of digit III was not statistically different between M280 null and 
control embryos (Fig. 30A). Therefore, I concluded that digit III is not dependent on the 
presence of M280, not even for minor inputs into its developmental integrity. 
To assess whether M1442tm1  -/- mice manifested minor, but significant decreases in the 
length of autopod elements I collected eight mutant and ten control E18.5 embryos and 
dissected away the forelimbs. The forelimbs were then stained with alizarin red and alcian blue 
– dyes which stain the bones and cartilage, respectively. Weights of each sacrificed embryo 
were also recorded. Results from my M1442GWtg experiments indicated that the anterior-most 
and posterior-most digit rays, digit rays I and V, would be more likely than other elements to 
undergo aberrant development in the absence of M1442. In each mutant and control forelimb I 
measured the length of each of the three individual elements of digit ray I (1st metacarpal, and 
the proximal and distal phalanges) and each of the four individual elements of digit ray V (4th 
metacarpal, and the proximal, intermediate and distal phalanges). These measurements were 
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Figure 30. Digit lengths in mutant M280 and M1442 mice. (A) Digit III lengths normalized to 
radius lengths in E18.5 M280 null and control embryos. (B) Digits I and IV lengths normalized to 
radius lengths in E18.5 M1442 null and control embryos.  
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then added together to achieve a total length for digit I and V, respectively, and the lengths of 
either digits I or V from both right and left limbs were averaged together. When digit I lengths 
were normalized to radii length the length of digit I was not statistically different between 
M1442 null and control embryos (Fig. 30B). The same was true for digit V (Fig.30B). 
Therefore, I concluded that digits I and V are not dependent on the presence of M1442, not even 
for minor inputs into their development along the proximal-distal axis of the autopod. 
 
Developmental progression of cartilaginous limb elements in mutant mice 
  
It is possible that the absence of M280 in mutant embryos results in transient defects in 
limb development. To test this hypothesis I collected mutant and control embryos from at least 
three litters generated from M280tm1 -/+ intercrosses at three embryonic time points: E13.5, 
E14.5, and E15.5. Embryos were then stained with alcian blue to visualize the developmental 
progression of cartilaginous limb elements. The lower time point, E13.5, was selected, because 
readily identifiable cartilaginous autopod elements become discernable at this time. By E15.5 
each of the cartilaginous precursors of the digit bones are present.  
In summary, I observed no indication that there is a transient developmental delay in the 
progression of autopod elements from E13.5 to E15.5 in M280 null embryos (Figs. 31-33). 
However, at E15.5 more than half the mutant-control pairwise comparisons showed that mutant 
limbs were smaller than controls. In E13.5 limbs I assessed the sizeand shape of the metacarpals 
and proximal phalanges of digits II-IV. (Only two litters were assessed at E13.5; it seems that 
with this time point Mendelian odds were not on my side!). Of seven mutant-control pairwise 
comparisons at E13.5 five scored as equal and two scored as mutant-larger-than-control. In 
E14.5 limbs I assessed the size and shape of metacarpals and the proximal and intermediate 
phalanges in digits II-IV. Of five mutant-control pairwise comparisons at E14.5 three were 
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Figure 31. Forelimb comparisons between M280 null and control embryos at E13.5. (A) 
Control tissue outlined in blue; mutant tissue outlined in red. Grey box shows cartilage elements 
used in comparison. (B) Each litter is represented by a different colored box: orange or green. 
Control limbs (blue) from each litter indicated by Arabic numerals. Mutant limbs (red) from each 
litter indicated by lowercase letters. If control limb is shorter (and/or more delayed) or larger 
(and/or more advanced) than mutant limb then it will be indicated by a dotted outline.  
Scale bars = 0.5 mm. 
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Figure 32. Forelimb comparisons between M280 null and control embryos at E14.5.  
(A) Control tissue outlined in blue; mutant tissue outlined in red. Grey box shows cartilage 
elements used in comparison. (B) Each litter is represented by a different colored box: orange, 
green or purple. Control limbs (blue) from each litter indicated by Arabic numerals. Mutant limbs 
(red) from each litter indicated by lowercase letters. If control limb is shorter (and/or more 
delayed) or larger (and/or more advanced) than mutant limb then it will be indicated by a dotted 
outline. Scale bars = 0.5 mm. 
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Figure 33. Forelimb comparisons between M280 null and control embryos at E15.5.  
(A) Control tissue outlined in blue; mutant tissue outlined in red. Grey box shows cartilage 
elements used in comparison. (B) Each litter is represented by a different colored box: orange, 
green, purple or brown. Control limbs (blue) from each litter indicated by Arabic numerals. 
Mutant limbs (red) from each litter indicated by lowercase letters. If control limb is shorter 
(and/or more delayed) or larger (and/or more advanced) than mutant limb then it will be indicated 
by a dotted outline. Scale bars = 0.5 mm.  
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scored as equal, one was scored as mutant-smaller-than-control, and one was scored as mutant-
larger-than-control. In E15.5 limbs I assessed the size and shape of all four digit elements, from 
metacarpals to distal phalanges, in digits II-IV. Of nine mutant-control pairwise comparisons 
four were scored as equal and five were scored as mutant-smaller-than-control. The majority of 
all pairwise comparisons over the three time points were scored as equal, but as mentioned, at 
E15.5 I recorded a trend towards shorter mutant limbs.  
I also pursued the hypothesis that M1442tm1 -/- embryos experienced a transient 
development defect in limb/autopod development. As was done with my M280 null mice, I 
tested this hypothesis by collecting mutant and control embryos from at least three litters 
generated from M1442tm1 -/+ intercrosses at three embryonic time points: E13.5, E14.5, and 
E15.5. The assessment of potential developmental defects in limb progression was then carried 
out in the exact manner as that described above for M280 null-control comparisons, with the 
notable exception that I focused on digits I and V, as these were the elements expressing lacZ in 
my M1442GWtg mice.  
In summary, I observed no indication that there is a transient developmental defect in the 
progression of autopod elements from E13.5 to E15.5 in M1442 null embryos (Figs. 34-36). In 
E13.5 limbs I assessed the size and shape of the 5th metacarpal and the hamate and triquetral, 
wrist bones near the 5th metacarpal. Of twelve mutant-control pairwise comparisons at E13.5 
seven scored as equal and five scored as mutant-larger-than-control. In E14.5 limbs I assessed 
the size and shape of the first and fifth metacarpals, the proximal phalange of digit I, the 
proximal and intermediate phalanges of digit V, and the hamate and triquetral. Of nine mutant-
control pairwise comparisons at E14.5 seven were scored as equal and two scored as mutant-
smaller-than-control. In E15.5 limbs I assessed the size and shape of all four digit elements, 
from metacarpals to distal phalanges, in digits I and V, as well as the hamate, triquetral and 
pisiform bones of the wrist. Of six mutant-control pairwise comparisons four were scored as 
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Figure 34. Forelimb comparisons between M1442 null and control embryos at E13.5. 
(A) Control tissue outlined in blue; mutant tissue outlined in red. Grey box shows cartilage 
elements used in comparison. (B) Each litter is represented by a different colored box: orange, 
green or purple. Control limbs (blue) from each litter indicated by Arabic numerals. Mutant limbs 
(red) from each litter indicated by lowercase letters. If control limb is shorter (and/or more 
delayed) or larger (and/or more advanced) than mutant limb then it will be indicated by a dotted 
outline. Scale bars = 0.5 mm.  
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Figure 35. Forelimb comparisons between M1442 null and control embryos at E14.5. 
(A) Control tissue outlined in blue; mutant tissue outlined in red. Grey box shows cartilage 
elements used in comparison. (B) Each litter is represented by a different colored box: orange, 
green or purple. Control limbs (blue) from each litter indicated by Arabic numerals. Mutant limbs 
(red) from each litter indicated by lowercase letters. If control limb is shorter (and/or more 
delayed) or larger (and/or more advanced) than mutant limb then it will be indicated by a dotted 
outline. Scale bars = 0.5 mm.  
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Figure 36. Forelimb comparisons between M1442 null and control embryos at E15.5.  
(A) Control tissue outlined in blue; mutant tissue outlined in red. Grey box shows cartilage 
elements used in comparison. (B) Each litter is represented by a different colored box: orange, 
green or purple. Control limbs (blue) from each litter indicated by Arabic numerals. Mutant limbs 
(red) from each litter indicated by lowercase letters. If control limb is shorter (and/or more 
delayed) or larger (and/or more advanced) than mutant limb then it will be indicated by a dotted 
outline. Scale bars = 0.5 mm. 
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equal and two were scored as mutant-larger-than-control. The majority of all pairwise 
comparisons over the three time points were scored as equal (Figs. 34-36).  
 
Assessing phenotypes in adult mutant mice 
 
 My research focused on the impact of enhancer deletions on embryonic limb 
development. However, I did pursue one experiment using adult mice that yielded three 
important observations about the limbs of adult mutant mice. In addition to this experiment, I 
made a phenotypic observation unrelated to limb development early in my analysis of M280tm1 -
/- mice that was later confirmed in a statistically rigorous fashion. I will first discuss the 
experiment conducted on adult limbs and the three resultant observations then proceed to 
describe the M280 null-specific phenotype.  
 Forelimbs from three 6-month-old control, M280tm1 -/-, and M1442tm1 -/- female mice 
were subjected to a micro CT scan and bone mass density (BMD) values and 3-dimensional 
(3D) surface renderings from each limb were collected. The first important observation from 
this experiment resulted from my dissecting away the forelimbs from each mouse (I also 
dissected off hindlimbs as well, but I did not submit them for micro CT scans); I was able to 
carefully analyze each autopod element as I did in the embryos described above. Additionally, I 
was able to sketch some of the soft tissue, such as the tendons and muscles. As was the case 
with my embryonic observations and comparative sketches I did not visually detect any 
phenotypes in either the hard or soft tissues in the adult mutant forelimbs (and hindlimbs). 
Secondly, there was no statistical difference in BMD between either control and M280 null mice 
or control and M1442 null mice (Students t-Test: Control and M280 null, P = 0.68; Control and 
M1442 null, P = 0.38; Appendix 1).  Thirdly, the 3D renderings produced during the micro CT 
scans showed that adult M280tm1 -/- and M1442tm1 -/- forelimbs were indistinguishable from 
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control limbs in size and shape (Fig. 37). These observations indicate that limb structure in adult 
mice is unaffected by the absence of the M280 and M1442 enhancers. 
 Now to the observation I made early on in my analysis of M280tm1 mice. To initially 
generate M280tm1 -/- mice I needed to set up heterozygous M280tm1 intercrosses. Obviously, 
pups obtained from these initial crosses would be a mix of M280tm1 heterozygotes or 
homozygotes and M280 wild types. At weaning age, 3 weeks post-birth, I began noticing that 
M280tm1 -/- males and females were often markedly smaller in overall body size than their 
heterozygous or wild-type littermates. Though the difference was somewhat subtle it was also 
clearly obvious that a high percentage of M280tm1 null animals were smaller (size difference is 
discernable in Fig. 13). To rigorously test the hypothesis that M280tm1 null mice were smaller, at 
least in terms of body weight, than either M280tm1 heterozygotes or control littermates I 
recorded the weight of males and females at time of weaning and at six weeks of age, when the 
animals undergo sexual maturation. All weights were taken at noon so as to reduce weight 
variation that may result from recordings taken at different times of the day – laboratory mice 
eat and are active at different times during the day/light cycle. Initially I had planned to use the 
Student’s t-Test to compare body weights of mice at the selected time points from litters of the 
same size. But I realized very quickly that it was difficult to consistently get litters of the exact 
size. Not impossible, of course, just difficult in a short time period. I decided, therefore, to 
submit all of my weight data, regardless of litter size, to a group of dedicated statisticians that 
could analyze for weight differences and remove confounding differences in weight that may 
arise due to litter size/milk accessibility. Needless to say, the statistical analysis was a bit more 
sophisticated than a standard Student’s t-Test. 
 The results of the statistical analysis confirmed my initial observations (Fig. 38A; see 
Appendix 2 for full report): Female and male M280tm1 -/- mice weighed less than control mice at 
3 weeks and 6 weeks. Moreover, the weight differences between female and male M280tm1 -/- 
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Figure 37. Micro CT surface renderings of five-week-old forelimb autopods from mutant 
and control mice. Images not to scale.  
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Figure 38. Adult and embryonic M280 null animals are smaller than controls. (A) Box plot 
showing distribution of adult body weight in control and heterozygous and homozygous M280 
mutant mice. (B-F) All other graphs denote either average weights or lengths as specified. Error 
bars indicate standard deviation. Asterisks indicate significant differences determined via 
Student’s t-Test. See text for details. 
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and M280tm1 -/+ mice were also either significant or marginally significant, with null mice 
weighing less that heterozygous mice. Likewise, the weight differences between female and 
male M280tm1 -/+ and control littermates were also significant or marginally significant, with 
heterozygous mice weighing less than controls. In graphical form these results take on a classic 
null-heterozygous-wild-type geometry, with M280 null animals showing the most extreme 
phenotype (lowest body weight relative to control animals), and M280 heterozygotes 
manifesting a moderate phenotype, somewhere in between null and control littermates. To be 
precise, at 3 weeks female and male M280tm1 -/- mice weigh, on average, about 1 gram 
(females) to 1.5 grams (males) less than control littermates (control females weigh 
approximately 10 grams; control males about 10.5 grams). At six weeks male and female 
M280tm1 -/- mice weigh, on average, approximately 2.5 grams less than control littermates 
(control females weigh approximately 18 grams; control males about 21.5 grams; exact numbers 
available in Appendix 2). Even qualitatively this is a dramatic phenotype. Another way of 
saying it is that at six weeks, for example, M280 null mice manifest approximately 10% less 
body weight than control mice. Interestingly, this phenotype appears to be completely unrelated 
to limb development or limb morphology as indicated by my careful analysis of embryonic limb 
development and my micro CT-based analysis of adult limb morphology. Moreover, I collected 
the body weights of E18.5 mutant and control embryos, all from same-sized litters, and 
determined that there is no difference in body weight at this late stage of development (N = 16 
control embryos; N = 10 M280 null embryos; Student’s t-Test, P = 0.87; Fig. 38B). Therefore, I 
concluded changes in body weight occur after birth, before weaning, and are amplified by six 
weeks of age in mutant M280 mice. 
 Upon confirming the post-birth weight differences in M280 null mice I recalled that the 
transgenic reporter lines M280L1 and L2 showed consistent lacZ expression in the first 
pharyngeal arch at E10.5-E11.5; this embryonic structure gives rise to the maxilla and mandible. 
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I hypothesized, therefore, that perhaps mandible development was perturbed during 
development and after birth this prohibited M280 null pups from obtaining nutriment. This 
could explain the overall decrease in body size in mutant mice. To test this prediction I 
measured mandible length in mutant and control E15.5 embryos from three litters. I noted no 
changes in mandible morphology in mutant embryos and when mandible length was normalized 
to embryo-crown-rump length I observed no differences in mandible length between M280 and 
control embryos (Fig. 38C). Therefore, aberrant mandible development does not seem to be 
causal in producing the body weight phenotype.  
 While doing the mandible/CR-length measurements I did notice, however, that mutant 
embryo CR-lengths were always shorter than the control CR-lengths in a given litter. This 
seemed to dovetail with the observation that overall body weight was decreased in adult mice – 
was body size in M280 mutants already stunted in E15.5 embryos? This supposition was in 
opposition to the fact that I had observed no body weight differences in E18.5 embryos. But this 
discrepancy could arise for at least two reasons: 1) perhaps E18.5 mutant and control embryos 
do, on average, weigh the same or at least if there are weight differences they are so minute that 
they are undetectable; or 2) perhaps the method of preparing the embryos introduces 
confounding variables that swamp the weight signal. Before weighing the E18.5 embryos I 
removed the embryonic fluid on their bodies using a Millipore vacuum manifold. However, it is 
entirely possible that this method did not uniformly dry the embryos; if so, any small weight 
difference would go undetected.  
 I was curious to know if the CR-length differences I noted in E15.5 embryos could be 
quantified. This didn’t seem possible at first because the numbers of each genotype, M280 null 
and control, in each litter were small and I didn’t want to compare CR-lengths across litters due 
to in utero differences that might influence differences between litters (e.g. size of litter; 
nutriment uptake of mother). But then I devised a way to compare across litters and look for 
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statistical differences in mutant and control CR-length (see examples of matrices in Appendix 
1). I created three matrices. In one matrix I calculated CR-length differences between all M280 
null embryos (N=6; NXN matrix), in another differences between all control embryos (N=10; 
WXW matrix), and in a third matrix the differences between all null and control embryos 
(N=20; NXW matrix). All difference values were squared to remove negative integers. These 
matrices allowed me to account for CR-length variation across all litters (in utero confounding 
variables, for example) and still assess whether differences existed between mutant and control 
animals, and to obtain enough independent observations to perform statistics. I predicted that 
M280 null CR-length was less that control CR length in a statistically significant manner. To 
test this I performed a Student’s t-Test between all matrices (assuming unequal variance; F-test 
indicated unequal variance between all matrices: NXN v. WXW, P=9.2 x 10-5; WXW v. NXW, 
P=5.8 x 10-9; NXN v. NXW, P=0.04). If indeed M280 null CR-lengths cluster together after 
accounting for variation in body size from litter to litter, and if the same is true for control CR-
lengths, then the average NXN value should not be statistically different that the average WXW 
value. This is what I see after carrying out a Student’s t-Test between NXN and WXW (P=0.14; 
Fig. 38D). On the other hand, if there are consistent differences in CR-length between E15.5 
mutant and control embryos then the average NXW value (that is CR-length differences 
between all control and mutant embryos across three litters) after accounting for across-litter 
variation should be significantly different than the average NXN or WXW values. This was also 
the case; differences in CR-length between mutant and control embryos are larger than CR-
length differences between either all null embryos or all control embryos (Student’s t-Test: 
WXW v. NXW, P=6.2 x 10-5; NXN v. NXW, P=0.0046; Fig. 38D). From these results I 
concluded that M280 animals already exhibited delayed body growth at E15.5. This means that 
by E18.5 either mutant animals have compensated for this delayed growth and then succumbed 
to it again by three weeks of age, or the delayed growth phenotype is present at E18.5 but I did 
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not detect it. These results also help explain why the majority of mutant forelimbs in E15.5 
cartilage comparisons were shorter than controls – the whole E15.5 embryos is smaller (Fig. 
33).  
Additional matrix-based analysis was done to compare other cartilage elements in E15.5 
M280 and control embryos from three litters. Not all of these comparisons indicated that E15.5 
mutant embryos were smaller than controls, but numerous comparisons were significant. Raw 
lengths for the ulna and humerus were shorter in mutant embryos than in controls when 
accounting for variation across litters (but this was not true for the mandible; Fig. 38E, F). 
However, when ulna and humerus lengths were normalized against CR-lengths there was no 
difference between mutants and controls (Fig. 38C). Again this demonstrates that the whole 
mutant animals, not just their individual limb elements, are smaller than control animals at 
E15.5. 
Lastly, the statistical analysis performed on adult body weights discussed earlier found 
no significant correlation between litter size and weight differences between genotypes 
(Appendix 2). Thus, I assumed that litter size does not confound comparisons of CR-length 
across litters – just as litter size did not confound body weight in adults. Therefore, I directly 
asked whether mutant M280 CR-lengths are significantly shorter than those of controls using 
just the raw CR-length values (not using the matrices described above). Embryos for this direct 
comparison were drawn from four litters generated by M280tm1 -/+ intercrosses. I found that CR-
lengths in E15.5 M280 mutants are significantly shorter than control CR-lengths (Fig. 39A, B; 
Student’s t-Test, p<0.001). Also concordant with these findings is that raw, non-normalized 
mandibular and ulnar lengths are shorter in M280 mutants than in controls; and the lengths of 
mutant humeri are also generally shorter than controls (Appendix 1). Therefore, we conclude 
from these observations that at E15.5 whole M280 embryos are smaller than control embryos, 
but that the proportional length of individual bone elements to overall body size, such as the 
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Figure 39. E15.5 M280 null animals are smaller than controls. (A) Box plot showing 
distribution of E15.5 CR-lengths in M280 null and control embryos. (B) Graph showing average 
E15.5 CR-length in M280 null and control embryos; error bars indicate standard deviation. 
Asterisk indicates significant difference determined via Student’s t-Test. See text for details. 
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mandible or ulna, are maintained in the mutants. Thus the weight differences observed between 
mutant and control postnatal mice are presaged by embryonic size differences by at least E15.5. 
These results underscore several important concepts in enhancer biology. Firstly, just 
because an enhancer regulates gene expression in a particular embryonic tissue, such as the 
limb, does not mean that its main function is to direct gene expression in that tissue during 
embryonic development. Such an enhancer may actually contribute to ordinary development 
before the time at which it is assayed (in a transgenic reporter study, for example) and/or 
contribute to tissue maintenance post-birth regardless of its regulatory potential during 
development. A corollary to this concept is the notion that enhancers with tissue-specific 
regulatory capacity during development may in fact be required in adult tissues that are 
completely different from the embryonic regions used to characterize the enhancer in the first 
place. My observations described above are at the very least suggestive of this concept. 
Enhancer M280 was characterized mainly as a limb-specific enhancer in transgenic reporter 
gene assays, but the result of its deletion from the mouse genome – reduced embryonic size and 
post-birth body weight – appears to be unrelated to its ability to drive gene expression in 
embryonic limbs. Presumably, the cells in some other tissue/organ in maturing pups that is not 
the limb (again, presumably, because I have not looked for lacZ expression in adult limbs) also 
expresses the proper milieu of M280-enhancer-binding transcription factors to engage M280 
with its target gene(s); and presumably this M280-guided transcription is required for proper 
mid-gestation and post-natal development or maintenance of body weight. 
 
In silico approach to identifying enhancers that may compensate for the deleted M280 
enhancer 
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 Numerous studies indicate that multiple enhancers, often positioned in relatively close 
genomic proximity, direct gene expression to the same region. Such enhancers are often called 
shadow enhancers because they mimic, or shadow, the action of one another. Even in 
experiments where no such shadow enhancers have been experimentally validated, their 
presence had been postulated because the disruption of a particular enhancer does not lead to an 
expected phenotype or the phenotype is of a subtle nature. One potential mechanistic 
explanation for this phenomenon is that each of these shadow enhancers possesses a similar 
combination, orientation and spacing of TF binding sites. Thus, in cells expressing the right mix 
of TFs all of the shadow enhancers should be able to contribute to the activation of their target 
gene(s). In theory then, it should be possible to identify shadow enhancers based on their 
composition of TF binding sites relative to an enhancer of interest. Following such logic I 
predicted that I could use M280’s combination of TF binding sites to locate M280-shadow 
enhancers within a restricted genomic window that encompasses M280.  
I submitted the entire M280 sequence to the ECR Browser, freely available software that 
aligns vertebrate genomic sequences and scores their level of conservation. After submission I 
noted that M280 could be divided into two conservation blocks, one large 520 bp block and one 
small 148 bp block. Core regions within the large and small blocks were conserved from mice to 
frogs. Transcription factor binding sites in these two blocks were obtained using rVista 
(rvista.dcode.org). Eleven of the 184 returned TF binding sites corresponded to TFs that had an 
association with limb development in previous publications. The M280-embedded TF binding 
sites include those for AP2α, E2F, Clox (Cux1), ETS, Hox TFs, GATA and Foxm1. These TF 
binding site motifs were used to identify other potential shadow enhancers ± 1 Mb from M280. 
Two putative shadow enhancers, drawn from a list of highly conserved and p300-associated 
putative enhancers, shared the same cluster of TF binding sites with M280 (Fig. 40). 
Interestingly, both these putative shadow enhancers are located within the same large second 
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Figure 40. Putative shadow enhancers reside in the same Rnf220 intron as M280.  
(A) Two sequence blocks within M280 evolutionarily conserved from mammals to anurans 
(Xenopus). Image generated on the ECR Browser (ECRbrowser.dcode.org) (Ovcharenko et al., 
2004): green = simple repeats; salmon = intronic regions. (B) Transcription factor (TF) binding 
sites within each conserved block identified in rVISTA. Color-coded TF binding sites in (B) 
correspond to colors in (C). (C) Two putative shadow enhancers obtained from previous screens 
for enhancers based on bioinformatics and p300-ChIP-seq datasets (Visel et al., 2008; Visel et al., 
2009a). 
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Rnf220 intron as M280 (M280-pSh1 and M280-pSh2, respectively; pSH = putative shadow 
enhancer). The putative enhancers are only separated by 2.3 kb, and are jointly approximately 
74.5 kb from M280. If common TF binding site signatures can predict common enhancer 
function, then it is possible that M280-pSH1/2 shares at least an overlapping regulatory roll with 
M280; thus the action of this putative shadow enhancer pair may dampen any limb phenotype 
would otherwise result from M280’s deletion.  
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DISCUSSION 
 
Mouse enhancer M280 influences embryonic and adult body size: the first phenotype 
reported for a deleted ultraconserved element  
 
 Although the decision to delete M280 from the genome was based on its ability to drive 
reporter gene expression in embryonic limb buds the results reported above demonstrate that it 
is required for the development of embryonic body size and adult body weight. Thus, though 
M280 certainly directs gene expression in particular tissues, such as the limb buds and first 
pharyngeal arch, its effects on organismal development are global in nature. The details of the 
molecular mechanism behind the size reduction that accompanies the targeted deletion of M280 
are not clear at this point. Nor is it clear whether M280’s role in body size production and/or 
maintenance is a result of its gene regulatory capacities throughout the entire organism or its 
role in one tissue, such as the liver or the placenta. The analysis of M280’s regulatory functions 
encompassed the whole external embryo, as well as a special focus on both the external and 
internal features of the limb. In future work it would be interesting to thoroughly examine the 
internal organs and extra-embryonic tissues in which M280 can drive reporter gene expression; 
such an analysis will likely provide clues as to when, where and how M280 is regulating gene 
expression essential to body size development. It is worth noting that numerous previous studies 
have linked genes involved in placental development with reduced adult body size in mutant 
mice (Li and Behringer, 1998; Rodriguez et al., 2004; Murthi et al., 2012); thus it will be 
especially interesting to assess M280’s ability to regulate gene transcription in the placenta 
(particularly between E14.5-15.5 when the beginnings of decreased body size in mutant M280 
mice was noted). 
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Importantly, along with its affiliation with the general transcriptional activator, p300, 
M280 also spans an ultraconserved element, which is defined as a sequence of ≥ 200 bps of 
perfect conservation between human, rat and mouse (Bejerano et al., 2004; Visel et al., 2008). 
To date, only four other ultraconserved elements had been deleted from the mouse genome 
(Ahituv et al., 2007). These four other ultraconserved elements were selected because of their 
proximity to genes that have been shown to be required for particular developmental processes 
in knockout mice experiments. However, none of the phenotypes resulting from the targeted 
deletion of the genes is recapitulated in the ultraconserved element-knockout mice (Ahituv et 
al., 2007). Therefore, the significant decrease in body size and weight noted in M280 null mice 
is the first phenotype reported for a deleted ultraconserved element; these results make the case 
that ultraconserved elements encode regulatory abilities necessary for the normal development 
of vertebrates.  
Additionally, these results suggest that the phenotypic consequences of manipulating an 
ultraconserved element, or perhaps any enhancer, may be unrelated to their capacities to drive 
expression in a particular tissue. This general observation should give pause to future 
researchers engaged in endogenous enhancer-deletion studies that don’t immediately score a 
phenotype in an expected tissue. An enhancer’s regulatory capacities in transgenic contexts – 
wherein the enhancer and an associated reporter gene are inserted randomly into the genome – 
may not recapitulate its role in an endogenous context. Thus conclusions drawn from transgenic 
reporter gene assays can be completely informative, partially informative, partially misleading, 
and possibly, entirely misleading; hence the importance for using gene targeting or similar 
techniques to delete or otherwise manipulate enhancers in situ. 
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M1442 and M280 not required for embryonic limb development 
 
The decision to assess the role of M280 and M1442 during mouse limb development 
stems from two initial observations surrounding their identification and characterization: 1) in 
mouse limb buds both these sequences were associated with p300, which is known to be 
associated with active enhancers and contributes to the acetylation of H3K27, a chromatin 
modification that is a signature of active transcription; and 2) their orthologous human 
sequences directed reporter gene expression in the limbs of E11.5 transgenic mice. I 
demonstrated that M280 and M1442, like their human sequence counterparts, direct gene 
expression in mouse limb buds. Importantly, I showed that transcription regulated by these 
enhancers begins before E11.5 (both M280 and M1442) and extends beyond this time as well 
(M1442). One important conclusion from this research, therefore, is that enhancers identified at 
specific time point in a specific tissue may well have regulatory capacities that extend beyond 
the criteria that led to their discovery.  
As discussed above, M280 is associated with p300 and harbors a 256 bp ultraconserved 
element. Moreover, its sequence identity along its entire length when compared to the 
homologous human sequence is 94.9% (UCSC Genome Browser, mm9 and hs19). Similarly, 
M1442 is associated with p300 and its sequence identity along a core 1,440 bp region that aligns 
to the homologous human sequence is 91.9% (UCSC Genome Browser, mm9 and hs19; more 
concerning the non-homologous sequences below). Both M280 and M1442 (and their human 
counterparts) drive lacZ expression in the developing limb. Despite these observations neither 
M280 nor M1442 are required for mouse limb development. In the absence of M280 and M1442 
limbs developed normally, without even transient developmental defects, all limb bone elements 
were accounted for, and right before birth limb bone lengths were indistinguishable between 
mutant and control animals. Much of this work focused on assessing the effect that 
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M280/M1442 absence might have on hard tissue development. However, in histological 
sections, adult dissections, and in the day-to-day observations of the mutant animals I did not 
see any indication that limb soft tissue was faulty. The lack of a limb phenotype in the M280 
and M1442 null mice represent only the second and third examples, respectively, of an 
undetected phenotype when a limb enhancer is deleted via gene targeting (Fig. 1). The first 
example, already discussed, showed that Prx1-limb-enhancer null mice manifested no tractable 
limb defects and that Prx1 transcription was unaltered by the absence of this enhancer (Cretekos 
et al., 2008). Hence another important general conclusion drawn from this research is that 
enhancers identified via their association with the chromatin modifying enzyme, p300, appear to 
be no more likely than enhancers discovered via traditional methods (proximity to genes and 
sequence conservation) to be required for limb development. 
The results of the M280 knockout experiment are relevant for another reason. Recently, 
Cotney et al. (2013) demonstrated that hs280, the homologous region in the human genome to 
M280, had increased H3K27ac relative to orthologous sequences in rhesus macaques and mice 
(Cotney et al., 2013). Authors of this study suggest that the increased H3K27ac specifically in 
the human lineage, like those observed at hs280, correspond to increased gene expression and 
thus to transcriptional differences that may account for the evolution of human-specific traits. 
The deletion of M280 in the mouse genome indicates, however, that neither sequence 
conservation nor increased H3K27ac during embryonic development nor ability to drive 
reporter gene expression can predict whether an enhancer is necessary for the generation of 
necessary anatomies and organs, such as the limb. I am not concluding that the convergence of 
multiple tests of importance for a particular enhancer are useless, but I am suggesting that our 
current understanding of what differentiates enhancers from other genomic elements and from 
each other is not sufficient to predict their role during embryonic or postnatal development. 
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 M280 -/- and M1442 -/- mice were not entirely without observable phenotypes. I 
demonstrated that minor, though statistically significant transcriptional changes were detected 
within the vicinity of each enhancer. I will discuss the transcriptional changes near M280 first, 
and then those observed near M1442. 
Although M280 is located within the second intron of Rnf220 its expression is not 
affected by the absence of M280. This is not surprising, as limb enhancers have been shown to 
reside both within the genes they regulate and within the introns of neighboring genes. What is 
interesting is that the transcription levels of Tmem53 and Dmap1 are reduced in E11.5 limbs, 
demonstrating that an enhancer’s regulatory effects can span quite large genomic distances, a 
total of 400 kb in the case of M280. Moreover, it is interesting to note that Eri3, which lies 
between M280 and Dmap1 does not experience a drop in transcription in the absence of M280. 
This transcriptional observation suggests a 3-dimensional structure to the DNA in this genomic 
interval. One can imagine that the chromatin in between M280 and Dmap1 must undergo a 
looping event to bring M280 into the vicinity of Dmap1’s promoter while skipping Eri3’s 
promoter, just like the ends of a jump-rope would move closer together if the middle of the rope 
were lifted vertically. Of course it is not possible to say whether M280’s main regulatory role is 
to promote Tmem53 and Dmap1 transcription because no distinctive limb-specific expression 
pattern of these genes via whole mount in situ hybridization. It is possible that M280’s 
regulation of these genes is secondary to a more central role in regulating a gene outside the 
assayed genomic window, perhaps one that does possess a central limb-specific expression 
pattern. 
Near the M1442 locus, Nme7, which is approximately 500 kb 5’ of M1442, experienced 
a 40% decrease in transcription in M1442tm1 -/- embryonic limbs. WMISH for Nme7 did not 
indicate a strongly demarcated limb expression pattern for this gene, but its general expression 
does appear to be slightly decreased in M1442 limb buds. Again, it is not possible to determine 
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that this regulatory effect is M1442’s primary role – it is entirely possible that a gene(s) outside 
the outside window is regulated by M1442 in a manner consistent with our transgenic mice. Of 
interest at the M1442 locus is the observation that three genes that span a 600 kb window show 
a slight increase in transcription levels, including Kifap3, which hosts the M1442 enhancer (the 
other genes are Gorab and Scyl3). This is a somewhat unexpected result because transgenic 
mouse experiments showed that M1442 should activate transcription, not repress it. One 
interpretation of these results is that it is not the absence of a repressor element within M1442 
per se that is causing the minor increase in transcription, but the topographical shift of the 
promoter regions of the affected genes (Spitz et al., 2005). Perhaps the removal of the 
approximately 3 kb M1442 sequence moved the promoter regions of these genes nearer to 
another enhancer element. Alternatively, it is possible that M1442 harbors repressor and 
enhancer sequences and in its endogenous context the repressor elements override the enhancer 
elements for at least Kifap3, Scyl3 and Gorab (M1442 also possesses flanking sequences that are 
not homologous to hs1442; these non-homologous sequences potentially encode repressor 
elements). Yet one more possibility is that additional enhancer sequences must act in concert 
with M1442 to properly regulate transcription in the genomic window and in the absence of 
M1442 this balanced regulatory interaction is thrown off and a slight up-regulation of nearby 
genes results. 
 
Potential explanations for the lack of limb phenotypes in M1442 and M280 mutant mice 
 
Gene transcriptional alterations near the M280 and M1442 enhancer deletions ranged 
from 30% increases to 45% decreases. Similar transcriptional alterations associated with other 
limb enhancer loci have been correlated with observable limb phenotypes. In particular, a 
malformed digit V accompanied a deletion of a particular enhancer region, which decreased the 
	  	   184	  
limb-specific transcription levels of Hoxd13 by 60 % (Montavon et al., 2011). Therefore it is 
inappropriate to suggest that the limbs of M280 and M1442 mutant animals are indistinguishable 
from controls because the qPCR results indicate that transcriptional changes were modest. 
Rather, the difficulty of scoring limb phenotypes in M1442 and M280 mutant mice is likely due 
to one or more complex molecular and environmental conditions explored below. 
A common explanation for the lack of phenotypes, or the presence of only minor 
phenotypes, in enhancer knockout experiments is that additional enhancers compensate for the 
loss of those that were deleted (Fig. 41A.a). This explanation is invoked in conceptual 
treatments of cis-regulatory elements as well as in empirical studies that record the discrepancy 
between the regional expression pattern driven by a particular enhancer and the absence or 
subtly of phenotypes in the same region in enhancer-knockout animals. Certainly, distinct 
enhancers, often referred to as shadow enhancers, capable of driving similar and overlapping 
expression patterns have been well documented in multiple species, from fruit flies to mice 
(Levine, 2010; Montavon et al., 2011; Marinic et al., 2013). Also, the evidence for networks of 
enhancers that contribute to the expression of a single gene or gene groups is incontrovertible. 
Perhaps the best-documented enhancer networks in limb development are those composed of 
numerous interacting enhancer regions 5’ and 3’ of the Hoxd cluster. Deletion of swaths of these 
enhancer regions result in aberrant autopod development in the mouse, but perhaps not as 
aberrant as initially expected. As just one example, Montavon, T. et al. (2011) deleted a 540 kb 
region 5’ of the Hoxd cluster that contains four transgenic-reporter-mouse-validated limb 
enhancers and recorded only a slight length reduction of digits II and V (Montavon et al., 2011). 
Though four well-characterized Hoxd cluster enhancers were deleted, additional enhancers in 
the network, 5’ of the deleted region, apparently compensated partially for the missing 
regulatory elements and softened the phenotypic impact. This example highlights both the 
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Figure 41. Models of enhancer behavior. (A) Enh = enhancer. (B) Hexagon = basal 
transcriptional machinery; blue circles = enhancers in same regulatory network. The green arrow 
represents the network-regulated gene; thickness of arrow indicates fidelity of transcription. 
V1442 = Vista1442 in reference to the human sequence (hs1442) on the Vista Enhancer Browser 
(enhancer.lbl.gov), and could also be M1442 in this study or any other ortholog of this sequence. 
Diagram based on figures in Montavon, T. et al. (2011) (Montavon et al., 2011). (C) Light blue 
shading highlights discrepancy between extra-regulatory capacity of an enhancer and its actual 
role in development or postnatal life. 
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strengths and weaknesses of arguments that invoke redundant enhancers as an explanation for 
absent or subtle phenotypes in enhancer knockout mice. 
The strength of such an argument lies in the interpretation that enhancer network 
elements may be partially redundant; this would explain the observation that noticeable 
phenotypes do accompany enhancer deletions, but such phenotypes do not span the entire 
anatomical domain within which the enhancer is able to operate, as shown through transgenic 
reporter assays, for example. One interpretation of current empirical evidence also suggests that 
partial regulatory redundancy may be common (Fig. 41B), while full redundancy likely is not: 
to date seven enhancers/enhancer regions known to regulate genes involved in limb 
development have been endogenously deleted, and in five of these six situations limb 
phenotypes were documented (Table 1) (Zuniga et al., 2004; Sagai et al., 2005; Cretekos et al., 
2008; Feng et al., 2008; Menke et al., 2008; Montavon et al., 2011; Marinic et al., 2013). This 
again suggests full redundancy is rarely, if ever, built into the regulatory structure of genomes. 
Therefore, the weakness of enhancer redundancy arguments lies in the interpretation that 
separate enhancers can completely compensate for each other; in other words, that one enhancer 
can be totally redundant with another. Though this extreme interpretation of the redundant 
enhancer model is rare, it can be easily invoked in situations where no detectable phenotypes 
accompany enhancer deletions – situations exactly like the one demonstrated herein. The reason 
for mistrusting the presence of fully redundant enhancers is because it is difficult to imagine 
situations in which fully redundant enhancers would evolve in the first place. If two genetic 
elements perform the same function in a completely redundant fashion then one or both 
elements will likely be open for accumulation of mutations, both adaptive and maladaptive – 
hence the observation of pervasive pseudogenes in genomes.  
Moreover, theoretically, rigidly conserved enhancer sequences are the least likely to be 
maintained along with redundant enhancers over evolutionary time. M280, for example, is 
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highly conserved in vertebrates, even comprising an ultraconserved element (256 bps of perfect 
conservation between mouse, rat and human). Therefore, if its regulatory action needed to be 
backed up by the evolution of a fully redundant shadow enhancer then it would be expected that 
M280 frequently acquired mutations that would compromise its regulatory ability. But in fact, 
the opposite is observed; M280 is highly conserved. Following this reasoning, highly variable 
enhancers (perhaps identified via pro-transcription chromatin signatures rather than sequence 
conservation) would be the enhancers most likely to evolve alongside redundant shadow 
enhancers. Thus a conceptual evolutionary paradox explains one reason why assigning fully 
redundant enhancers as the explanation for the lack of phenotypes in the limb enhancer 
knockout experiments of this study is dissatisfying: only enhancers prone to frequent mutation 
would be expected to evolve alongside shadow enhancers that completely compensate for their 
regulatory activity, but the very observation of high conservation in enhancers such as M280 
and M1442 suggests the opposite; it suggests that they are either not subject to frequent 
mutation for some genomic-architectural reason or that mutations within them are strongly 
selected against (Halligan et al., 2011). Highly conserved enhancers are unlikely to work in 
concert with fully redundant enhancers precisely because their very conservation precludes them 
from requiring the parallel evolution of a fully redundant enhancer.  
This discussion about the semantics of enhancer redundancy is valuable because it 
permits one to move beyond a conclusion that only posits regulatory redundancy as an 
explanation for the fact that limb development is unaffected in mice lacking enhancers that most 
certainly possess limb-specific regulatory capacities. Other equally valid explanations may not 
be as straightforward but they integrate the whole of the data produced from M280 and M1442 
null mice and they hint at potential experimental paths that could lead to a better understanding 
of enhancer identification and function. 
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One possible explanation for the lack of a limb phenotype in M280 and M1442 mice is 
that these sequences can actively promote transcription when removed from their endogenous 
loci, but in situ their limb-regulatory properties are largely suppressed (Fig. 41A.b). Perhaps 
adjacent to M280 and M1442 are additional regulatory elements that override their ability to 
regulate transcription in the limb domain. One way to test this possibility would be to use gene 
targeting to knock in a minimal promoter and reporter gene, such as HSP68 and lacZ, 
respectively, adjacent to either M280 or M1442. If the reporter gene were silent throughout limb 
development one interpretation would be that at their endogenous loci M280 and M1442 are 
acted on by other regulatory elements in such a way that their implicit limb-regulatory capacity 
is inhibited. It has been shown that an enhancer’s activity is different depending on whether it is 
assayed at endogenous or ectopic genomic locations. The transposon-based enhancer sensor, 
SBlac, is distributed throughout the mouse genome. When proximal to enhancer elements lacZ 
is expressed from the SBlac sensor. Ruf et al. (2011) demonstrated that when SBlac is 
positioned near enhancers characterized via their association with p300, the expression pattern 
of lacZ from the transposon is often more restricted than when a p300-enhancer (such as M280 
or M1442) drives lacZ in an ectopic transgenic context (Ruf et al.).  
Another explanation for the observed results could be that numerous enhancers, though 
promoting transcription throughout embryogenesis, may in fact not be required for development 
but rather for an organism’s adult life. Certainly there are numerous exigencies experienced in a 
wild adult mouse lifespan that may require genetic input – these may include the physiological 
responses to the drives for and stress of finding a mate, finding shelter and food, avoiding 
predation, and defending and patrolling a territory. Physiological exertions required to meet 
these demands would take a toll on tissues such as muscles and bones. Tissue homeostasis is 
also an important cellular process that is likely taxed in non-laboratory conditions – certainly 
genetic switches and pathways that determine when and where to allocate metabolic resources 
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in response to stress and other environmental cues are an important aspect of an organism’s 
fitness. Concordant with this reasoning then is the possible conclusion that M280 and M1442 
(and other deleted enhancers that have no observed phenotypic effect such as UC248, UC329, 
UC467 and UC482) (Ahituv et al., 2007) are developmentally tolerated enhancers. That is, 
M280 and M1442 can promote transcription in embryonic limbs, but that is secondary to their 
role in the adult mouse (or in the regulation of embryonic body size in the case of M280; Fig. 
41C). Thus they are developmentally tolerated in the sense that they attract metabolically 
expensive pro-transcriptional machinery – p300 for sure and likely a menagerie of TFs – and yet 
the result of this pro-transcription milieu, which is gene transcription in the limb bud, is not 
even necessary for limb elaboration. Perhaps these enhancer sequences are highly conserved 
because of the physiological processes they regulate in adult life rather than during 
development. 
One way to test this explanation in a laboratory setting would be to subject control and 
mutant M280 and M1442 adults to assays that require physical exertion that may mimic that 
experienced in a natural setting. For example, myogenin null mice exhibit deficiencies in 
skeletal muscle metabolism and exercise endurance only after run on a treadmill (Flynn et al., 
2010; Meadows et al., 2011). Mice lacking M280 or M1442 could be assayed in a similar 
manner, perhaps with a focus on looking at the responses of limb elements to prolonged 
physical exertion.  
In the context of the foregoing discussion it is worth noting that M280 mice did exhibit a 
body weight phenotype, and this only strongly confirmed after birth. Six-week old male and 
female M280tm1 -/- mice were on average about two grams lighter than control littermates. Both 
the developmental analyses and adult BMD/microCT scan results suggest that this phenotype is 
unrelated to the limbs, though this cannot be ruled out. Measurements of CR-length at E15.5 
also showed that M280 mutant embryos were smaller than control littermates. This observation 
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too appeared to be unrelated to limb development. Importantly, therefore, the phenotype that 
results from the genomic deletion of M280 is manifested clearly in postnatal mice, not 
embryonic limb buds (Fig. 41C). This concrete observation suggests that M280 is 
developmentally tolerated in the limb bud and that its extreme sequence conservation may be a 
result of selection pressures acting on its ability to regulate whole embryo body size and/or adult 
body weight. This demonstrates that an enhancer may have essential regulatory capacities not 
directly related to its entire spatial regulatory potential (Fig. 41C). Also, the adult expression 
patterns directed by either M280 or M1442 have not been documented, but certainly could be 
using the M280GWtg and M1442GWtg lines. Such documentation may provide insight into the 
roles these enhancers may play during mouse adult life or indicate potential sights of postnatal 
phenotypes that have gone undetected. 
Explanations for the observed results have, to this point, focused on the action and 
function of enhancers – they may regulate gene transcription during embryonic or postnatal 
development and apparently may act in partially redundant fashion. It is also possible, however, 
that the unaffected limb development in mutant mice is a result of redundancy in genetic 
pathway activity rather than regulatory activity. For example, although M1442 may be required 
for the proper limb expression of a particular gene, the effects of reduced transcription of that 
gene in mutant mice may be compensated for by another redundantly expressed gene that feeds 
into the same genetic circuit. Redundant gene function has been amply demonstrated for 
numerous gene families during limb development, including Hoxa and Hoxd cluster members, 
Bmps and Fgfs (Niswander et al., 1993; Bandyopadhyay et al., 2006; Montavon et al., 2011). 
Thus, if M280 or M1442 regulates members of these genetic pathways and circuits then the 
potential phenotypic effects could be masked by redundant genetic inputs. But even this 
possibility does not satisfactorily explain why M280 and M1442 possess so many independent 
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signatures of enhancer activity and yet are not required in limb development (Bejerano et al., 
2004; Visel et al., 2008; Visel et al., 2009a). 
 
Genome-wide enhancer studies highlight potential causes of discrepancy between 
transgenic reporter assays and endogenous enhancer function 
 
Further reason to suspect that transgenic experiments may not faithfully represent an 
enhancer’s endogenous function come from the complex picture of enhancer behaviors drawn 
from experiments in cell lines, stem cell and otherwise. For example, Whyte, A. et al. (2013) 
demonstrated that large modular enhancers (median size approximately equal to 8500 bps), 
termed super-enhancers, are occupied by high concentrations of the TFs Klf4 and Esrrb and 
interact with high concentrations of Mediator (Whyte et al., 2013). Super-enhancers are 
particularly important in driving the transcription of genes necessary for stem cell pluripotency. 
Interestingly, depletion of either Mediator or Oct4 (also an important super-enhancer-bound TF) 
leads to preferential transcriptional disruption of pro-pluripotency genes, indicating that 
enhancers that regulate specific cellular states may also have specific signatures of bound TFs 
and activator complexes; such signatures may or may not be re-created at sites of transgene 
insertion. 
In another report it was shown that long-range interactions between enhancers and 
promoters spanned, on average, 120 kbps, and that only 7% of these long-range interactions 
were between an enhancer and its nearest genes (Sanyal et al., 2012). Such long-range 
interactions simply cannot be reproduced at the random insertions sites of transgenes, thus in 
many instances it is possible that enhancer behavior in the context of its host transgene is not a 
complete representation of its endogenous activity. Another study showed that posttranslational 
modifications of nucleosomes conducive to enhancer-promoter interactions occurred within 
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domains such that groups of enhancer and promoters were modified together (Shen et al., 2012). 
But in transgenic experiments, enhancers are likely far removed from the coordinately regulated 
domain within which their endogenous loci reside; therefore their activity is likely altered in the 
transgenic context. 
The above specific examples, along with those covered in numerous reviews, indicate 
that enhancers rarely, if ever, act in isolation (Malik and Roeder, 2010; Ong and Corces, 2011; 
Spitz and Furlong, 2012). Current evidence suggests that modular enhancers are themselves 
embedded within larger regulatory modules called by various names: enhancer-promoter units 
(Shen et al., 2012), archipelagos (Montavon et al., 2011), holo-enhancers (Marinic et al., 2013), 
long-range interaction landscapes (Sanyal et al., 2012) and super-enhancers (Whyte et al., 
2013), to name a few. These various enhancer and enhancer network types indicate that many, 
rather than one or a few, regulatory elements contribute to the transcription of individual genes 
and groups of genes. The concerted effects of all of these regulatory inputs likely results in 
partial redundancy and dampening of genomic perturbation (including gene targeting) and 
consequently phenotypic outcomes. Thus, given what is known about enhancers in limb 
development specifically (see discussion above), and in other tissues and cell lines generally, it 
is not unreasonable to hypothesize that some form of enhancer network compensation is 
absorbing the developmental costs of the deletion of M1442 and M280 in embryonic mutant 
mouse limbs. 
 
Potential experimental approaches to further explore the role of M1442 and M280 during 
limb development 
 
The absence of a limb phenotype in M280 and M1442 null mice is a record of negative 
data. It is possible that M280 and/or M1442 do adversely affect limb development in some way. 
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The assays employed to assess limb development may not have detected an existing phenotype. 
This admission adds context to several conventional experiments that could be carried out to 
further interrogate the regulatory roles of M280 and M1442. For example, it has been 
demonstrated that Dmap1 and Nme7 transcription is reduced to approximately half that of 
control levels in M280 and M1442 null mice, respectively. Therefore, it may be possible to 
compromise the genetic background of developing mutant embryos by crossing M280tm1 -/- or 
M1442tm1 -/- mice to heterozygous Dmap1 or Nme7 mutant mice, respectively. Homozygous 
Dmap1 null embryos die early in development(Mohan et al., 2011). Homozygous Nme7 null 
mice manifest phenotypes associated with defunct ciliary motility, including situs inversus 
(Vogel et al., 2010). By crossing heterozygous Dmap1 or Nme7 mice with M280 or M1442 null 
mice, respectively, it may be possible to induce a limb-specific phenotype that reflects a genetic 
interaction between the enhancers and the genes. 
Another logical extension of this research would be to use whole genome 
transcriptomics to identify candidate loci regulated by M280 and M1442. The local 
transcriptional impact of deleting M280 and M1442 using qPCR has been presented in this 
study. And though significant transcriptional differences were noted, none of the genes that are 
misregulated are immediately relatable to limb development, nor are they expressed in a finely 
delineated manner as assayed with in situ hybridization. Collection of whole genome transcript 
levels via RNA-seq in mutant and control limbs at E11.5 may permit a clearer picture of the loci 
that are strongly associated with either M280 or M1442. (Also, though unrelated to the limb, it 
would be worthwhile to collect whole genome transcript levels at E15.5, or slightly earlier, to 
relate particular transcript levels with the mutant body size detected in M280 mutant embryos). 
Bioinformatic evidence presented herein suggests that two previously described 
enhancers contain a collection of TF binding sites that are also found in M280. Perhaps these 
putative enhancers, which together span roughly 3 kb, serve as a partially redundant enhancer 
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for M280. This proposed M280-shadow-enhancer could be cloned upstream of a minimal 
promoter and lacZ and used in transgenic mouse experiments to address whether or not it directs 
limb-specific expression. 
Lastly, M280 and M1442 may be useful as tissue-specific drivers of Cre recombinase or 
other proteins capable of modifying or acting on the mouse genome. For example, M1442 
directs transcription in specific wrist bones including the hamate, triquetral and pisiform, and 
possibly the scaphoid as well. Using M1442 to drive Cre recombinase to these specific bones in 
order to modify target loci could permit a better understanding of the molecular genetic 
mechanisms that direct wrist development. The genetic mechanisms underlying the diversity of 
wrist bone elements are particularly important from an evolutionary perspective. 
Transformations in the wrist accompanied important transitions during vertebrate evolution 
including the so-called fin-to-limb transition as well as the unique autopod adaptations specific 
to the primate lineage (Sanchez-Villagra and Menke, 2005; Shubin et al., 2006; Prabhakar et al., 
2008; Shubin et al., 2009; Mitgutsch et al., 2012; Cotney et al., 2013). 
 
Implications for future studies aimed at deleting enhancers in situ 
 
 Both M1442 and M280 were deleted because their human orhtologs, hs1442 and hs280, 
respectively, were capable of driving limb-specific expression in transgenic mouse embyros and 
because they were affiliated with p300, a transcriptional activator. However, nothing was known 
about the gene or genes these enhancers regulate. Consequently, interpreting our results in the 
light of a specific signaling pathway or genetic circuit known to be active during limb 
development is not possible. Furthermore, though M280 mice manifest a weight phenotype we 
cannot at this point correlate the phenotype with any specific gene or genetic pathway for the 
same reasons described above. Thus in future studies that employ gene targeting to delete or 
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otherwise manipulate enhancers it will be important to rely on as many data sets as possible to 
select enhancers whose manipulation can advance our knowledge of enhancer behavior and 
development of specific structures the most. For example, in combination with the p300-ChIP-
seq data set one could utilize knowledge of enhancer-gene proximity, published enhancer-
promoter units, published catalogs of pro-transcription chromatin marks in specific tissues or 
cell types, and even data sets that take into account signatures of selection in the genome. The 
combination of such information should better lead researchers to enhancers that will likely 
yield tractable, mechanistic information upon endogenous manipulation. 
 It is important to re-emphasize the patience and attention to detail that ventures into 
enhancer function require. If indeed partial redundancy and robustness are persistent features of 
enhancer regulation then researchers need to be prepared to identify and characterize subtle 
phenotypes that result from functional experiments at endogenous enhancer loci (subtle relative 
to particular gene knockout experiments). Additionally, as these results indicate, it is imperative 
to remember that results of a particular enhancer-driven transgenic reporter assay do not 
necessarily predict the tissues and processes that will be affected upon deletion of that particular 
enhancer from the genome. Lastly, as enhancers continue to be deleted from the mouse genome 
it may be wise to consider experiments that foster conditions similar to those experienced by 
natural populations; it is in these contexts, especially after birth, that phenotypic consequences 
of enhancer deletions may be brought into sharper focus. 
 
 
 
  
	  	   197	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 1 
  
	  	   198	  
 
 
Quantification of Transcript Levels in E11.5 fore- and hindlimb buds, 
Relative to Wild-type 
      Numbers indicate average levels ± SD; each sample comprised of limb buds  
from three individuals (n=8) 
  Prdx1 Tmem53 Rnf220 Eri3 Dmap1 
wt: M280 +/+ 1 1 1 1 1 
M280 -/- 0.84 ± 0.10 0.62 ± 0.12 1.09 ± 0.09 0.79 ± 0.14 0.54 ± 0.15 
P ≤ 0.05   ✓     ✓ 
       
 
Quantification of Transcript Levels in E11.5 fore- and hindlimb buds, Relative to Wild-
type 
        Numbers indicate average levels ± SD; each sample comprised of limb buds from three 
individuals (n=8) 
  Prx1 Gorab Kifap3 Scyl3 BC055324 Nme7 Atp1b1 
wt: M1442 
+/+ 1 1 1 1 1 1 1 
M1442 -/- 
1.07 ± 
0.18 
1.31 ± 
0.27 
1.33 ± 
0.15 
1.34 ± 
0.20 
0.90 ± 
0.20 
0.65 ± 
0.17 
1.16 ± 
0.07 
P ≤ 0.05   ✓ ✓ ✓   ✓   
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Litter ID Genot.
! N-=-null ! !
N2
N3
N4
W-=-wt
W2
W3
W4
W5-
NXN 1 2 3 4 WXW 1 2 3 4 5
1 (N1:N2)^2 etc. etc. 1 (W1:W2)^2 etc. etc. etc.
2 (N2:N3)^2 etc. 2 (W2:W3)^2 etc. etc.
3 etc. 3 etc. etc.
4 4 etc.
5
NXW 1nl 2nl 3nl 4nl # N-X-N W-X-WN-X-W
1wt (N1:W1)^2 etc. etc. etc. 1
2wt etc. etc. etc. etc. 2
3wt etc. etc. etc. etc. 3
4wt etc. etc. etc. etc. 4
5wt etc. etc. etc. etc. 5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Avg.
S.D.
Color-
code
d-by-
litter
C:R-length
N-=-6
N-=-10
N-=-20
Key:-Matrices-used-to-account-for-between:litter-variation-in-CR:length-in-E15.5-embryos
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Litter ID Genot. C:R-length
469 1 280-null 981
473 2 280-null 989.6
531 3 280-null 966.6
573 4 280-null 895.7
472 wt 1087
534 wt 1039
536 wt 1068
567 wt 1043
571 wt 1071
N-X-N 1 2 3 4 W-X-W 1 2 3 4 5
1 73.96 207.4 7276 1 2275 353.4 1962 240.3
2 529 8817 2 835.2 11.56 1037
3 5027 3 650.3 10.89
4 4 829.4
5
W-X-N 1nl 2nl 3nl 4nl Sam. N-X-N W-X-W W-X-N
1wt 11215 9467 14472 36557 1 73.96 2275 11215
2wt 3387 2460 5271 20592 2 207.4 353.4 9467
3wt 7586 6162 10302 29722 3 7276 1962 14472
4wt 3795 2809 5776 21580 4 529 240.3 36557
5wt 8172 6691 10983 30870 5 8817 835.2 3387
6 5027 11.56 2460
7 1037 5271
8 650.3 20592
9 10.89 7586
10 829.4 6162
11 10302
12 29722
13 3795
14 2809
15 5776
16 21580
17 8172
18 6691
19 10983
20 30870
Avg. 3655 820.6 12394
S.Dev 3902 771.8 10131
Matrices:-E15.5-CR:length-(arbitrary-units;-Photoshop-rule-tool)
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Transcription	  Factor	  Binding	  Sites	  located	  within	  M280:	  Used	  to	  find	  putative	  M280	  
Shadow	  Enhancers	  
Large	  Block	  (520	  bp):	  defined	  by	  mouse-­‐to-­‐frog	  conservation	  via	  NCBI:Dcode	  (ECR	  
Browser)	  AP2alphal/Tfap2a	   a)Eckert,	  D.	  et	  al.	  2005.	  The	  AP-­‐2	  family	  of	  transcription	  factors.	  Genome	  Bio.	  6:246;	  b)	  Feng,	  W.	  et	  al.	  2008.	  Identification	  and	  analysis	  of	  a	  conserved	  Tcfap2a	  intronic	  enhancer	  element	  required	  for	  expression	  in	  facial	  and	  limb	  bud	  mesenchyme.	  Mol	  Cell	  Biol.	  28:315	  	  E2F	   a)	  Iaquinta,	  P.	  and	  Lees,	  J.	  2007.	  Life	  and	  death	  decisions	  by	  the	  E2-­‐F	  transcription	  factors.	  Curr	  Opin	  Cell	  Biol.	  19:649;	  b)	  Cobrinik,	  D.	  et	  al.	  1996.	  Shared	  role	  of	  the	  pRB-­‐related	  p130	  and	  p107	  proteins	  in	  limb	  development.	  Genes	  Dev.	  10:1633	  	  GATA	   Karamboulas,	  K.	  et	  al.	  2010.	  Regulation	  of	  BMP-­‐dependent	  chondrogenesis	  in	  early	  limb	  mesenchyme	  by	  TGFbeta	  signals.	  J.	  Cell	  Science	  123:2068	  	  Foxm1	   Abassi,	  A.	  et	  al.	  2010.	  Human	  intronic	  enhancers	  control	  distinct	  sub-­‐domains	  of	  Gli3	  expression	  during	  mouse	  CNS	  and	  limb	  development.	  BMC	  Dev	  Bio.	  10:44	  	  CLOX/CUX1	   Lizarraga,	  G.	  et	  al.	  2002.	  Studies	  on	  the	  role	  of	  Cux1	  in	  regulation	  of	  the	  onset	  of	  joint	  formation	  in	  the	  developing	  limb.	  Dev	  Biol.	  243:44	  	  	  
Small	  Block	  (148	  bp):	  defined	  by	  mouse-­‐to-­‐frog	  conservation	  via	  NCBI:Dcode	  (ECR	  
Browser)	  ETS	   Iwamoto,	  M.	  et	  al.	  2007.	  Transcription	  factor	  ERG	  and	  joint	  and	  articular	  cartilage	  formation	  during	  mouse	  limb	  and	  spine	  skeletogenesis.	  Dev	  Biol.	  305:40	  	  Pea3	   a)	  Eloy-­‐Trinquet,	  S.	  et	  al.	  2009.	  FGF	  signaling	  components	  are	  associated	  with	  muscles	  and	  tendons	  during	  limb	  development.	  Dev	  Dynamics	  238:1195;	  b)	  Arber,	  S.	  et	  al.	  2000.	  ETS	  Gene	  Er81	  Controls	  the	  Formation	  of	  Functional	  Connections	  between	  Group	  Ia	  Sensory	  Afferents	  and	  Motor	  Neurons.	  Cell	  101:485;	  c)	  Ladle,	  D.	  and	  Frank,	  E.	  2002.	  The	  role	  of	  the	  ETS	  gene	  PEA3	  in	  the	  development	  of	  motor	  and	  sensory	  neurons.	  Physiol.	  and	  Behavior	  77:571	  	  CHX10	  and	  HoxA4	   HoxA4	  (similar	  to	  CHX10)	  sight	  could	  be	  bound	  by	  any	  number	  of	  hox	  genes.	  NRF2	   a)	  Hinoi,	  E.	  et	  al.	  2007.	  Nuclear	  factor	  E2	  p45-­‐related	  factor	  2	  negatively	  regulates	  chondrogenesis.	  Bone	  40:377;	  b)	  Hinoi,	  E.	  et	  al.	  2006.	  Nrf2	  negatively	  regulates	  osteoblast	  differentiation	  via	  interfering	  with	  Runx2-­‐dependent	  transcriptional	  activation.	  J	  Biol	  Chem.	  281:18015	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Subject:              Analysis of mouse weight data.  
 
 
  
 
Objectives 
 
The objectives of the analysis are to examine whether the weights of the mouse are different 
between genotypes (wild type/control, heterozygous, and mutant) for male and female mice 
separately. 
 
Description of the data set 
 
Body weight at 3 weeks and 6 weeks were measured in mice with litter size ranges from 3 to 
10. 
 
Methods  
 
Summary statistics 
 
Mouse weights were summarized using the mean (s.d.) and median (range) by group, time 
point, and gender.  
 
Comparing body weights among genotypes 
We use linear mixed models to examine the differences in body weights among genotypes, 
adjusted for litter size (as continuous variable).  The linear mixed models include fixed effect of 
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genotype and litter size, and a random effect of litter to account for the correlation between 
mice within the same litters.   Pairwise comparisons between genotypes were carried out using 
the least square of the means with adjustment for multiple comparisons within model using 
Tukey’s method.  We used quantile-quantile plots to examined the normality assumption of the 
residuals of the linear models.  All analyses were performed using SAS 9.3 and R. 
 
Summary of main findings  
    
 
1. Comparing body weight differences at 3 week in female mice. 
 
The differences among genotypes are statistically significant (type 3 test of fixed effects 
p <0.0001), with the mutant mice being the lightest, followed by heterozygous mice. 
The wild-type mice are the heaviest.  All pairwise comparisons between genotypes were 
statistically significant at the 0.05 significance level after Tukey-Kramer adjustment for 
multiple comparisons. The inverse association between litter size and body weight was 
marginally significant (p=0.09). 
 
2. Comparing body weight differences at 3 week in male mice. 
 
The differences in body weights among genotypes were statistically significant (type 3 
test of fixed effects p =0.003).  Mutant mice had the significantly lighter weights than 
heterozygous and wild-type mice. The differences in body weights between 
heterozygous and wild-type mice were not statistically significant.  The inverse 
association between litter size and body weight was marginally significant (p=0.09). 
 
3. Comparing body weight differences at 6 week in female mice. 
 
The differences among genotypes were statistically significant (type 3 test of fixed 
effects p <0.0001), with the mutant mice being the lightest, followed by heterozygous 
mice. The wild-type mice are the heaviest.  With Tukey-Kramer adjustment for multiple 
comparisons, the difference between heterozygous and mutant mice was marginally 
significant (adjusted p=0.07).  The differences between heterozygous and wild-type 
mice and between mutant mice and wild-type mice were significant after Tukey-Kramer 
adjustment. The association between litter size and body weight was not significant 
(p=0.8). 
 
4. Comparing body weight differences at 6 week in male mice. 
 
The differences among genotypes were statistically significant (type 3 test of fixed 
effects p <0.0001), with the mutant mice being the lightest, followed by heterozygous 
mice. The wild-type mice are the heaviest.  With Tukey-Kramer adjustment for multiple 
comparisons, the difference between heterozygous and mutant mice was significant 
(adjusted p=0.01).  The difference between heterozygous and wild-type mice was not 
significant (p=0.25), the difference between mutant mice and wild-type mice was 
significant (p=0.001). The association between litter size and body weight was not 
significant (p=0.7). 
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Detail Results:  
 
i. Comparing body weight differences between genotypes  
 
1. Comparing body weight differences at 3 week in female mice. 
 
The differences in body weights among genotypes were statistically significant (type 3 
test of fixed effects p <0.0001), with the mutant mice being the lightest, followed by 
heterozygous mice. The wild-type mice are the heaviest.  All pairwise comparisons 
between genotypes were statistically significant at the 0.05 significance level after 
Tukey-Kramer adjustment for multiple comparisons. The inverse association between 
litter size and body weight was marginally significant (p=0.09). The residuals based on 
the raw weight scale are normally distributed. 
 
Solution for Fixed Effects 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Intercept   11.7283 0.9842 18 11.92 <.0001 
Genotype het -0.7192 0.2407 51 -2.99 0.0043 
Genotype null -1.5255 0.2952 51 -5.17 <.0001 
Genotype wt 0 . . . . 
litter_size   -0.2454 0.1429 51 -1.72 0.0919 
 
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Genotype 2 51 13.52 <.0001 
litter_size 1 51 2.95 0.0919 
 
Least Squares Means 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Genotype het 9.3519 0.2478 51 37.73 <.0001 
Genotype null 8.5456 0.3035 51 28.16 <.0001 
Genotype wt 10.0711 0.2646 51 38.07 <.0001 
 
 
Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
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Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
Genotyp
e 
het null 0.8063 0.2773 51 2.91 0.005
4 
Tukey-
Kramer 
0.014
6 
Genotyp
e 
het wt -0.7192 0.2407 51 -2.99 0.004
3 
Tukey-
Kramer 
0.011
8 
Genotyp
e 
null wt -1.5255 0.2952 51 -5.17 <.000
1 
Tukey-
Kramer 
<.000
1 
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2. Comparing body weight differences at 3 week in male mice. 
 
The differences among genotypes are statistically significant (type 3 test of fixed effects 
p =0.003).  Mutant mice had the significantly lighter weights than heterozygous and 
wild-type mice (adjusted p-values =0.04, and 0.003, respectively). The differences in 
body weights between heterozygous and wild-type mice were not statistically 
significant.  The inverse association between litter size and body weight was marginally 
significant (p=0.09).. 
 
 
Solution for Fixed Effects 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Intercept   12.1065 1.2671 20 9.55 <.0001 
Genotype het -0.4965 0.2966 55 -1.67 0.0997 
Genotype null -1.0715 0.3111 55 -3.44 0.0011 
Genotype wt 0 . . . . 
litter_size   -0.3069 0.1784 55 -1.72 0.0909 
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Genotype 2 55 6.61 0.0027 
litter_size 1 55 2.96 0.0909 
 
Least Squares Means 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Genotype het 9.4302 0.3032 55 31.10 <.0001 
Genotype null 8.8552 0.3294 55 26.89 <.0001 
Genotype wt 9.9268 0.3683 55 26.95 <.0001 
 
Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
Genotyp
e 
het null 0.5750 0.2274 55 2.53 0.014
4 
Tukey-
Kramer 
0.037
6 
Genotyp
e 
het wt -0.4965 0.2966 55 -1.67 0.099
7 
Tukey-
Kramer 
0.224
1 
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Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
Genotyp
e 
null wt -1.0715 0.3111 55 -3.44 0.001
1 
Tukey-
Kramer 
0.003
1 
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3. Comparing body weight differences at 6 week in female mice. 
 
 
The differences among genotypes are statistically significant (type 3 test of fixed effects 
p <0.0001), with the mutant mice being the lightest, followed by heterozygous mice. 
The wild-type mice are the heaviest.  With Tukey-Kramer adjustment for multiple 
comparisons, the difference between heterozygous and mutant mice was marginally 
significant (adjusted p=0.07).  The differences between heterozygous and wild-type 
mice and between mutant mice and wild-type mice were significant after Tukey-Kramer 
adjustment (adjusted p-value=0.01, and p<0.0001, respectively). The association 
between litter size and body weight was not significant (p=0.8). 
 
 
Solution for Fixed Effects 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Intercept   17.3571 0.9954 18 17.44 <.0001 
Genotype het -1.2724 0.4218 49 -3.02 0.0040 
Genotype null -2.3136 0.4887 49 -4.73 <.0001 
Genotype wt 0 . . . . 
litter_size   0.02883 0.1413 49 0.20 0.8392 
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Genotype 2 49 11.51 <.0001 
litter_size 1 49 0.04 0.8392 
 
Least Squares Means 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Genotype het 16.2755 0.3259 49 49.93 <.0001 
Genotype null 15.2343 0.4088 49 37.26 <.0001 
Genotype wt 17.5479 0.3593 49 48.83 <.0001 
 
Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
Genotyp het null 1.0412 0.4620 49 2.25 0.028 Tukey- 0.072
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Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
e 7 Kramer 2 
Genotyp
e 
het wt -1.2724 0.4218 49 -3.02 0.004
0 
Tukey-
Kramer 
0.011
1 
Genotyp
e 
null wt -2.3136 0.4887 49 -4.73 <.000
1 
Tukey-
Kramer 
<.000
1 
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4. Comparing body weight differences at 6 week in male mice. 
 
The differences among genotypes are statistically significant (type 3 test of fixed effects 
p <0.0001), with the mutant mice being the lightest, followed by heterozygous mice. 
The wild-type mice are the heaviest.  With Tukey-Kramer adjustment for multiple 
comparisons, the difference between heterozygous and mutant mice was significant 
(adjusted p=0.01).  The difference between heterozygous and wild-type mice was not 
significant (adjusted p=0.25), the difference between mutant mice and wild-type mice 
was significant (adjusted p=0.001). The association between litter size and body weight 
was not significant (p=0.7). 
 
 
Solution for Fixed Effects 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Intercept   20.0895 1.3848 21 14.51 <.0001 
Genotype het -0.9064 0.5576 54 -1.63 0.1099 
Genotype null -2.3147 0.6179 54 -3.75 0.0004 
Genotype wt 0 . . . . 
litter_size   0.07039 0.1934 54 0.36 0.7173 
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Genotype 2 54 7.97 0.0009 
litter_size 1 54 0.13 0.7173 
 
Least Squares Means 
Effect Genotype Estimate Standard Error DF t Value Pr > |t| 
Genotype het 19.6749 0.3972 54 49.53 <.0001 
Genotype null 18.2666 0.4904 54 37.25 <.0001 
Genotype wt 20.5813 0.5594 54 36.79 <.0001 
 
Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
Genotyp
e 
het null 1.4083 0.4605 54 3.06 0.003
5 
Tukey-
Kramer 
0.009
5 
Genotyp het wt -0.9064 0.5576 54 -1.63 0.109 Tukey- 0.243
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Differences of Least Squares Means 
Effect Genotyp
e 
_Genotyp
e 
Estimat
e 
Standar
d Error 
D
F 
t Valu
e 
Pr > 
|t| 
Adjustme
nt 
Adj P 
e 9 Kramer 8 
Genotyp
e 
null wt -2.3147 0.6179 54 -3.75 0.000
4 
Tukey-
Kramer 
0.001
3 
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ii. Summary statistics  
 
 
Table 1. Summary of mouse weights by gender, time point, litter size, and genotype. 
 
At 3 week: 
Gender litter_size Genotype mean std max median min 
f 3 null .  .  .  .  .  
f 3 wt  .  .  .  .  .  
f 4 het  10.5500 3.18198 12.8 10.55 8.3 
f 4 null 10.8000 .  10.8 10.80 10.8 
f 4 wt  10.9000 1.83848 12.2 10.90 9.6 
f 5 het  10.0000 0.42426 10.3 10.00 9.7 
f 5 null 8.9500 0.63640 9.4 8.95 8.5 
f 5 wt  11.1333 0.15275 11.3 11.10 11.0 
f 6 het  9.1941 1.05087 11.4 9.20 7.1 
f 6 null 8.7429 0.72078 9.8 9.00 7.8 
f 6 wt  10.1600 0.82037 11.1 10.20 8.9 
f 7 het  7.4500 2.19203 9.0 7.45 5.9 
f 7 wt  9.7000 1.27671 11.1 9.40 8.6 
f 8 het  10.0000 1.30894 11.3 10.50 7.5 
f 8 null 9.1500 1.67033 10.9 9.35 7.0 
f 8 wt  9.6857 1.06994 10.7 9.90 8.0 
f 9 het  8.7000 0.96437 9.4 9.10 7.6 
f 9 wt  10.4000 0.42426 10.7 10.40 10.1 
f 10 het  9.0000 .  9.0 9.00 9.0 
f 10 null 7.8000 .  7.8 7.80 7.8 
f 10 wt  8.7000 0.84853 9.3 8.70 8.1 
m 3 het  .  .  .  .  .  
m 3 wt  .  .  .  .  .  
m 4 het  10.7400 2.47952 13.4 10.70 7.8 
m 4 null 13.4000 .  13.4 13.40 13.4 
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Gender litter_size Genotype mean std max median min 
m 5 het  11.6000 .  11.6 11.60 11.6 
m 5 wt  9.9000 .  9.9 9.90 9.9 
m 6 het  9.2692 1.46024 11.2 9.50 5.4 
m 6 null 9.0375 1.29608 10.3 9.30 6.9 
m 6 wt  10.7667 0.23094 10.9 10.90 10.5 
m 7 het  9.3600 1.70822 11.7 9.70 7.2 
m 7 null 8.2667 0.65064 8.9 8.30 7.6 
m 7 wt  9.7000 .  9.7 9.70 9.7 
m 8 het  9.4231 0.66226 10.6 9.40 8.3 
m 8 null 9.1375 0.93799 10.3 8.95 7.6 
m 8 wt  10.5571 0.83238 11.7 10.80 9.0 
m 9 het  8.0333 1.41892 9.3 8.30 6.5 
m 9 null 6.1000 .  6.1 6.10 6.1 
m 10 het  8.7333 0.32146 9.1 8.60 8.5 
m 10 null 7.9000 .  7.9 7.90 7.9 
m 10 wt  9.0000 0.14142 9.1 9.00 8.9 
 
 
At 6 weeks: 
Gender litter_size Genotype mean std max median min 
f 3 null 15.5000 1.97990 16.9 15.50 14.1 
f 3 wt  19.7000 .  19.7 19.70 19.7 
f 4 het  15.8500 0.63640 16.3 15.85 15.4 
f 4 null 14.8000 .  14.8 14.80 14.8 
f 4 wt  16.1000 1.55563 17.2 16.10 15.0 
f 5 het  16.5000 1.41421 17.5 16.50 15.5 
f 5 null 15.4000 3.67696 18.0 15.40 12.8 
f 5 wt  18.9667 1.46401 20.3 19.20 17.4 
f 6 het  15.9533 1.64006 19.4 15.40 13.7 
f 6 null 15.0000 1.26227 16.9 14.70 13.2 
f 6 wt  17.2250 1.93800 19.8 16.90 15.3 
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Gender litter_size Genotype mean std max median min 
f 7 het  13.2000 .  13.2 13.20 13.2 
f 7 wt  18.1500 2.75772 20.1 18.15 16.2 
f 8 het  17.0857 1.20752 18.5 17.80 15.6 
f 8 null 15.7500 2.25758 19.1 14.85 14.2 
f 8 wt  16.6714 1.41270 18.9 16.20 14.9 
f 9 het  15.7667 1.40119 16.9 16.20 14.2 
f 9 wt  18.2500 0.77782 18.8 18.25 17.7 
f 10 het  18.4000 .  18.4 18.40 18.4 
f 10 null 15.6000 .  15.6 15.60 15.6 
f 10 wt  18.1500 0.35355 18.4 18.15 17.9 
m 3 het  18.6000 .  18.6 18.60 18.6 
m 3 wt  21.4500 0.35355 21.7 21.45 21.2 
m 4 het  19.8400 2.99299 24.0 18.70 17.1 
m 4 null 20.9000 .  20.9 20.90 20.9 
m 5 het  19.6000 .  19.6 19.60 19.6 
m 5 wt  20.9000 .  20.9 20.90 20.9 
m 6 het  19.0231 2.46751 22.9 18.80 15.3 
m 6 null 18.1333 2.47925 23.0 16.90 16.6 
m 6 wt  20.9500 0.63640 21.4 20.95 20.5 
m 7 het  20.6200 2.48737 23.7 21.20 17.7 
m 7 null 18.6333 2.17792 20.4 19.30 16.2 
m 7 wt  21.7000 .  21.7 21.70 21.7 
m 8 het  19.6769 1.77208 22.1 19.60 16.3 
m 8 null 18.5000 2.41306 23.0 18.10 15.8 
m 8 wt  20.8714 1.39847 23.1 20.80 18.5 
m 9 het  19.5000 1.73494 21.4 19.10 18.0 
m 9 null 15.2000 .  15.2 15.20 15.2 
m 10 het  21.3667 0.58595 21.8 21.60 20.7 
m 10 null 19.5000 .  19.5 19.50 19.5 
m 10 wt  22.0000 1.55563 23.1 22.00 20.9 
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Figure 1. Mouse weights at 3 week by genotype and gender averaged over litter size. 
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Figure 2. Mouse weights at 6 week by genotype and gender averaged over litter size.  
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Figure 3. Female mouse weights at 3 week by litter size with genotype (for trend in litter size). 
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Figure 4. Female mouse weights at 3 week by litter size and genotype 
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Figure 5. Female mouse weights at 6 week by litter size with genotype (for trend in litter size).  
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Figure 6. Female mouse weights at 6 week by litter size and genotype.  
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Figure 7. Male mouse weights at 3 week by litter size with genotype (for trend in litter size). 
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Figure 8. Male mouse weights at 3 week by litter size and genotype 
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Figure 9. Male mouse weights at 6 week by litter size with genotype (for trend in litter size).  
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Figure 10. Male mouse weights at 6 week by litter size and genotype.  
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